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ABSTRACT 
 The virion host shutoff protein (Vhs) is a herpes simplex virus (HSV) protein involved in 
early shutoff of the host cell. It is a component of the infecting virion, located in the tegument 
region, that works by rapidly degrading both viral and cellular messenger RNA (mRNA). in vivo 
and within infected cells, Vhs is selective for degrading messenger RNA  opposed to non-
messenger RNA. This dissertation sought to examine Vhs cleavage of an mRNA that utilizes the 
cap-dependent scanning mechanism for translation initiation and to see if cleavage was 
connected to early events of translation initiation.  mRNA encoding HSV-1 thymidine kinase 
(pBK2) was used for the majority of the experiments, and studies were designed to map the cut 
sites produced by Vhs in a rabbit reticulocyte lysate (RRL) system. Additional experiments 
investigated whether Vhs was selective for degrading certain types of mRNAs over others, 
particularly IRES-containing mRNAs.  
 Studies revealed that Vhs specifically cleaves pBK2 mRNA within the first 300 bases 
from the 5’ cap, and these cut sites are close to and slightly upstream from the first three AUG 
codons of the sequence. The proximity of the cutting to the AUG codons led to speculations that 
early events of translation initiation might be involved in Vhs degradation of mRNA. This was 
found to be true, where data revealed that blocking early stages such as (1) recruitment of 
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translation initiation factors to the 5’ cap and/or (2) ATP hydrolysis RNA helicase activity 
important for unwinding RNA secondary structure and the scanning process hinder Vhs 
cleavage. However, blocking later stages of translation initiation only had a modest effect on 
RNase activity. Results also found that a 5’ cap analog inhibits Vhs site-specific cleavage of 
mRNA at regions near the 5’ cap. Interestingly, a cap appears to be required for Vhs production 
of specific cleavage sites within the first 300 bases of the transcript.  
 Work went on to study whether there was a difference between Vhs cleavage of 
circularized RNA that normally experiences cap-dependent scanning and circularized RNA that 
initiates translation in a cap-independent manner. Results indicated that Vhs requires a free 5’ 
end for specific cleavage of mRNA that undergoes cap-dependent scanning. However, Vhs does 
not require a free 5’ end to specifically cleave a circular RNA that utilizes cap-independent 
methods for translation initiation. Mutational work, with pBK2 mutants which contained 
mutations in or surrounding the AUG codon, further supported a mechanism for Vhs cleavage 
that involved Vhs association with the scanning complex to reach some of its preferred cut sites. 
Mutating the first AUG to a non-AUG inhibited Vhs specific cleavage of pBK2 mRNA at a region 
just upstream from the AUG codon. Additionally, mutating bases surrounding the AUG codon 
to put it in an optimal context enhanced cleavage at regions near the start codon. Inserting a 
stable hairpin near the 5’ cap to block scanning also reduced Vhs cleavage at prominent sites 
within the first 300 bases of the transcript.  To conclude, this work provides several indications 
that Vhs associates with components of the translational apparatus to access at least some of its 
cut sites. 
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CHAPTER 1 
 
INTRODUCTION 
 Lytic infection with herpes simplex virus (HSV) causes a global reduction in protein 
synthesis and mRNA abundance in the cell. One of the key players in shutoff is the virion host 
shutoff protein (Vhs), a component of the infecting virion that is active immediately upon 
infection at degrading both viral and cellular mRNA. The mechanism for how Vhs recognizes 
mRNA opposed to non messenger RNA remains uncertain, however many lines of evidence 
suggest that Vhs may associate with cellular factors when targeting mRNA. These proposed 
factors are involved in early stages of protein synthesis.  
 Prior to this dissertation, no connections had been made between translation initiation 
and Vhs degradation of mRNA. Specifically, no previous studies investigated the importance of 
cap-dependent scanning and recruitment of translation initiation factors to the 5’ cap for Vhs 
activity. Additionally, the two defining features of mRNA, a 5’ cap and a poly(A) tail, had never 
been shown to be vital for Vhs site-specific cleavage. Many studies were focused on determining 
the sequences that were preferable for Vhs cutting, but they lacked an explanation about how 
Vhs cleavage might be affected by mRNA secondary structure. 
 This dissertation investigates the importance of early events of translation initiation on 
Vhs function. mRNA was analyzed in an in vitro Vhs degradation system where specific cut sites 
were mapped and then further studied in the presence of several translation inhibitors. mRNA 
was analyzed using many different methods for radiolabeling. The results from these 
experiments indicate that early stages of translation initiation are required for Vhs site-specific 
cleavage. The assay was then studied to test whether mutating the AUG codon or bases 
surrounding the codon affected Vhs cleavage in an attempt to determine whether Vhs utilized 
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the scanning complex to achieve cutting. RNA was further manipulated to block the cap-
dependent scanning process through circularization experiments and studies with hairpin 
inserts to further tie together the role of early translation events in Vhs cleavage.  
 
Herpesviridae 
 The three subfamilies of the family Herpesviridae are alphaherpesvirinae, 
betaherpesvirinae, and gammaherpesvirinae. The members of this group are characterized 
within Herpesviridae because they have a similar genome and commonalities in their virion 
structure (83). They infect a plethora of vertebrate hosts and perform DNA replication and 
capsid assembly in the nucleus. Productive infection with members of the family Herpesviridae 
leads to destruction of the host cell (83). They are known for synthesizing a wide variety of 
proteins important for DNA synthesis, nucleic acid metabolism, and protein processing (83). 
These viruses have the ability to establish latency and maintain regulation of their genome in the 
nucleus under the expression of few viral genes (83). Only eight herpesviruses have the ability to 
regularly infect humans. They are herpes simplex virus 1 (HSV-1), herpes simplex virus 2 (HSV-
2), human cytomegalovirus (HCMV), varicella-zoster virus (VZV), Epstein-Barr virus (EBV), 
human herpes virus 6A/B (HHV6A, HHV6B), human herpesvirus 7 (HHV7), and human herpes 
virus 8 (Kaposi’s sarcoma-associated herpesvirus (KSHV)) (83).   
 There are many general differences between the three viral subfamilies. 
Alphaherpesviruses have a short reproductive cycle of around 18 hrs. and establish infection in 
neuronal cells (83). They have a wide host range and destroy the productively infected cell (83). 
Examples of alphaherpesviruses are HSV-1, HSV-2, and VZV. HSV-1 causes labial, ocular, and 
facial lesions and HSV-2 infection causes genital lesions. VZV leads to chicken pox, and 
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reactivation of virus results in shingles. Betaherpesviruses have a limited host range and a much 
longer reproductive cycle (83). They are lymphotropic and characterized by causing enlargement 
of the infected cell (83). HCMV belongs to this class, and it is an important infectious cause of 
birth defects. Gammaherpesviruses are also lymphotropic, but their latency is restricted to T and 
B lymphocytes (83). Members of this family include the EBV and KSHV. EBV and KSHV are 
cofactors to human cancers. 
The herpes simplex virus infects 40-80% of the population (83). HSV-1 infection is 
performed in 80% of Americans by the age of 50 (109). Although most genital infections (HSV-1 
or HSV-2) are mild and leave the patient unharmed, infection can be severely detrimental to 
individuals in developing countries who are later infected with the human immunodeficiency 
virus (HIV). Infection with both viruses causes a 2-4 fold rise in the transmission of HIV (82). 
HSV is generally a mild virus, however infection of newborns or immunocompromised 
individuals can lead to serious problems such as encephalitis or hepatitis.  
 
HSV Virion 
 Herpes simplex virus is the prototypical member of the neurotropic alphaherpesviruses. 
The HSV virion is composed of 4 main components; the core, icosadeltahedral capsid, tegument, 
and viral envelope (83). The core contains the viral linear, double stranded DNA genome which 
consists of around 152,000 bases, and it is surrounded by the icosadelthedral capsid (Fig. 1) (83). 
The capsid contains 162 capsomeres and is predicted to be 100-110 nm in diameter (83). The 
tegument is a flexible region located between the viral capsid and outer envelope which contains 
around 20 proteins that are components of the infecting viral particle (83). The outer envelope 
contains several glycoproteins important for viral attachment to cell surface receptors, and they  
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Figure 1.HSV Virion Components 
The four main components of the HSV virion are listed in Figure 1. The core contains the 
double stranded DNA genome. The capsid is an icosadeltahedral structure which 
surrounds the core. The tegument is an amorphous region between the capsid and the 
viral envelope which contains several proteins that are packaged into the virus during 
assembly. The outer envelope contains glycoproteins which project out of the virion and 
make contacts with the host that are important for viral entry. 
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are also vital for fusion with the host plasma membrane (83). There are 33 known proteins  
within the virion structure (Table 1, derived from ref. 95). The outer envelope contains 16 
membrane proteins, and 12 of them are glycoproteins (96). 22 proteins are located in the 
tegument and six are present on the capsid surface (96). HSV stands out from most nuclear-
replicating DNA viruses because it brings regulatory proteins into the cell and does not have to 
wait for gene expression.  
 
HSV Entry 
HSV has been demonstrated to enter the cell through two different mechanisms. In the 
primary pathway, HSV enters by binding the cell membrane and fusing its viral envelope with 
the plasma membrane (84). An alternative mechanism for entry involves endocytosis of the 
virion followed by fusion of the viral envelope with endocytic vesicular membranes (105, 109). 
Since this pathway has only recently been brought to attention, it is still unknown how 
important it is in a natural infection. Therefore, background information will focus on the 
prominent pathway. Several lines of evidence indicate that attachment of the viral envelope to 
the cellular membrane is first achieved by virion binding to cell surface proteoglycan 
glycosaminoglycan (GAG) chains (97, 107, 108). Heparan sulfate is the prevalent GAG receptor 
used for binding, but it is not a receptor utilized for entry. Glycoprotein B (gB) and/or 
glycoprotein C (gC) binding to heparan sulfate greatly enhances infectivity, however binding is 
not required for productive infection (97, 99,100). Filopodia protrusions contain heparan sulfate 
proteoglycan (HSPG)-rich sites and may be involved in assisting this binding (98). Glycoprotein 
H (gH), L (gL), B (gB), D (gD), and C (gC) are all involved in the entry process, but gC is the only 
nonessential protein (97, 102). However, absence of gC can have as much as a 10 fold reduction 
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in viral infectivity, but results vary depending on the serotype of HSV studied (101). 
 Upon virion binding, gD associates with various receptors on the cell surface to trigger 
fusion with the host cell in a process that is mediated by gB and the heterodimer gH/gL 
(reviewed in 103, 104). gD itself is not a fusogen, however gB and gH display properties 
common to many fusion proteins and are speculated to be important for this function (102, 106). 
HSV associates with 3 types of cellular receptors for viral entry. These include the herpes virus 
entry mediator (HVEM), which belongs to the tumor necrosis factor (TNF) receptor family; 
components of the immunoglobulin superfamily, nectin 1 and 2; and 3-0-sulfotransferase sites 
within heparan sulfate (104). HVEM and nectin-1 appear to be the prominent receptors for entry 
(104). Following fusion, the nucleocapsid and tegument components enter the cytoplasm (87, 
88). All herpesviruses have structural conservation in gB, gH, and gL; but structural 
conservation in gD and gC is only maintained in alphaherpesviruses.  
 
Capsid Translocation to the Nucleus 
 After fusion, viral capsid and tegument proteins enter the cytoplasm. Tegument proteins 
have one of three fates; they remain in a complex with the capsid, stay in the cytoplasm, or travel 
to the nucleus (109).  The capsid, along with associating tegument proteins, is transported to the 
nuclear perimeter and DNA is inserted through nuclear pores in a process that is heavily 
dependent on UL36 VP1-2 (110, 111). DNA replication, viral transcription, and capsid assembly 
all occur in the nucleus (109). The virus utilizes host RNA polymerase II for RNA synthesis, 
however the process is regulated by several viral proteins (109).  
 Once viral DNA enters the nucleus it quickly circularizes, and several nuclear 
remodeling events occur. Replication takes place near cellular nuclear domain 10 (ND-10) 
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structures (112, 113). It is unclear whether the DNA travels to ND-10 sites or if ND-10 structures 
target viral DNA. It is also unknown if association of viral DNA with ND-10 bodies requires 
expression of viral proteins and whether transcription occurs at these sites (109). Infectious cell 
protein 0 (ICP0) has been shown to breakdown ND-10 structures (109,118). During DNA 
synthesis, replication compartments expand and overwhelm the nucleus which causes cellular 
chromatin condensation at the nuclear border (109, 114, 115, 116, 117). This condensation may 
play a role in inhibiting cellular transcription. Eventually, the chromatin disperses which 
improves viral egress.  
 
Gene Expression 
Transcription of the HSV genome occurs in the nucleus, and protein synthesis takes 
place in the cytoplasm. All viral DNA is transcribed by cellular RNA pol II, yet viral proteins can 
regulate RNA pol II activity and configuration (119, 120). Transcription undergoes a temporal 
regulation of gene expression, featuring three different classes of viral genes. HSV α (immediate 
early) genes are expressed 2-4 hours post infection when cells are infected with a multiplicity of 
infection (MOI) of 10-20 plaque forming units per cell (PFU) (83). Alpha gene expression is 
stimulated by VP16, however, no de novo protein synthesis is required for immediate early gene 
expression. Viral α promoters have been shown to contain key sequences for cellular 
transcriptonal factor binding (135, 136). Six immediate early proteins are produced from alpha 
gene expression, and five of them are involved in regulating β (early) gene expression. β genes 
are expressed 4-8 hours postinfection and require functional immediate early protein ICP4 (83). 
Early proteins regulate DNA replication and expression of late (γ) genes. β proteins are also 
involved in turning down α gene expression. Once DNA replication begins, γ genes are 
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increasingly expressed which encode structural proteins (121). Products of late gene expression 
will turn off α and β gene expression. During lytic infection over 80 viral proteins are 
synthesized.  
 
RNA Export 
 In the cellular system, mRNA export and splicing are tied together in a sequential  
process. It appears that HSV infection stimulates a new mRNA export system since splicing is 
inhibited. The immediate early protein ICP27, the product of the α27 gene, has the ability to 
travel to and from the nucleus, and several lines of evidence indicate that it promotes RNA 
export (137-142).  
 
HSV Latency and Reactivation 
 When skin or mucous membrane is infected with virus, most of the virus will first take 
part in replicating DNA at the site of infection before traveling to the dorsal root ganglion 
sensory neurons (83, 85, 86). The virus then travels to the cell body by retrograde transport along 
axons and latency is established (83, 85, 86). Upon reactivation, the virus will travel in the 
opposite direction toward the axon perimeter to cause lytic infection or unnoticeable shedding at 
the site of original infection (83). Dynein and kinesin host molecular motors are believed to be 
involved in HSV neuronal transport (90, 91, 92, 93, 94).  
 
Key Factors for Host Invasion 
 HSV has mastered the ability of settling into a host to cause destruction of the infected 
cell. Yet, it cleverly works to maintain forever establishment in the body by recruiting progeny 
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virus to sensory neurons to establish latency. The virus achieves this by using several key 
strategies. The earliest strategy is how the virus quickly shuts off protein synthesis and delivers 
its DNA to the nucleus for immediate transcription and replication (109). A second strategy 
involves inhibition of the host’s advances at removing virus by interfering with mRNA splicing 
and apoptosis (109). A third strategy is the virus’s ability to keep its genome safe from 
destruction in the central nervous system during latency and then carefully direct virus to the 
sites of initial infection during reactivation (109).   
One key protein involved in shutting down cellular protein synthesis is the UL41 virion 
host shutoff protein (Vhs). Vhs is located in the virion tegument, so it’s immediately active at 
downregulating cellular protein synthesis, degrading mRNA, and destroying pre-existing 
polyribosomes upon viral fusion with the host cell (reviewed in 1).  
A second important viral protein is the VP16 tegument protein. VP16 is involved in 
rapid gene expression once viral DNA enters the nucleus, because it directs cellular RNA pol II 
to viral genes (109). VP16 has been found to assist in the binding of chromatin-modifying 
proteins to α gene promoters, and it also decreases levels of histone H3 to promote active 
chromatin formation (133, 134). The immediate early protein, ICP27, is believed to inhibit 
splicing by interacting with SRPK1 to regulate SR protein phosphorylation levels. However, 
ICP27 still permits viral unspliced mRNA export into the cytoplasm (143, 144, 145). Hindering 
mRNA splicing leads to reduction of cellular mRNA, but most viral mRNA is unaffected 
because few transcripts are spliced (109). 
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Vhs Characteristics 
 The defining characteristics attributed to virion host shutoff activity are the rapid  
inhibition of cellular protein synthesis, degradation of mRNA, and disruption of pre-existing 
polyribosomes (54, 122, 131, 132, 146). Inhibition of cellular protein synthesis, degradation of 
mRNA, and polyribosome disassembly are still achieved when cells are infected with UV-light 
irradiated virus or in the presence of Actinomycin D (a drug that blocks transcription), 
indicating that the shutoff function is caused by a component of the infecting virion (123, 124-
132). The viral function causes degradation of both viral and cellular RNAs (14). Studies testing 
mutants deficient in protein shutoff and mRNA degradation mapped shutoff activity to the HSV 
open reading frame (ORF) UL41 which encodes the 58-kDa phosphoprotein Vhs (129, 130, 147, 
148).  Interestingly, Vhs mutants cause an increase in viral mRNA half lives, indicating that the 
virion host shutoff function is important for temporal regulation of HSV gene expression (14, 
129). Vhs has been shown to be a nonessential protein for viral propagation in cell culture, 
however Vhs mutants are significantly reduced in viral growth (129, 151). Importantly, several 
lines of evidence in mice indicate that Vhs is critical for pathogenesis (152-157).  
 Work testing solubilized virions has shown that, in the absence of cellular factors, Vhs is 
not restricted to mRNAs and will cleave target RNAs at many locations (4). However; in vivo, in 
cytoplasmic extracts, and in the RRL system Vhs preferentially cleaves mRNA, as opposed to 
non-messenger RNA (4, 9, 52, 53, 55). For some of these mRNAs, cleavage is preferred near 
regions at the 5’ cap (5, 8). Northern blot analysis of viral thymidine kinase mRNA revealed that 
the 5’ end was degraded before the 3’ end in vivo (8). in vitro work in a rabbit reticulocyte lysate 
(RRL) system found that Vhs degraded SRP  (the signal recognition particle receptor alpha) 
mRNA at specific sites within the 5’ quadrant of the mRNA from bases 200-700 (5).  
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However, Vhs has been reported to not cleave all mRNAs at the 5’ end (4). According to 
Zelus et al., Vhs cleaves globin γ mRNA at regions near the 3’ UTR, and in these studies Vhs 
appeared to cleave preferentially at AC and CU dinucleotides (4). It has been suggested that Vhs 
cleavage near regions at the 5’ cap is dependent on the type of mRNA studied (45-47). While it 
was previously believed that all mRNAs had similar sensitivities to Vhs cleavage, more recent 
reports have suggested that Vhs degrades certain mRNAs with different efficiencies (9, 14, 45-47, 
49, 50, 52-54). Roizman has shown that certain mRNAs such as IEX-1, COX-2, IkB, and c-Fos 
(which contain an AU-rich element (ARE) in their 3’ UTR and have very short half lives) appear 
to be regulated differently upon infection (45-47). During infection, these mRNAs are 
deadenylated and then cleaved just upstream of the AREs, leaving a stable 5’ product that 
remains in the cell for an extended time prior to degradation (45-47). Since the ARE is located in 
the 3’ UTR, these data support a model where Vhs is targeted to the 3’ end of the transcript. Vhs 
has been suggested to target the 3’ UTR of mRNAs containing AREs by binding the protein 
tristetraprolin (TPP) (45, 50). This has been built around the findings that TPP protein levels are 
increased after infection with HSV-1, and TPP has been found to associate with Vhs in 
coimmunoprecipitation assays (45, 50). Tristetraprolin is a protein that has an important role in 
the degradation of some AU-rich mRNAs by facilitating their recruitment to the exosome (51, 56, 
57).  
At present, whether or not Vhs cleaves cellular stress-inducible IEX-1 mRNA at its 3’ 
UTR is controversial. Initial studies on HSV-1 regulation of ARE mRNAs suggested that these 
mRNAs were spared from cutting due to ICP27 binding at the ARE (58). Additional studies have 
implicated that the increase in intermediate IEX-1 mRNA products is not due to Vhs cleavage 
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but is instead due to HSV-1 infection having an inhibitory effect on the normal turnover of ARE 
mRNAs (5).   
 
Vhs Sequence Preference 
A purified GST-Vhs fusion protein has been shown to have substrate specificity similar 
to RNase A, where it prefers cleaving mRNA after C and U bases (10,11).  However, Zelus et al. 
have reported a preference for cleavage between AC and CU dinucleotides, and work by Smiley 
has indicated that Vhs has a slight preference for cleaving between purines but an overall lax 
sequence specificity (4, 5). Additional studies by Smiley showed that secondary cleavage of the 
3’ cleavage product that results from cutting of an EMCV IRES proceeds in a 5’ to 3’ direction 
(48). The endoribonucleolytic activity was concluded to be sequence nonspecific with a slight 
preference for cleaving between purines (5).  
 
Vhs Effect on Immune Response 
 Although Vhs is not essential for viral growth in cell culture, it appears to play a vital 
role in virulence, replication, and pathogenesis in vivo (152-157). In continuous cell lines, Vhs 
null viruses display similar growth kinetics to wild type and feature single and multi-step 
curves. Yet in primary cells, the growth pattern switches to a novel multi-step curve. Vhs has an 
effect on innate and adaptive immune response (238). Cell culture studies have shown that Vhs 
is important for decreasing interferon recognition, hindering dendritic cell response, and turning 
down regulation by major histocompatibility factor I (MHCI) (235, 236, 237). It is believed to 
have a more prominent role in interfering with the innate immune response, because Vhs null 
virus is significantly hindered in its ability to replicate in the mouse cornea and vaginal 
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epithelium just 24 hours postinfection (239, 156). HSV-2 Vhs has been shown to hinder the 
interferon (IFN)-mediated cellular response to virus (240). Animal models using Vhs null viruses 
as live attenuated vaccines have been successful in preventing or ameliorating HSV infection 
(241-244). 
 
Vhs Association with Viral Factors 
 Current data indicate that Vhs exists in three different states throughout the viral 
lifecycle. In the first state, Vhs exists as a component of the virion that is located in the tegument 
region. The mRNA in the tegument region is either inaccessible, or Vhs is inactive in this state 
because it does not lead to mRNA decay in the complex (227). Upon infection, Vhs enters the 
cytoplasm and exists in its second state where it is active at degrading mRNA and in additional 
shutoff functions. Several hours after infection, at the commencement of late protein synthesis, 
Vhs exists in its third state where it no longer shows RNase activity. Vhs association with VP16 
leads to inhibition of de novo synthesized Vhs in a process that is believed to require further 
association with VP22 (228, 229, 230, 231). Vhs can interact with VP16 and VP22, however, it is 
unable to associate with VP22 in the absence of VP16 (231). VP22 is a tegument protein that is 
able to travel from infected to uninfected cells (232, 233). in vitro studies have revealed that it can 
bind mRNA, and it has been speculated to be important for transporting mRNA into virions 
during virus assembly (234).  
 
Vhs Homologues 
 HSV-1 and HSV-2 both encode Vhs, and the sequence is 87% identical (249). Additional 
alphaherpesviruses which contain a UL41 homolog include the varicella-zoster virus, bovine 
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herpesvirus, gallid herpesvirus, equine herpesvirus, and pseudorabies virus (245, 246, 247, 248). 
All viral UL41 open reading frames (ORFs) have sequence homology in their amino, internal, 
and C-terminal domains (246, 31, 250). There are around 100 conserved amino acids in the N and 
C terminus, and mutations that lead to a loss of Vhs activity are often mapped to one of the three 
regions of homology (13, 31, 32, 250, 72).  
Vhs also shows sequence homology to a family of nucleases important in DNA synthesis 
and repair (13, 31, 149). This family contains members from bacteria, yeast, mammals, and phage 
(13). These members have sequence homology in their amino and internal domains (251, 252, 
253, 150). Vhs shares this sequence homology, but it varies in the length of amino acids that 
separate the conserved domains (13). However, the C-terminal domain of Vhs has no sequence 
homology to the nonviral nucleases (13).  
There are 8 conserved amino acids in all cellular and viral members. They include 3 
charged residues in the amino terminal domain, 3 charged residues in the internal region, and 1 
uncharged residue in the internal domain (13). Key members of the nuclease family include the 
flap 1 endonucleases (FEN-1), XPG proteins, DNA polymerases, and the RAD2 nucleases 
involved in DNA repair (13). FEN-1 nucleases have also been shown to cleave RNA by working 
during DNA synthesis to remove Okazaki fragment RNA primers (150). Crystal structures have 
been obtained for some of the nonviral nucleases, and further analysis has found that the active 
site contains many residues that were previously found to be vital for nuclease activity. At least 
two divalent metal ions bind each active site, and the conserved residues are vital for this 
binding (251, 13). These conserved residues were altered in HSV-1 Vhs, and every mutant 
strongly reduced or eliminated Vhs cleavage of mRNA (13). 
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Vhs Association with Translation Initiation Factors 
 The mechanism for how Vhs targets mRNA, as opposed to non-messenger RNA, 
remained a mystery until yeast-2-hybrid studies revealed that Vhs could associate with 
eukaryotic translation initiation factor eIF4H (6). This finding was also confirmed through GST 
pull-down and coimmunoprecipitation studies. Additionally, mutations in Vhs that abrogated 
association with eIF4H led to Vhs loss of function (6, 13). Vhs was later found to associate with 
eIF4A in GST pull-down and coimmunoprecipitations and eIF4B through Far Western analysis 
(7,27). Vhs was recently shown to associate with the eIF4F cap binding through experiments 
using 7-methyl cellulose beads to pull out eIF4E from infected cells (59). Furthermore, siRNA-
mediated knockdown against eIF4H, eIF4B, or eIF4AI/II has indicated that eIF4H and eIF4AI/II 
are essential for Vhs degradation of GAPDH mRNA while eIF4B is not required (28, Agarwal et 
al. unpublished).    
 
Cap-mediated Translation Initiation 
 Cap-dependent scanning is the canonical mode for protein synthesis in eukaryotes. 
Currently, nine initiation factors have been determined to be required for this process. The 
ribosomal subunits involved in translation are constantly recycled and further recruited to 
mRNA transcripts for additional rounds of scanning and polypeptide production. The first step 
involves assembly of the 43S pre-initiation complex. During the recycling process, eukaryotic 
translation initiation factors eIF3, eIF1, and eIF1A associate with the 40S small ribosomal subunit 
(Fig. 2). Another complex, known as the ternary complex, is also assembled. The ternary 
complex is composed of eIF2-GTP-Met-tRNAMeti, and it is recruited to the 40S subunit that has 
pre-bound eIF3, eIF1, and eIF1A to form the 43S pre-initiation complex (reviewed in reference 
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  Figure 2.Cap-mediated Translation Initiation 
Figure 2 shows a summary of the key events involved in cap-dependent translation initiation. 
Beginning at the top right, the ribosomal subunits are recruited from post translation 
complexes (pTCs) for additional rounds of translation. The small ribosomal subunit associates 
with various initiation factors to form the 43S complex. This complex is then recruited to the 
5’ cap to bind the eIF4F cap-binding complex. The complex scans to the start codon, and the 
Met-tRNAMeti anticodon binds the AUG codon. The large ribosomal subunit is then recruited 
and polypeptide synthesis begins. Figure derived from reference 73. 
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73). The high degree of secondary structure in a natural 5’ UTR hinders direct binding of the 43S 
complex to mRNA (64, 73). Yet, the eIF4F cap-binding complex, along with eIF4H and/or eIF4B, 
works in a cooperative manner to facilitate binding of 43S to the 5’ end (161-164, 168, 73).  
The eIF4F cap-binding complex consists of three proteins; eIF4E, eIF4G, and eIF4A. eIF4E 
is the cap binding protein that ties eIF4F to the 5’ end (165). eIF4G serves as a scaffolding protein 
whose binding to several initiation factors is vital for assembly of the 48S complex at the 5’ end 
(73). A region of eIF4G wraps around the amino terminal region of eIF4E which enhances 
binding of eIF4E at the 5’ cap (166, 167). eIF4G also binds eIF3 of the 43S complex and the poly(A 
)-binding protein (PABP). eIF4A has intrinsic RNA helicase/ATPase activity, due to its DEAD-
box motif, which facilitates unwinding of the 5’ UTR secondary structure (159, 160, reviewed in 
ref. 73). eIF4A alone has low helicase activity, however it is greatly enhanced by eIF4G and 
eIF4B/H (168). Unwinding creates a favorable environment for binding of (1) the 43S complex to 
the 5’ end and (2) scanning (73).  
 Although a substantial amount of data have revealed how many initiation factors are 
configured at the 5’ cap, much remains unknown about how mRNA is transported through the 
mRNA binding channel of the 40S ribosomal subunit. Once the 43S complex is assembled at the 
5’ cap, the complex travels along the mRNA transcript in a downstream direction until it reaches 
the AUG start codon. eIF1 and eIF1A are crucial for scanning, and are believed to facilitate an 
optimal complex conformation for movement (64, 65). ATP, eIF4A, and eIF4G are also required 
for scanning, even when the 5’ UTR contains a low degree of secondary structure (64).  
Currently, varying opinions exist about whether eIF4G, 4A, and 4H are located behind 
or in front of the 40S ribosomal subunit (reviewed in 73). Modeling by cryoelectron microscopy 
predicts that eIF4G is positioned behind the ribosome so that the ribosome unwinds mRNA 
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secondary structure and eIF4G, eIF4A, and eIF4B/H serve to ‘ratchet’ mRNA through the 
binding channel using their helicase activity (74). However, an alternative model proposes that 
eIF4G, 4A, and 4H are positioned in front of the 40S ribosomal subunit and are involved in 
unwinding mRNA secondary structure before it enters the mRNA binding channel (75). Even 
though much data have been obtained to understand how the 43S complex is assembled at the 5’ 
end, it is still unclear how the complex is oriented after leaving the 5’ end during the initial 
events of scanning. Futhermore, it remains uncertain what conformational changes take place 
during the processive scanning process.  
The complex scans along the transcript until it reaches the start codon. This is usually the 
first AUG codon of the mRNA sequence with optimal bases of a -3 purine and a +4 guanine 
surrounding the codon, with the first A in the AUG sequence located at +1 (170). eIF1 has a vital 
function in recognition of AUG vs. non-AUG sequences, and it is also important in finding 
AUGs that are in an optimal context and are not located too close to the 5’ end (64, 171, 172). 
Once the complex locates an optimal AUG codon, ribosomal conformational changes occur that 
are mediated by eIF1 (171, 172). This allows binding of the Met-tRNAMeti anticodon to the AUG 
codon and leads to tighter binding of eIF4AI to 40S. eIF1 is then displaced from the 40S P site 
and the complex transitions to a ‘locked’ conformation around the mRNA (65, 173, 174).  At this 
step the 48S complex is formed. Displacement of eIF1 permits eIF5 GTP hydrolysis of eIF2-GTP-
Met-tRNAMeti (173, 175). eIF1A is required for proper ribosomal subunit joining by taking part in 
an event involving interaction of its C-terminal domain with eIF5B (176, 177). This interaction 
recruits the large 60S ribosomal subunit to 40S and permits eIF5B-stimulated hydrolysis of GTP 
(176,177). eIF1A is most likely displaced with eIF5B after subunit joining (178, 179). eIF3, and 
eIF2-GDP are displaced at some time in this process, but it remains uncertain whether it occurs 
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before, during, or after ribosomal subunit binding. Polypeptide synthesis then commences upon 
40S and 60S subunit joining to form the 80S ribosomal complex. 
 
Cap-independent Translation Initiation 
 Some mRNAs use cap-independent mechanisms for ribosomal recruitment during 
translation initiation. One method involves binding of the 40S subunit to an internal ribosome 
entry site (IRES) at or near the AUG start codon. IRESs have been identified in cellular and viral 
mRNA transcripts, but they have been best characterized in viral transcripts. Studies were first 
performed in poliovirus to understand how a virus that used protease 2A to cleave eIF4G and 
shut down cellular translation was still able to synthesize viral protein. A viral IRES was 
identified which recruited the ribosomal subunit to an internal site in a process that was not 
dependent on containing a cap.  
Viral IRESs contain a large amount of secondary structure and are located at regions 
within the 5’ UTR. Currently, there are four classifications of viral IRES; Type 1, Type 2, Type 3, 
and Type 4 (Fig. 3) (reviewed in Ref. 73). In Type 1 and 2 IRESs, eIF4G and eIF4A bind the IRES 
structure through interaction of eIF4G’s p50 domain with the IRES which is enhanced by eIF4A 
(Fig. 3) (70, 23, 180). The 43S complex then associates with this region, however, cap-binding 
protein eIF4E is not recruited. The poliovirus is a member of Type 1 IRESs and 
encephalomyocarditis virus (EMCV) contains a Type 2 IRES. The eIF4F cap-binding complex, 
eIF4B, eIF1A, and eIF1 are not involved in translation initiation on Type 3 IRESs (Fig. 3). Instead, 
the 43S complex binds directly to the AUG codon through IRES interactions with eIF3 and the 
small 40S ribosomal subunit (74, 181). Hepatitis C virus contains a Type 3 IRES. Translation   
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Figure 3. Viral Internal Ribosome Entry Sites 
Figure 3 shows the four classifications of viral IRESs. Type 1 and 2 IRESs do not require cap-binding 
protein eIF4E, but they still require the remaining canonical translation initiation factors. Type 3 
IRESs do not require any proteins of the eIF4F complex, but they still recruit the 40S ribosomal 
subunit through association with eIF3 and additional translation initiation factors. The Type 4 IRES 
does not utilize any of the common translation initiation factors or tRNAi
Met for recruitment of the 
40S ribosomal subunit, and it instead has an IRES structure that forms a pseudo-tRNA-like 
structure.  Figure derived from reference 73. 
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initiation of Type 4 IRESs is rather intriguing because it does not require any of the canonical 
translation initiation factors nor Met-tRNAMeti. Instead, the mRNA transcript forms a pseudo-
tRNA structure, and the small ribosomal subunit is directly recruited to bind the IRES in its P-
site (71, 182). The cricket paralysis virus (CrPV) contains a Type 4 IRES.  
 
RNA Regulation 
RNA is important for several biological processes. As mentioned previously, it carries 
the code for protein synthesis, and it recruits initiation factors and the 40S and 60S ribosomal 
subunits to the start codon. However, it plays a role in many functions besides translation. It has 
been shown to form supramolecular complexes, catalyze biochemical reactions, and regulate 
gene expression (183, 184, 185). Bacterial riboswitches have been found to be important in 
controlling nucleic acid, vitamin, and purine metabolism (186). Bacterial expression can be 
regulated by small noncoding RNAs (185). RNA is involved in regulating gene expression in 
eukaryotes by siRNA and micro RNA silencing of chromosomes and binding to mRNA 
sequences to cause degradation or inhibition of protein synthesis (187).  
RNA also plays a role in regulating protein synthesis. One example is RNA regulation of 
ferritin mRNA. Ferritin mRNA contains iron regulatory elements at the 5’ and 3’ ends which 
recruit proteins involved in regulating iron metabolism (190-193). The bovine growth hormone 
receptor has many 5’ UTR splice variants that have been shown to have varying degrees of 
translation (194).   
Another form of RNA regulation is when structural barriers in the mRNA secondary 
structure prevent or enhance scanning of the 43S complex to the AUG start codon (188, 183, 189). 
mRNAs with highly structured 5’ UTRs often code for regulatory proteins such as ligand 
 
 
23 
 
receptors, DNA binding proteins, transcription factors, and growth factors (35,197). Studies that 
analyzed mRNA 5’ UTR structure were first performed by Kozak, and they showed that 
secondary structure near the 5’ end inhibited protein synthesis (170). Through in vitro work she 
determined that a -30kcal/mol hairpin inhibits translation when it is positioned within 12 bases 
of the 5’ cap (34). However, this same type of hairpin does not have an inhibitory effect when it 
is positioned 52 bases downstream of the cap (34). In her early studies using Cos7 cells, she 
found that a -30 kcal/mol hairpin did not inhibit translation, but a -50kcal/mol hairpin inhibited 
translation 85-95% (195). Recent studies by Tsien using advanced algorithms for determining 
hairpin thermodynamic stability have concluded that, in Cos7 cells, translation efficiency 
sharply decreases as the hairpin increases in stability from -25 to -35 kcal/mol (35). This lab also 
showed that a hairpin within the first 4 bases from the 5’ cap inhibits translation, but a hairpin at 
a +7 or +13 position stimulates translation in live cells (35). Studies in live cells showed that no 
hairpin was able to completely block translation. It was proposed that, during this type of severe 
inhibition, the complex might skip over the hairpin or the skipping event may occur by 
ribosomal shunting (35). 
 Additional work in yeast and Cos7 cells has revealed that hairpins with a higher GC 
content cause greater inhibition of translation, independent of their intrinsic stability (35, 196). It 
was hypothesized that structures with relatively weak thermodynamic stability still hinder 
translation if they contain high GC content. This idea was based on a model for scanning 
complex unwinding of mRNA secondary structure that involved the complex scanning in a 
progressive manner to locally unzip each base pair (35). Under this model it was predicted that if 
mRNA contains a high enough GC content in one area, then it might exceed the amount of 
energy available to the scanning complex for unwinding.    
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mRNA Turnover 
 mRNA turnover is one of the key factors that controls gene expression in the cell. The 
half lives of mRNAs can differ substantially. Some mRNAs have longer decay rates and remain 
in the cell for several cycles, while others have rates that are 100-fold shorter than a single 
generation cycle (198). Environmental cues can also control mRNA degradation rates and 
quickly convert previously unstable transcripts to stable constructs. 7-methylguanosine cap 
addition to the 5’ end and polyA tail incorporation into the 3’ end are two key RNA 
modifications. These modifications ensure transcript stability, enable proficient processing and 
export from the nucleus, and aid in protein synthesis (199). Alterations in normal mRNA 
turnover have been suggested to cause a variety of problems such as cancer, coronary disease, 
and chronic inflammatory issues (200). mRNA degradation is also vital during nonsense 
mediated decay for turnover of mRNAs encoded by mutant alleles. An important regulatory 
step in mammalian gene expression is the control of cytoplasmic mRNA half lives. Since Vhs 
regulates the rate of mRNA turnover, it plays a key role in the overall scheme of gene regulation 
in infected cells.  
 The primary mode of mRNA turnover begins with removal of the 3’ poly(A) tail. The 
majority of studies have been performed with yeast. In this model, the polyA tail is removed by 
the poly(A) binding protein (Pab)1-dependent Pan2/Pan3 (poly(A) nuclease) complex (201, 202, 
203). Carbon catabolite repression 4 (Ccr4) and a Ccr4-associated factor (Caf1) have also been 
suggested to be important for mRNA deadenylation (203, 204). Following removal of the 
poly(A) tail, decapping enzyme Dcp1 is stimulated and removes the 5’ cap with the help of 
several additional factors (205, 206). The remaining RNA transcript is then susceptible to 5→’3’ 
or 3’→5’ mediated cleavage. RNA is cleaved in the 5’→3’ direction by 5’ exonuclease Xrn1 (207). 
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It is subject to 3’→5’ digestion by the exosome. In yeast, 5’→3’ exonuclease activity is 
substantially more rapid, and the overall disappearance of mRNA is believed to be attributed to 
this digestion (208-210). The deadenylation-dependent mRNA decay pathway is not as clearly 
understood for large multicellular organisms. 
 Poly(A) binding protein binding to the poly(A) tail helps protect the mRNA from 
degradation (213). PABP also binds the eIF4G scaffolding protein, a component of the eIF4F cap-
binding complex (214). These interactions cause mRNA to circularize in vitro, permit translation, 
and are believed to protect the transcript from exposure to deadenylases and decapping 
enzymes (215). in vitro and in vivo studies have shown that the deadenylating nuclease PARN 
binds the 5’ cap to access the poly(A) tail for degradation (216). Furthermore, eIF4E and cap 
analog inhibit PARN activity because they serve as competitors for 5’ cap binding (216, 217). 
However, in the presence of cap analog, decapping activity is stimulated because eIF4E and 
PARN are blocked from binding the 5’ cap and translation initiation is inhibited (217,218). It is 
believed that, following degradation of the poly(A) tail, PARN dissociates from the transcript 
allowing binding of the decapping enzyme to the 5’ cap (199). Interestingly, mRNAs are 
destabilized when translation initiation is inhibited, but they are stabilized in the presence of 
translation elongation-inhibiting drugs like cycloheximide (211, 212).  
 The sequence within a transcript can impact how RNA is regulated. Certain sequences 
have been determined to promote or deter mRNA decay. One example is mRNA which contains 
an A + U rich element (ARE) in the 3’ UTR. Many mRNAs that contain an ARE encode growth 
factors, cytokines, or proto-oncogenes (200, 219). Several different types of ARE-containing 
mRNAs have been identified. These AREs appear to accelerate the rate of removal of the poly(A) 
tail, leading to rapid mRNA degradation (200). On the other hand, some mRNAs contain 
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sequences which allow stabilization in the cell. The 3’ end of α–globin mRNA contains a 
cytosine-rich region which promotes assembly of a stabilizing complex that inhibits mRNA 
decay (220, 221, 222). c-fos mRNA contains an ARE sequence in its 3’UTR and a major protein-
coding –region determinant (mCRD) sequence in its 5’UTR (223). The mCRD promotes assembly 
of a complex in the transcript’s coding region that leads to rapid destabilization (223). 
Interleukin-2 mRNA contains sequence elements at its 5’ and 3’ ends which have opposite 
functions. In the absence of T cell activation, the 3’ ARE allows rapid deadenylation and constant 
mRNA instability. However, once T cells are stimulated, the transcript is stabilized by 
interaction with nucleolin and YB-1 proteins at its 5’ UTR responsive element (225). This element 
recruits factors involved in the c-Jun amino-terminal kinase (JNK) signaling pathway (224).  
In non-sense mediated decay, mRNA transcripts with premature stop codons are 
degraded. The premature stop codon isn’t recognized until translation termination, and yeast 
studies reveal that the decay process does not involve deadenylation (226). Instead, mRNA is 
decapped by the same decapping enzymes used in the deadenylation-dependent decay.  
 
 
 
  
 
 
 
27 
 
CHAPTER 2 
 
MATERIALS AND METHODS 
 
Plasmids and DNA Isolation and Separation 
pBK2 
 The pBK2 plasmid (8) was constructed by Bradley Karr, a previous member of the lab. It 
contains a BglII/SmaI 1,165 bp HSV-1 thymidine kinase fragment that was inserted into the 
pSP64polyA vector purchased from Promega (Madison, WI) at BamHI. The final construct 
contains an SP6 promoter upstream of a 5’ UTR that is 91 bases long and encodes all but the last 
6 codons of the thymidine kinase sequence followed by a stretch of 30 dA:dT nucleotides. The 
vector confers ampicillin resistance. Prior to in vitro transcription, the plasmid was linearized 
with EcoRI and then added to an RNA synthesis reaction resulting in RNA template of 1244 
bases. pBK2 plasmid was used for construction of all site-directed mutants and hairpin 
constructs. 
 
pKOSamp 
pKOSamp was constructed by David Everly, Jr., a previous member of the lab (32). It 
contains the UL41 open reading frame of HSV-1 strain KOS downstream of a CMV and T7 
promoter. The HindII/XbaI fragment of pKOS (31) was cloned into the corresponding sites of 
Invitrogen vector pCDNA1.1amp (San Diego, CA). The fragments contained 89 bp of viral DNA 
upstream of the UL41 gene. The DNA was linearized with XbaI. in vitro transcription followed 
by in vitro translation resulted in a 58 kDa protein.  
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pcDNA1.1amp 
 pcDNA1.1amp was used for control samples during mock transfections to confirm that 
cells were transfected with equal amounts of DNA. It was purchased from Invitrogen (San 
Diego, CA) and previously propagated in TOP10F’ E.coli competent cells by David Everly, Jr. It 
confers ampicillin resistance and eukaryotic origins from SV40 and polyoma virus. in vitro 
transcription is carried out with a T7 phage RNA polymerase promoter and the immediate early 
CMV promoter allows expression in cells. The vector also contains polyadenylation signals and 
a SV40 splice region.   
 
p333amp 
 p333amp was previously created by David Everly, Jr. It contains the UL41 open reading 
frame of HSV-2 strain 333 excised at HindIII/XbaI from p333 (31) and cloned into pcDNA1.1amp 
(San Diego, CA) at the corresponding positions (32). It contains a T7 and CMV immediate early 
promoter upstream of UL41. The DNA was linearized with XbaI followed by in vitro 
transcription and in vitro translation resulting in a 58 kDa protein. 
 
pC53 
The C53 bicistronic vector was kindly provided by Peter Sarnow (38, 80). It contains an 
upstream cistron which encodes renilla luciferase and a downstream cistron encoding firefly 
luciferase (Fig. 4). The intergenic region encodes EMCV RNA secondary structure with 
mutations making it a nonfunctional IRES (ΔEMCV) (26, 38, 80). The vector was created by 
cleaving pRL-SV40 vector from Promega (Madison, WI) with BglII and XbaI to yield a fragment  
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Figure 4.Cartoon Depiction of Bicistronic Construct 
Figure 4 shows the bicistronic construct containing a functional EMCV IRES (pC64), nonfunctional 
EMCV IRES (pC53), or the cricket paralysis viral IRES (CrPV) in the intergenic region. SV40 and T7 
promoters precede the first cistron, renilla luciferase (Rluc). The downstream cistron is firefly 
luciferase (Fluc), and it is followed by an SV40 late poly(A) signal. 
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containing the T7 and SV40 promoter upstream of renilla luciferase. This fragment was then 
inserted into the Promega pGL Basic Vector (Madison, WI) at SmaI following a Klenow reaction. 
A nonfunctional EMCV IRES fragment of around 440 bases (26) was then added to the 
intergenic region of the construct at EcoRI (38, 80). The vector has ampicillin (amp) resistance 
and a late SV40 polyadenylation signal following the second cistron. For these studies C53 was 
linearized with BamHI, and in vitro transcription resulted in an RNA template of 3390 bases. The 
first cistron is located from bases 12-946 and the second cistron is located from bases 1474-3126 
of the RNA template. The intergenic region is between bases 947-1473 of the RNA transcript.  
 
pCrPV 
The CrPV bicistronic vector was kindly provided by Peter Sarnow (38, 80). It contains an 
upstream cistron which encodes renilla luciferase and a downstream cistron encoding firefly 
luciferase (Fig. 4). The intergenic region encodes a CrPV functional IRES (38, 80). The vector was 
created by cleaving pRL-SV40 vector from Promega (Madison, WI) with BglII and XbaI to yield a 
fragment containing the T7 and SV40 promoter upstream of renilla luciferase. This fragment was 
then inserted into the Promega pGL Basic Vector (Madison, WI) at SmaI following a Klenow 
reaction. A functional CrPV IRES fragment of 189 bases was then added to the intergenic region 
and is located between bases 1474-1662 of the sequence (38, 80). The vector has ampicillin 
resistance and a late SV40 polyadenylation signal following the second cistron. For these studies 
CrPV was linearized with BamHI, and in vitro transcription resulted in an RNA template of 3594 
bases. The first cistron is located from bases 12-947 and the second cistron is located from bases 
1678-3330 of the RNA template. The intergenic region is between bases 948-1677 of the RNA 
transcript. 
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pC64 
pC64 was kindly provided by Peter Sarnow (38, 80). It contains an upstream cistron 
which encodes renilla luciferase and a downstream cistron encoding firefly luciferase (Fig. 4). 
The intergenic region encodes a functional EMCV IRES (26, 38, 80). The vector was created by 
cleaving pRL-SV40 vector from Promega (Madison, WI) with BglII and XbaI to yield a fragment 
containing the T7 and SV40 promoter upstream of renilla luciferase. This fragment was then 
inserted into the Promega pGL Basic Vector (Madison, WI) at SmaI following a Klenow reaction. 
A functional EMCV IRES fragment of around 440 bases (26) was then added to the intergenic 
region of the construct at EcoRI (38, 80). The vector has ampicillin resistance and a late SV40 
polyadenylation signal following the second cistron. For these studies pC64 was used solely for 
transient transfections. 
  
pCITELUC 
 pCITE-4c(+) was purchased from Novagen (Madison, WI). The vector contains a pCITE 
region which encodes the EMCV IRES from EMCV strain pEC9 nucleotides 212-713 of the 
sequence (81). A T7 phage RNA polymerase promoter is located upstream of the IRES and a 
poly A recognition sequence is located from nucleotides 701-730 of the vector. For construction 
of the pCITELUC vector, renilla luciferase from the Promega vector pGEMLUC (Madison, WI) 
was cloned downstream of the EMCV IRES. Both vectors were first propagated in JM109 
competent cells from Promega (Madison, WI) following the transformation protocol. Five 
colonies were picked and grown in LB media containing 100ug/ml ampicillin for 8 hours (hr.) at 
37˚C, 300 revolutions per minute (rpm). After 8 hr., 50ul of the starter culture was added to 25 
milliliters (ml) Luria-Bertani broth (LB) with 100ug/ml amp, and cultures grew overnight at 
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37˚C, 300rpm.  
DNA was extracted using a Qiagen Midi Prep Kit (Germantown, MD) and 15 
micrograms (ug) of DNA was double digested, first by incubating DNA with XhoI for 3 hr. at 
37˚C followed by addition of BamHI and an additional 3 hour incubation at 37˚C with both 
enzymes at a concentration of 5 units (U)/ug DNA. The samples were then phenol/chloroform 
extracted and precipitated with 2.5 volumes 95% ethanol and 0.1 volume 3M sodium acetate, pH 
5.2 overnight at -80˚C. Digestion of pCITE-4c(+) vector with BamHI and XhoI produced a 40 
nucleotide (nt.) and 3661 nt. DNA fragment. Digestion of pGEMLUC with these enzymes 
resulted in DNA fragments of 3215 and 1716 nucleotides. The double digested DNA was then 
pelleted by spinning it at 13,000 rpm in a table top microcentrifuge at 4˚C for 20 minutes. The 
pellets were resuspended in 20ul 10mM Tris-Cl pH 7.5 + 1mM EDTA (TE buffer) pH 8.0 and 
stored until further use. 15ul of the sample was run on a 1% agarose 1X TAE gel with 0.5ug/ml 
ethidium bromide (EtBr) at 100 Volts (V) for 1.5 hours. The 3361 nt vector from pCITE-4c(+) and 
the 1716 nt. insert from pGEMLUC were excised and extracted using the Qiagen Gel Extraction 
Kit (Germantown, MD) and samples were eluted with 30ul elution buffer (EB).  
13ul of the 1716 nt. renilla luciferase insert was combined with 1.85ul of the 3661 nt. 
pCITE-4c(+) vector in a T4 DNA ligase reaction with a final concentration of 1X T4 DNA ligaton 
buffer and 1U total T4 DNA ligase from Promega (Madison, WI). Samples incubated at room 
temperature for 30 minutes. 5ul of sample was used for transformation of 100ul JM109 
competent cells following the Promega protocol (Madison, WI). 100ul, 1:10, and 1:100 dilutions 
were spread on LBamp plates, and colonies grew overnight at 37˚C.  
8 colonies were picked and grown up in 4ml LBamp with 100ug/ml ampicillin for 8 
hours at 37˚C, 300rpm. The starter cultures were then diluted as described previously and grown 
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up overnight. 900ul aliquots were stored in box LAS plasmids 1 with a final concentration of 
10% sterile glycerol, and the samples were labeled pCITE4c(1-8)LUC. Pellets were harvested by 
centrifuging for 15 minutes at 6,000 relative centrifugal force (rcf). DNA was extracted using the 
Qiagen Midi Prep Kit (Germantown, MD) and pellets were resuspended in TE buffer pH 7.9.  
Plasmids were tested for proper construction by double digestion of 2ug of sample with 
BamHI and XhoI. Samples were then run on a 1% agarose 1X TAE gel with 0.5ug/ml EtBr and a 
BioRad 1kb marker (Hercules, CA) to confirm a vector around 3.7kb and a 1.7kb insert. All 
plasmids except pCITE4c4LUC were constructed correctly.  
 
DNA Isolation and Separation 
Following plasmid construction, all vectors used for the in vitro transcription reaction 
were grown in starter cultures of 3ml LB containing 100ug/ml of amp for 8 hours at 37˚C and 300 
rpm. 200ul was then added to 100ml of LBamp and grown up 12-16 hours followed by extraction 
with Qiagaen Midi Prep Kit (Germantown, MD) and resuspension in 100ul of H2O or 10mM 
Tris-Cl pH 8.5 [elution buffer (EB)]. 10ug of DNA was used in a linearization reaction to ensure 
that transcription ended at the same location so that all starter RNA was the same length. 50U of 
restriction enzyme was added to the reaction for a final concentration of 5U/ug DNA. DNA 
samples incubated at 37°C for 4 hr. followed by precipitation with a 0.1 volumes of 3M sodium 
acetate pH 5.2 and 2.5 volumes of 95% ethanol for 1 hour at -80˚C. Samples were then spun in a 
microcentrifuge for 20 min. at 4˚C and resuspended in 20ul H2O or EB. 
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in vitro Transcription and RNA Labeling 
Internally-labeled mRNA 
 8.50ul of EcoRI-linearized pBK2 DNA was added to a Promega SP6 Riboprobe in vitro 
transcription reaction (Madison, WI) containing 50U Recombinant RNasin Nuclease Inhibitor, 
2.85ul H2O, 50uCi *α-32P]GTP with a specific activity of 800 Ci/mmol, 40U SP6 RNA polymerase, 
a final concentration of 1X SP6 Transcription Optimized Buffer, 10mM DTT, 0.5mM ATP, 0.5mM 
UTP, 0.5mM CTP, 50uM GTP, and 0.5mM capping analog in a total volume of 50ul. The 
components incubated at 37˚C for 1 hr. 4U of RQ1 RNase-free DNase (1U/ul) was added to the 
system and samples incubated for 15 min. at 37˚C. RNA was then taken through two rounds of 
phenol/chloroform extraction at room temperature followed by precipitation with 2.5 volumes 
ice-cold Ethanol (EtOH) and 0.1 volumes 3M sodium acetate pH 5.2 at -80˚C overnight. mRNA 
was pelleted in a table top microcentrifuge for 20 minutes at 1300 rpm and 4˚C and resuspended 
in 20ul H2O.  
 
5’ Cap-labeled vs. 3’ PolyA Tail-labeled mRNA 
 6-9ul of EcoRI linearized pBK2 DNA was added to a Promega SP6 RiboMAX in vitro 
transcription kit (Madison, WI) containing 44ul H20, 170U SP6 RNA polymerase, and a final 
concentration of 5mM of each dNTP and 1X SP6 Transcription Optimized Buffer in a total 
volume of 100ul. The reaction incubated at 37˚C for 3 hr. followed by addition of 4U RQ1 RNase-
free DNase and an additional 15 min. incubation at 37˚C. The RNA was taken through 2 rounds 
of phenol/chloroform extraction and precipitated with 2.5 volumes of ice-cold 95% EtOH and 0.1 
volume of 3M sodium acetate for at least 1 hr. at -80˚C. RNA was pelleted by spinning for 20 
min. at 13,000 rpm and 4˚C. 20ug of pBK2 RNA was used in an unlabeled capping reaction, and 
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20ug was used in a labeled capping reaction using EPICENTRE’s m7G Capping Kit (Madison, 
WI). For the experiment shown in Figures 14 and 15, 5.50ul of RNA was combined with 21.5ul 
H2O and incubated for 8 min. at 65˚C and then placed on ice. 40U ScriptGuard RNase Inhibitor, 
20U ScriptCap Capping Enzyme, and a final concentration of 1X ScriptCap Capping Buffer, 
1mM unlabeled GTP (for unlabeled cap sample) or 40uCi *α-32P]GTP with a specific activity of 
800Ci/mmol (for cap-labeled sample), and 0.1mM SAM were added to the tube. The samples 
were mixed and incubated at 37˚C for 1 hr. The RNA was phenol/chloroform extracted and 
precipitated with 2.5 volumes ice-cold 95% EtOH and 0.1 volume 3M sodium acetate, pH 5.2 for 
at least 1hr. at -80˚C.  
The samples were resuspended in 9ul H2O and used in an EPICENTRE poly(A) 
polymerase tailing reaction (Madison, WI). The sample with the labeled 5’ cap received an 
unlabeled poly(A) tail, and the sample with the unlabeled 5’cap received a labeled poly(A) tail. 
The RNA was combined with 40U ScriptGuard RNase Inhibitor, 8U Poly(A) Polymerase, and 
4ul cold 10mM ATP (for the RNA with a labeled 5’ cap) or 10uCi *α-32P]ATP with a specific 
activity of 3,000Ci/mmol + 3ul H20 (for the RNA with an unlabeled 5’ cap) in a total volume of 
40ul. The reaction incubated at 37˚C for 20 minutes. The samples were then precipitated with 2.5 
volumes ice-cold 95% EtOH and 0.1 volume 3M sodium acetate, pH 5.2 for 1hr. at -80˚C. RNA 
was pelleted at 13,000 rpm for 20 min. at 4˚C and resuspended in 10ul H2O. Samples were run on 
a 1.4% agarose 1X TBE gel containing 0.5ug/ml EtBr at 50 Volts for 3.5 hours. RNA bands were 
excised from the gel and purified with BioRad Freeze ‘N Squeeze DNA gel extraction spin 
columns according to the protocol (Hercules, CA). RNA was precipitated using the procedure 
described previously, spun at 13,000 rpm and resuspended in 20ul H2O.  
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Cap-labeled pBK2 mRNA Used in Titration Assay and Inhibition Studies with Cycloheximide, 
GMP-PNP, AMP-PNP, and Cap Analog 
 
 pBK2 RNA was synthesized with the Promega SP6 in vitro RiboMAX kit and extracted as 
described previously (Madison, WI). For these experiments, 50ug of RNA was used in a 5’ cap-
labeling reaction. It was first incubated with H2O for 8 min. at 65˚C in order to unwind secondary 
structure. It was then combined with 80uCi of *α-32P]GTP with a specific activity of 3000Ci/mmol, 
40U ScriptCap Capping Enzyme, 100U of ScriptGuard RNase Inhibitor, and a final concentration 
of 0.1mM unlabeled GTP, 1X ScriptCap Capping Buffer, and 0.1mM SAM in a total volume of 100ul. 
Samples incubated at 37˚C for 1 hr. followed by phenol/chloroform extraction and precipitation 
with 2.5 volumes ice-cold EtOH and 0.10 volume 3M sodium acetate for at least 1 hr. at -80˚C. 
The RNA pellet was then spun at 13,000 rpm, dried, and resuspended in 20ul nuclease-free H2O. 
This RNA was not gel-extracted prior to incorporation into the RRL system. 
 
mRNA Used for Primer Extension Analysis 
 RNA was prepared by using 7-9ul linearized DNA in a Promega SP6 or T7 RiboMAX in 
vitro transcription reaction (depending on the construct), according to the protocol for 
synthesizing RNA without a cap analog (Madison, WI). Samples incubated at 37˚C for 2-4 hr. 
Following RNA synthesis, 4U of RQ1 RNase-free DNase was added to the system and tubes 
were incubated at 37˚C for 15 minutes. The RNA was taken through two rounds of 
phenol/chloroform extraction and then precipitated with 2.5 volumes ice-cold 95% EtOH and 0.1 
volumes 3M sodium acetate pH 5.2 at -80˚C for at least 1 hour. RNA was pelleted for 20 min. at 
13,000 rpm and 4˚C. Samples were resuspended in 20ul nuclease-free H2O. 50ug samples were 
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used in an EPICENTRE m7G capping reaction with unlabeled GTP according to the protocol 
(Madison, WI). Following the 1 hr. incubation at 37˚C, samples were precipitated with 2.5 
volumes ice-cold 95% EtOH and 0.1 volumes 3M sodium acetate pH 5.2 for at least 1 hr. at -80˚C. 
Samples were then centrifuged for 20 min. at 13,000 rpm and 4˚C, and pellets were resuspended 
in 15ul nuclease-free H2O. The RNA was then run on a 1.4% agarose 1X TBE gel containing 
0.5ug/ml EtBr at 50V for 3.5 hours. RNA was extracted using BioRad Freeze ‘N Squeeze tubes 
(Hercules, CA) followed by precipitation with 2.5 volumes ice-cold EtOH and 0.1 volumes 3M 
sodium acetate pH 5.2 for at least 1 hour at -80˚C. Samples were pelleted by centrifuging for 20 
min. at 13,000 rpm and 4˚C. RNA was resuspended in 20ul nuclease-free H2O. 
 
in vitro Translation 
 Vhs Used for Internally-labeled RNA Substrates 
 6-9ul of pKOSamp XbaI linearized DNA was added to an in vitro T7 RiboMAX RNA 
synthesis reaction from Promega (Madison, WI) containing 23.06ul H2O, 190U T7 RNA 
polymerase, a final concentration of 1X T7 Transcription Optimized Buffer, 1X DTT, 7.5mM ATP, 
7.5mM UTP, 7.5mM CTP, 0.6mM GTP, and 3mM capping analog in a total volume of 100ul. The 
reaction incubated for 2-4 hrs. (for this experiment 2 hrs.) at 37˚C and then DNA was degraded 
by adding 5U RQ1 RNase-free DNase and incubating samples for 15 min. at 37˚C. RNA was 
taken through 2 rounds of phenol-chloroform extraction with equal volumes of solution 
followed by precipitation of RNA with of 2.5 volumes EtOH and 0.1 volume 3M sodium acetate 
pH 5.2 at -80˚C for at least 1 hour. 
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Unlabeled, capped pKOSamp mRNA was then pelleted by spinning in a table top 
centrifuge at 13,000 rpm for 20 min. at 4˚C, and the pellet was resuspended in 200ul EB. 2.3ug 
pKOSamp mRNA was used in an in vitro translation Promega Flexi RRL system (Madison, WI). 
One tube did not receive any pKOSamp RNA and served as the negative control where water 
replaced mRNA (RRL), and the other tube contained pKOSamp mRNA (Vhs). Both tubes 
contained 33ul RRL, 20uCi [35S]methionine with a specific activity of 1200Ci/mmol, 40U RNasin, 
a final concentration of 20uM amino acid (-) methionine mix, 1mM magnesium acetate, 70mM 
KCl, and 2mM DTT in a final volume of 50ul.  Prior to adding pKOSamp RNA, the RNA was 
heat denatured at 65˚C for 3 min. in order to unravel mRNA secondary structure. After all of the 
components were mixed, samples incubated at 30˚C for 1.5 hr. and were then placed on ice for 
rapid use or stored at -20˚C. 
 
Vhs Assays with All Other mRNA (mRNA that was not internally labeled) 
 pKOSamp RNA was synthesized according to the methods described above. However, 
14ug of mRNA was used for the in vitro translation reaction in the Flexi RRL system (Madison, 
WI) instead of the previously described 2.3ug.  
 
Vhs Used to Test the Effect of Inhibitors on in vitro Translation 
 To test the effect of cycloheximide, GMP-PNP, and AMP-PNP on protein synthesis, 
normal Promega Flexi RRL in vitro translation reactions were cut in half (Madison,WI). Each 
tube contained 16.5ul RRL, 0.5ul 1mM amino acid minus methionine, [35S]methionine as directed 
by the protocol, 1ul 25mM magnesium acetate, 0.70ul 2.5M KCl, 0.5ul 100mM DTT, and 20U 
RNasin. Different amounts of H2O plus AMP-PNP, GMP-PNP, or cycloheximide were added 
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and samples incubated at 30˚C for 10 minutes. The different combinations of H2O and 
analog/drug allowed various concentrations to be tested. After the incubation, 3.5-7.0ug of cap-
unlabeled pBK2 or pKOSamp mRNA was added and samples incubated for 1.5 hr. at 30˚C. For 
positive controls, no drug/analog was added to the RRL system prior to addition of mRNA. For 
negative controls, mRNA was replaced with H2O. The different concentrations tested were 
0.1mM, 0.2mM, 0.5mM, 1mM, and 2mM non-hydrolyzable analogs and 50-100ug/ml 
cycloheximide. 
 
Vhs Assay 
Internally-labeled Substrate mRNA 
 30ul TE buffer pH 7.5 was added to Tube 1 for analysis of zero time point samples, 30ul 
of RRL lacking Vhs protein (RRL) from the in vitro translation reaction was added to Tube 2 to 
serve as the negative control, and 30ul of RRL containing Vhs protein (Vhs) was added to Tube 3 
(Fig. 5). 5ul of capped, internally-labeled pBK2 mRNA was then added to each tube and 5ul 
aliquots were removed at the indicated time points and added to 245ul TE buffer pH 7.5 
followed by mixing. This was to achieve a workable volume for accurate pipetting. The mixed 
sample was then added to 750ul TriZol which contained 15ug carrier tRNA, mixed, and 
incubated at room temperature for at least 5 minutes. 200ul chloroform was added to the tubes 
and then they were vigorously shaken for 15 seconds. The tubes incubated at RT for at least 2 
minutes, and samples were spun in a table top microcentrifuge at 4˚C top speed for 15 minutes. 
The aqueous layer was transferred to a new tube, and samples were precipitated by addition of 
500ul isopropanol to the new tube and incubation at RT for 10 minutes. The RNA was  
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Figure 5.Vhs Assay Procedure with Internally-labeled mRNA Substrate 
Figure 5 is a diagram of the Vhs assay procedure used for experiments that examined internally-
labeled mRNA substrate. Step 1 shows the amount of substrate mRNA that was added to the zero 
time point (TE buffer pH 7.5), RRL lacking Vhs (RRL), or RRL containing Vhs (Vhs) system. Step 2 
represents 5ul aliquot extractions at the indicated time points that were added to 245ul TE pH 7.5. 
Step 3 shows that the entire mixture was then added to 750ul Trizol containing 15ug of carrier 
tRNA, followed by addition of 200ul chloroform (listed in step 4). 
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centrifuged at 4˚C top speed for 10 minutes, and the pellet was air dried and resuspended in 
10ul nuclease-free water. 5ul of samples was combined with 15ul Ambion NorthernMax 
formaldehyde load dye (Austin, TX) and samples were incubated at 65˚C for 15 minutes. They 
were then spun briefly, placed on ice for a few minutes, and loaded onto a 1.2% agarose 
1XMOPS formaldehyde denaturing gel from Ambion’s NorthernMAX Denaturing Gel Buffer 
(Austin, TX) and run at 50V for 3.5 hr. with recircularization of 1XMOPS buffer halfway through 
the run. The gel was then dried for 4 hr. at 80˚C and then placed under a phosphorimaging 
screen. The gel was then viewed by autoradiography using a Storm 840 Imager by GE 
Healthcare and GE ImageQuant 5.0 software (Waukesha, WI). 
 
5’Cap-labeled vs. 3’ Poly(A) Tail-labeled pBK2 mRNA 
 4.0ul of either 5’ cap-labeled 3’ polyA tail-unlabeled or 5’ cap-unlabeled polyA tail-
labeled pBK2 mRNA was added to (1) 12.60ul 10mM Tris-Cl pH 7.5 + 0.9ul H2O (2) 12.60 RRL 
lacking Vhs (RRL) + 0.9ul H2O, or (3) 12.60 RRL containing Vhs (Vhs) + 0.9ul H2O (Fig. 6). The  
remaining procedure was carried out identical to the procedure described under Internally-
labeled Substrate mRNA with the exception that mRNA was washed with 70% and 99.9% EtOH 
following precipitation and it was resuspended in 12ul nuclease-free H2O. 5ul was used for 
analysis on a 1X MOPS gel and 5ul was used for analysis on a 7% polyacrylamide 8M urea 1X 
TBE sequencing gel. For analysis on the sequencing gel, the gel was cast for 45 min. and then 
preheated for 1.5 hrs. at 50W constant power. 5ul of the sample was then combined with 5ul of 
Ambion Gel Loading Buffer Dye II (Austin, TX) and tubes were heated to 90˚C for 10 min. 
Samples were then run on the preheated sequencing gel at a constant power of 50W for 1.5 hrs 
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Figure 6.Vhs Assay Procedure for Cap-labeled or Poly(A) Tail-labeled mRNA 
4ul of RNA substrate was incubated in 12.5ul 10mM Tris-Cl pH 7.5, 12.5ul RRL lacking Vhs, 
or RRL containing Vhs from left to right, respectively (1). 5ul aliquots were removed at the 
indicated time points and combined and mixed in 245ul 10mM Tris-Cl pH 7.5 (2). The entire 
mixture was then added to 750ul TriZol containing 20ug carrier tRNA and mixed (3). 
Following 5 minutes, 200ul of chloroform was added to each tube and samples were shaken 
vigorously followed by incubated for at least 2 minutes before centrifugation. 
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 using a BioRad Sequi-Gen GT apparatus (Hercules, CA). The gel was transferred to Whatman 
3MM filter paper, dried at 80˚C for 1 hr., and placed under a phosphorimaging screen for 
eventual analysis.  
 
Vhs Titration 
 Following in vitro translation, RRL containing Vhs was diluted 2 fold with RRL lacking 
Vhs to yield 0.5X Vhs. 0.5X Vhs was then diluted 2 fold with RRL lacking Vhs to yield .25X Vhs. 
12.60ul of the sample was used in a Vhs titration assay, and 12.60 ul of RRL without Vhs was 
used as a control. 3.4ul H2O was added to each tube followed by addition of 2.5ul cap-labeled 
pBK2 mRNA. 5ul aliquots were removed from the system at 0, 3, 9, and 15 minute time points.  
 
AMP-PNP 
 Six tubes were used in this study. Two tubes contained 12.60ul 10mM Tris-Cl pH 7.5 
(Fig. 7). Two tubes contained 12.60ul RRL without Vhs (RRL), and two tubes contained 12.60ul 
RRL with Vhs (Vhs) (Fig. 7). One of the tubes in the group received 3.40ul H2O and the other 
tube received 3.40ul of 9.44mM AMP-PNP from Sigma-Aldrich (St. Louis, MO) for a final 
concentration of 2mM AMP-PNP. After addition of H2O or AMP-PNP, the tubes incubated at 
30˚C for 12 min. followed by addition of 2.50ul pBK2 cap-labeled mRNA. 5ul aliquots were 
removed at 3, 9, and 15 minute time points from the RRL and Vhs samples and at 0 minutes 
from the 10mM Tris-Cl samples. The aliquots were added to 245ul 10mM Tris-Cl pH 7.5. The 
rest of the RNA extraction was performed as described previously. RNA did not undergo 
washes with 70% and 99.9% EtOH.  
 
 
 
44 
 
 
 
 
 
  Figure 7.Vhs Assay Procedure from Inhibition Studies with Cap-labeled mRNA 
3.4ul H2O was added to three tubes containing 12.6ul of 10mM Tris-Cl pH 7.5, RRL without Vhs, 
or RRL with Vhs (1). 3.4ul of water + drug/analog was added to three other tubes with the same 
components (1). Samples were incubated for 12 minutes at 30˚C (2). 2.5ul Cap-labeled mRNA 
was added to samples (3) and aliquots were removed at the indicated time points and combined 
and mixed in 245ul 10mM Tris-Cl pH 7.5 (4). The entire mixture was then added to 750ul TriZol 
containing 14ug carrier tRNA and the remaining RNA extraction followed according to the 
protocol previously described. 
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For analysis of full length RNA, the pellets were resuspended in 5ul H2O followed by 
addition of 15ul Ambion NorthernMAX formaldehyde load dye (Foster City, CA). Samples  
incubated for 15 min. at 65˚C and were then loaded onto a 1.4% agarose 1XMOPS denaturing gel 
and run at 50V for 3.5 hours. The gel was transferred to Whatman 3MM filter paper and dried 
for 4 hrs. at 80˚C.  
For analysis of smaller RNA cut sites, pellets were resuspended in 10ul nuclease-free 
H2O followed by addition of 10ul gel loading buffer dye II. Samples were heated at 95˚C for 5 
min. and then loaded onto a 6% polyacrylamide 8M urea 1X TBE gel. They were run on a BioRad 
Protean II xi cell at 150V for 5.5 hours. The gel was then transferred to Whatman 3MM filter 
paper and dried for 3 hr. at 80˚C. 
 
GMP-PNP 
 The reaction was performed identical to the AMP-PNP experiments except 1.60ul of 
20mM GMP-PNP and 1.80ul nuclease-free H2O were added to the tubes receiving GMP-PNP for 
a final concentration of 2mM GMP-PNP.  
 
Cycloheximde 
 Experiments were performed identical to the AMP-PNP studies, except instead of AMP-
PNP, cycloheximide was added to half of the tubes at a final concentration of 50ug/ml. 
 
Cap analog 
 Experiments were performed identical to the AMP-PNP studies except AMP-PNP was 
replaced with Promega m7G cap analog (Madison, WI). For 3mM inhibition studies, 1.20ul 
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40mM cap analog plus 2.40ul nuclease-free H2O was added to half the tubes. For the 5mM cap 
analog studies, 2.0ul 40mM cap analog plus 1.60ul nuclease-free H2O was added to half the 
samples.  
 
Primer Extension Analysis 
Vhs Assay 
 The Vhs assay was performed with identical amounts of Vhs and substrate mRNA as 
described in the Vhs assay protocol for the inhibition studies. The only difference was that the 
RNA used in these studies was gel extracted after the capping reaction. Following the Vhs assay, 
mRNA was washed with 70% and 95% EtOH, dried, and resuspended in 10-20ul nuclease-free 
H2O (depending on the experiment). For each time point analyzed, 5ul of sample was used for 
primer extension analysis.  
 
Primer labeling 
 10 picomoles (pmol) primer (Table 2) was combined with 30uCi *γ-32P]ATP with a 
specific activity of 6,000 Ci/mmol, 10U T4 polynucleotide kinase, a final concentration of 1X T4 
PNK buffer, and H2O to a final volume of 10ul. Samples incubated at 37˚C for 10 min. and were 
then heated to 90˚C for 2 minutes to inactivate T4 PNK. Tubes were then centrifuged briefly in a 
microcentrifuge and water was added to a final concentration of 100fmol/ul. The primers used 
for primer extension analysis were ordered from IDT Technologies and are listed in Table 2 
(Coralville, IA). 
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TABLE 2 
PRIMERS USED FOR PRIMER EXTENSION ANALYSIS 
 
  
Primer Description Sequence
P 165 (pBK2) 5’-TCGGTTGCTATGGCCGCGAGAACGC-3’
P 235 (pBK2) 5’-CGTGGGCATTTTCTGCTCCAGGCGG-3’
P 325 (pBK2) 5’-GATATCGTCGCGCGAACCCAGGGCC-3’
EMCV (pCITELUC) 5’-TCATAGCCTTATGCAGTTGC-3’
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RNA Melting and Reverse Transcription 
5ul of RNA sample was combined with 1ul labeled primer plus 5ul AMV Primer 
Extension 2X buffer. The tubes were heated at 67˚C (or at a temperature near their Tm) for  
20 min. and then incubated at RT for 10 minutes. 9ul of reverse transcription mix was added to 
each tube. Reverse transcription mix contains 5ul 2X AMV Primer Extension buffer, 1.4ul 40mM 
sodium pyrophosphate, 1.6ul nuclease-free H2O, and 1U AMV reverse transcriptase. Samples 
incubated for 30 min. at 41-42˚C and then 20ul loading dye was added to each tube. Samples 
were heat denatured at 90˚C for 10 min. and loaded onto a pre-heated 7-8% polyacrylamide 8M 
urea 1X TBE gel. Samples were run at a constant power of 50W for 1.5 hr. on a BioRad Sequi-Gen 
GT apparatus (Hercules, CA). The gel was transferred to Whatman 3MM filter paper and dried 
for 1 hr. at 80˚C. The gel was then placed under a phosphorimaging screen and visualized 
through autoradiography.  
 
RNA Circularization 
Preparation of Circular pBK2 RNA 
 RNA was synthesized and extracted according to the procedure described above for the 
5’ cap-labeled vs. 3’ poly(A) tail-labeled mRNA. 50ug RNA was then taken through a 
dephosphorylation reaction with 1X Dephosphorylation Buffer and 5U Calf Alkaline Intestine 
Phosphatase (CIAP) from the Ambion KinaseMAX kit (Foster City, CA). The final volume was 
20ul. RNA incubated for 1hr. at 37˚C, and then 50ul of Phosphatase Removal Reagent (PRR) was 
added to the tube and samples incubated for 3 min. at RT with occasional flicking. Tubes were 
then centrifuged briefly for 15 seconds up to top speed, and the supernatant was carefully 
removed. The RNA was then precipitated by adding 2.5 volumes of ice-cold EtOH and 0.1 
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volumes 3M sodium acetate pH 5.2 for at least 1 hr. at -80˚C. The RNA was pelleted by 
centrifuging for 20 min. at 13,000rpm and 4˚C.  
The pellet was resuspended in 16ul nuclease-free H2O and used in a PNK kinase reaction 
to add a single monophosphate onto the 5’ end. 2ul 10X PNK Buffer, 1ul of unlabeled 10mM 
ATP, and 1ul PNK (10U/ul) were added to the tube and samples incubated for 1hr. at 37˚C. 
Tubes were then incubated for 2 min. at 90˚C to stop the reaction. 500mM Tris-Cl pH 7.5, 5mM 
EDTA, and 4.5M NaCl were then added to a final concentration of 10mM, 0.1mM, and 100mM, 
respectively. 10ug of pBK2 circle oligonucleotide (used 0.5ul of 20ug/ul solution) from IDT 
(Coralville, IA) was added to bind the 5’ and 3’ ends of the RNA (Table 3). This oligonucleotide 
was present in 6.5 molar excess compared to pBK2 mRNA. Samples were incubated at 90˚C for 5 
min. followed by removal of the heat block to RT for a slow cool for 1.5 hrs. to anneal the 
oligonucleotide to RNA. 2ul of sample was set aside for eventual gel analysis. 4ul of T4 DNA 
ligase (1U/ul) and 8 ul 5X T4 DNA ligase buffer were added to the tube and the reaction 
incubated overnight at RT. Samples were then precipitated with 2.5 volumes ice-cold EtOH and 
0.1 volumes 3M sodium acetate pH 5.2 for at least 1 hr. at -80˚C. The RNA was pelleted by 
centrifuging for 20 min. at 13,000 rpm and 4˚C. Samples were resuspended in 10ul H2O. DNA 
loading dye was added to the samples and they were run on a 1.6% agarose 1X TBE gel 
containing 0.5ug/ml EtBr. Circular pBK2 was extracted and purified using BioRad Freeze ‘N 
Squeeze columns (Hercules, CA). Samples were resuspended in nuclease-free H2O and the 
spectrophotometer was used to record concentrations.  
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Primer Description Sequence
pBK2 Circularization 5’-TGCAGCCCAAGCTTGTATTCGGGCGTCGCAGATCGTCGGT-3’
pCITELUC (EMCV) Circularization 5’-TTTTTTTTTTTCAAATTTGTCCCGCTTAATTAAGGCCAAT-3’
TABLE 3 
PRIMERS USED FOR CIRCULARIZING pBK2 AND EMCV RNA 
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Preparation of Linear mRNA 
 pBK2 RNA was synthesized and extracted according to the procedure described above 
for the 5’ cap-labeled vs. 3’ poly(A) tail-labeled mRNA. pCITELUC RNA was synthesized by 
adding 6-9ul SpeI linearized DNA to a Promega T7 RiboMAX in vitro transcription reaction 
(Madison, WI).  The T7 reaction contained 20ul T7 5X Transcription Buffer, 7.50 of each 100mM 
dNTP, and 10ul T7 enzyme in a final volume of 100ul. The in vitro transcription reaction and 
RNA extraction followed the same guidelines as those previously described for RNA used for 5’ 
cap-labeled vs. 3’ poly(A) tail-labeled experiments. 50ug of RNA was then used in an 
EPICENTRE m7G capping reaction (Madison, WI) with unlabeled GTP identical to the 
procedure described for mRNA used in the primer extension analysis experiment. RNA was 
then run on a 1.6% agarose 1X TBE gel containing 0.5ug/ml EtBr at 50V for 3.5 hours. The RNA 
fragment was excised and extracted from the gel with BioRad Freeze ‘N Squeeze columns 
(Hercules, CA). Samples were resuspended in 20ul nuclease-free H2O and the 
spectrophotometer was used to record concentrations.  
 
Preparation of Circular EMCV RNA 
 7-9ul of SpeI linearized pCITELUC DNA was used in a Promega in vitro T7 RiboMAX 
RNA synthesis reaction (Madison, WI). However, in this reaction GMP was present in 10:1 
abundance than GTP. 20ul of T7 5X Transcription Buffer, 7.5ul 100mM ATP, 7.5ul 100mM CTP, 
7.5ul 100mM UTP, 6.75ul 100mM GMP, 0.75ul 100mM GTP, 33ul H2O, and 10ul T7 enzyme mix 
were combined with the linearized DNA. Sample incubated at 37˚C for 3.5 hours. Following the 
RNA synthesis reaction, 4U of RQ1 RNase-free DNase was added to sample, and tubes 
incubated at 37˚C for 15 minutes. RNA was then phenol/chloroform extracted and precipitated 
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with 2.5 volumes ice-cold 95% EtOH and 0.1 volumes 3M sodium acetate pH 5.2 at -80˚C for at 
least 1 hour. RNA was pelleted by centrifuging for 20 min. at 13,000 rpm and 4˚C. Sample was 
resuspended in 13ul nuclease-free H2O. Tris-Cl pH 7.5, EDTA, and NaCl were added to a final 
concentration of 10mM, 100mM, and 0.1mM, respectively. Next, 7ug of EMCV pCITELUC 
circular oligonucleotide was added (by adding 0.5ul of 14ug/ul stock) to the system so that it 
was present in an 8.42 fold higher molar ratio compared to RNA substrate. The primer was 
purchased from IDT (Coralville, IA). Sample was incubated at 90˚C for 10 minutes, and then the 
heat block was removed and placed at RT for a 1.5 hour slow cool to allow primer annealing. 
After cooling, T4 DNA Ligase Buffer was added to a final concentration of 1X. Lastly, T4 DNA 
ligase was added to a final concentration 100U/nanomole of RNA transcript and the ligation 
reaction incubated at RT overnight.  
 The next day, circular RNA precipitated with 2.5 volumes ice-cold 95% EtOH and 0.1 
volumes 3M sodium acetate pH 5.2 at -80˚C for at least 1 hour. The RNA was spun down and gel 
extracted following the same procedure as described for pBK2 circular RNA.  
 
Vhs Assay of Linear vs. Circular RNA 
pBK2 Experiment 
 3.4ul (0.4ug) of linear or circular RNA was added to 12.60ul of 10mM Tris-Cl pH 7.5, 
RRL lacking Vhs, or RRL containing Vhs (Fig. 8). Samples incubated at 30˚C and 5ul aliquots 
were removed from the 10mM Tris-Cl sample immediately (0’) and from the the RRL and Vhs 
samples at 3, 9, and 15 minutes. The aliquots were added to 245ul 10mM Tris-Cl pH 7.5 and 
mixed. The entire solution was then added to 750ul TriZol with 20ug carrier tRNA. The 
remaining RNA extraction was performed as described previously. RNA was washed with  
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Figure 8.Vhs Assay Procedure for Analysis of Vhs Cleavage of Circular vs. Linear pBK2 RNA  
0.40 ug linear or circular RNA was added to tubes containing 12.6ul of 10mM Tris-Cl pH 
7.5, RRL without Vhs, or RRL with Vhs (1). 5ul aliquots were removed at the indicated 
time points and combined and mixed in 245ul 10mM Tris-Cl pH 7.5 (2). The   RNA 
extraction was followed according to a previously described procedure. After RNA was 
resuspended, 5ul of sample was used for primer extension analysis. 
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70% and 99.9% EtOH and resuspended in 10ul nuclease-free H2O. 5ul of sample was used for 
primer extension analysis. 
 
EMCV Experiment 
 
 4.0ul (0.3ug) of linear or circular RNA was added to 8.40ul of 10mM Tris-Cl pH 7.5, RRL 
lacking Vhs, or RRL containing Vhs. Samples incubated at 30˚C, and 5ul aliquots were removed 
from the 10mM Tris-Cl sample immediately (0’) and from the RRL samples at 3 and 15 minutes. 
The aliquots were added to 245ul 10mM Tris-Cl pH 7.5 and mixed. The entire solution was then 
added to 750ul TriZol with 20ug carrier tRNA. The remaining RNA extraction was performed as 
described previously. RNA was washed with 70% and 99.9% EtOH and resuspended in 5ul 
nuclease-free H2O. The entire sample was used for primer extension analysis. 
 
Site-directed Mutagenesis 
 The Stratagene Lightning Multi Site-directed Mutagenesis Kit was used to mutate pBK2 
DNA (La Jolla, CA). All primers used for these studies were purchased from IDT Technologies 
(Coralville, IA). 50ng pBK2 DNA was combined with 100ng primer, 2.50ul 10X QuikChange 
Lightning Multi Reaction Buffer, 1ul dNTP mix, and 1ul QuikChange Lightning Multi Enzyme 
Blend in a final volume of 25ul. The primers used for mutagenesis are listed in Table 4. Sequence 
in red represents part of the AUG codon and sequence in blue represents bases within or 
surrounding the AUG codon that were mutated. The DNA was amplified by PCR according to 
the parameters listed in Table 5. Following PCR, samples were placed on ice for 2 minutes. 1ul 
DpnI was added in order to cleave the non-mutated methylated and hemimethylated DNA. 
Samples were mixed, briefly centrifuged, and incubated at 37˚C for 5 minutes. Figure 9 shows a  
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Primer Sequence
AUG1→CCC 5’-CCTTGTAGAAGCGCGTCCCGCTTCGTACCCCTGCC-3’
AUG1→AUG1--OPT 5’-GCGCCTTGTAGAAGCCACCATGGCTTCGTACCCC-3’
AUG2→CCC 5’-CGCCTGGAGCAGAAACCCCCCACGCTACTGCGG-3’
AUG2→AUA 5’-CGCCTGGAGCAGAAAATACCCACGCTACTGCGG-3’
TABLE 4 
PRIMERS USED FOR AUG MUTAGENESIS 
TABLE 5 
QUIKCHANGE LIGHTNING MUTAGENESIS PARAMETERS 
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 Figure 9.Procedure for Mutating AUG Codons 
Figure 9 was obtained from the Stratagene protocol. Primer containing pBK2 sequence with 
mutations at or near the first or second AUG codon was used in these studies. During the PCR 
reaction, the primers bound to the antisense DNA strand, so DNA was synthesized to contain 
the proper mutations in the sense strand. DNA nicks were ligated with a Pfu fusion-based 
enzyme blend. Following PCR, DpnI was added to the system for cleavage of all methylated and 
hemimethylated DNA. Therefore, all non-mutated DNA was degraded, but DNA containing the 
mutation was spared. Lastly, XL10 Gold ultracompetent cells were transformed, and the single 
stranded DNA was converted to double stranded DNA in vivo. 
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diagram obtained from the Stratagene protocol that explains the mutagenesis procedure. The 
DNA was then propagated in Stratagene XL10-Gold ultracompetent cells according to the 
protocol, except that NZY+ broth was replaced with SOC media (La Jolla, CA). Colonies were 
picked and grown for 12-16 hours in 10ml LB cultures containing 100ug/ml amp. DNA was 
extracted using a Qiagen Mini Prep Kit (Germantown, MD). Mutations were confirmed through 
sequencing. 
 
Construction of Hairpin and CAA Constructs 
BamHI and BglII Restriction Enzyme Sites 
Two primers were purchased from IDT Technologies (Coralville, IA) to mutate the pBK2 
sequence to contain a BamHI restriction enzyme site upstream of the T7 promoter and a BglII 
restriction enzyme site downstream of the T7 promoter (Table 6). The BamHI site was located 27 
bases upstream from the SP6 transcription start site, and the BglII site was located 58 bases 
downstream from the transcription start site and 26 nucleotides upstream from the first AUG. 
The mutations were created using Stratagene’s QuikChange Lightning Multi Site-directed 
Mutagenesis Kit (La Jolla, CA). Both primers were added to one reaction. First, 1ul of 50ng/ul 
pBK2 DNA was combined with 2.50ul 10X QuikChange Reaction Buffer, 16.70ul nuclease-free 
H2O, 1,80ul of 100ng/ul BamHI primer, 1ul of 100ng/ul BglII primer, 1ul dNTP mix, and 1ul 
QuikChange Lightning Multi Enzyme Blend. The BamHI primer was 25 nucleotides larger than 
BglII, therefore, an increased amount of BamHI was added to the reaction to obtain equal molar  
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Primer Sequence
BamHI Restriction Enzyme Site 5’-GCTACAATTAATACATAACCTTATGGATCCTACACATACGATTTAGGTGACACTA-3’
BglII Restriction Enzyme Site 5’-GGCGTGAAACTCCCGCAGATCTTCGGCCAG-3’
TABLE 6 
PRIMERS FOR CREATING BAMHI AND BGLII RESTRICTION ENZYME SITES 
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ratios. The components were mixed and then PCR amplified and propagated as described 
previously (Table 5, Fig.9) 
10 colonies were picked from LBamp plates and grown in 10mL LB media with 100ug/ml 
ampicillin for 12-16 hr. at 37˚C and 300rpm. DNA was extracted using a Qiagen Mini Prep Kit 
(Germantown, MD) and resuspended in 50ul EB. The DNA was labeled pBK2 1-10 RE. Samples 
were then tested to confirm the BamHI or BglII restriction enzyme sites by separate restriction 
digests. Only 1 of the 10 colonies selected contained the two restriction enzyme sites, pBK2-4-RE. 
This construct was used for cloning of the hairpin and CAA constructs.  
 
Cloning of IDT 98 Nucleotide Inserts 
pIDTSMART-amp resistant vectors, which contained a 98 nucleotide sequence encoding 
a hairpin or CAA sequence within the multiple cloning site, were purchased from IDT 
Technologies (Coralville, IA). The 5’ end of the sequence was flanked with a BamHI restriction 
enzyme site and the 3’ end was flanked with BglII. The 98 base sequences are listed in Figure 10. 
Four constructs were ordered, the hairpin constructs were predicted to have a hairpin with a 
thermodynamic stability of -30kcal/mol (35). The CAA sequence has no predicted secondary 
structure (35). The sequence in green represents the bases that were mutated in the pBK2 
sequence to yield a BamHI or BglII restriction enzyme site. The sequence in red represents the 
region that is transcribed in an in vitro SP6 reaction to make RNA, and the region in blue 
represents sequence that encodes a hairpin. The pIDTSMART-amp resistant vectors were  
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HP + 1 and CAA
5’-GGATCCTACACATACGATTTAGGTGACACTATAGGTCCACCACGGCCGATATCACGGCCGTGGTGGACAACAACAACAACAACAACAGATCT-3’
CAA 19 Repeatable Repeats
5’-GGATCCTACACATACGATTTAGGTGACACTATAGCAACAACAACAACAACAACAACAACAACAACAACAACAACAACAACAACAACAACAACAGATCT-3’
HP + 7 no CAA
5’-GGATCCTACACATACGATTTAGGTGACACTATAGAATACAGTCCACCACGGCCGATATCACGGCCGTGGTGGACGTGGCGTGAAACTCCCGCAGATCT-3’
HP + 13 no CAA
5’-GGATCCTACACATACGATTTAGGTGACACTATAGAATACAAGCTTGGTCCACCACGGCCGATATCACGGCCGTGGTGGACTGAAACTCCCGCAGATCT-3’
Figure 10.Nucleotide Sequence Constructed by IDT Technologies and Inserted into a 
pIDTSMART Mini Gene 
The 5’ end of each sequence contains the BamHI restriction enzyme site and the3’ end 
contains BglII. Sequences were designed to contain a -30kcal/mol hairpin at a +1 shift from the 
5’ cap followed be a CAA repeat, a CAA long stretch, a hairpin at a +7 shift from the 5’ cap, and 
a hairpin at a +13 shift from the 5’ cap from top to bottom, respectively.  
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propagated in HB101 competent cells, grown in LB media with 100ug/ml ampicillin, and  
extracted with Qiagen Mini Prep and Midi Prep Kits (Germantown, MD). 
10ug of pIDTSMART and pBK2-4-RE DNA were used in a double digestion reaction 
with BamHI and BglII. Samples incubated at 37˚C for 3 hours. Samples were precipitated by 
adding 2.5 volumes ice-cold 95% EtOH and 0.1 volumes 3M sodium acetate pH 5.2 and freezing 
for at least 1 hr. at -80˚C. DNA was centrifuged for 20 min. at 13,000 rpm and 4˚C. The DNA was 
resuspended in 10ul nuclease-free H2O and pIDTSMART DNA and pBK2-4-RE DNA were run 
on a 1.6% and 1.2% agarose, respectively, 1X TBE gel containing 0.5ug/ml EtBr. The large vector 
was excised from the pBK2-4-RE digested gel, and the small 93 base inserts were excised from 
the pIDTSMART vectors. The DNA was extracted from the gel using a Qiagen Gel Extraction Kit 
according to the protocol and samples were eluted in 50ul EB (Germantown, MD). The 
pIDTSMART insert and pBK2-4-RE vector were used in a ligation reaction with 6:1, 3:1, and 1:1 
molar ratio ligations of insert to vector. 100ng of vector was used for the ligation reactions. 
Ligation reactions contained final volumes of 10ul with 400 cohesive end units of New England 
Biolabs T4 DNA ligase and a final concentration of 1X T4 DNA ligase buffer (Ispwich, MA). The 
reaction incubated at room temperature for 2 hours. 50ng of sample was used to transform 
Promega HB101 competent cells according to the protocol (Madison, WI). LBamp plates 
incubated at 37˚C overnight. Colonies were grown in LBamp as described previously, DNA was 
extracted using a Qiagen Mini Prep Kit, and the correct insertions were confirmed by restriction 
digests with BamHI and BglII (Germantown, MD). Since BamHI and BglII are ischizomers, if the 
pBK2 vector religated, then the plasmid could not be cleaved with the enzymes because ligation 
created novel restriction enzyme sites. The inserts were also confirmed through sequencing 
analysis.   
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RNA Synthesis and Radiolabeling 
 RNA was synthesized and extracted using the same protocol as previously described for 
5’ cap-labeled vs. 3’ poly(A) tail-labeled RNA. For the +1 HP and 19 stretch of CAA repeats, 50ug 
RNA was incubated with 62.9ul nuclease-free H2O at 65˚C for 8 minutes. 5ul (50uCi) of *α-
32P]GTP with a specific activity of 3,000Ci/mmol was combined with 5ul 3.33umol/L unlabeled 
GTP. Following incubation at 65˚C, the RNA was chilled on ice and 10ul 10X ScriptCap Buffer, 
5ul 2mM SAM, 2.5ul RNase inhibitor, 8ul of the GTP mix, and 5ul ScriptCap Capping Enzyme 
were added to the RNA. For the +7HP and +13HP samples, the procedure was the same except 
that 23.30ul of *α-32P]GTP with a specific activity of 3,000Ci/mmol was combined with 11.7ul of 
3.33umol/L unlabeled GTP (but the same volume of GTP mix was used). The samples incubated 
at 37˚C for 1 hr. and were later phenol/chloroform extracted and precipitated for at least 1 hr. at -
80˚C with 2.5 volumes ice-cold 95% EtOH and 0.1 volume 3M sodium acetate pH 5.2. The RNA 
was resuspended in 10ul and run on a 1.3% agarose 1X TBE gel containing 0.5ug/ml EtBr for 3.5 
hours at 50V. RNA was excised and extracted with BioRad Freeze ‘N Squeeze tubes and then 
precipitated as described previously. Samples were resuspended in 20ul nuclease-free H2O. The 
+1 HP and CAA RNA were incubated at 65˚C for 8 minutes and then cooled to RT for 1 hour in 
order to restore structure prior to the Vhs assay. The predicted RNA structures of the 4 
constructs are shown in Figure 11. 
Vhs Assay 
 1ul +1HP RNA + 3ul H2O or 3ul CAA stretch RNA + 1ul H2O was added to 8.40ul of 
either 10mM Tris-Cl pH 7.5, RRL without Vhs, or RRL with Vhs. The difference in amount of 
RNA added was determined by cpm measurements, and the amount added is estimated to be  
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Figure 11.RNA Structures 
Figure 11 shows the mRNA sequence of the first 59 bases of the 4 constructs containing either a 
hairpin or CAA stretch. HP+1 (A), CAA stretch (B), HP+7 (C), and HP+13 (D) 
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0.3ug. 5ul aliquots were removed immediately from the 10mM Tris solution (0 minutes) and at 3 
and 15 minutes for the RRL samples. The remaining Vhs assay and RNA extractions were 
performed as described previously. RNA was run on a 7% polyacrylamide 8M urea 1X TBE gel. 
For the +7 and +13 HP samples, 2.80ul +7HP RNA +1.2ul H2O or 4ul +13 HP RNA + 0ul H2O was 
added to 8.40ul of either 10mM Tris-Cl pH 7.5, RRL without Vhs, or RRL with Vhs. The rest of 
the procedure was followed identical to the +1 HP and CAA stretch experiment.  
 
Cells 
 Vero and HeLa cells were purchased from the American Type Culture Collection 
(Rockville, MD). They were grown in GIBCO essential medium (MEM) (Grand Island, NY) 
which contained antibiotics and 10% (vol/vol) calf serum (9). 
 
Transient Transfections 
Vero Cells 
Vero cells were plated by splitting 1, 75cm2 flask containing 1x107 cells/flask into 6, 60 x 
15 mm dishes. 18 dishes were plated with 10ml MEM containing 10% CS. The cells grew for 48 
hr. at 37˚C. After 45 hrs. of growth, the media was refreshed with 10ml MEM containing 10% CS. 
4 hr. after the media was refreshed, cells were transfected with different combinations of 6ug of 
each plasmid (Fig. 12). Each type of dish contained 1 replicate. The procedure was performed 
according to the Promega Profection Transfection Kit protocol (Madison, WI). 16 hours after 
transfection, the media was refreshed with MEM 10% CS. Fourty-eight hours post transfection, 
the cells were washed two times with 1X PBS and then scraped in 400ul 1X Passive Lysis Buffer 
(PLB) from the Promega Dual Luciferase Reporter Assay System (Madison, WI).  
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  Figure 12.Outline of Plasmid Combinations  
HeLa or Vero cells were transfected with 2 plasmids. 6ug of each plasmid was 
added to the cells. The plasmid combinations are listed above. 
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The replicate cell samples were pooled. Cells were mixed by pipette and taken through two 
rounds of freeze thaw in an EtOH/dry ice slurry. The lysate was cleared by centrifuging at top 
speed for 15 seconds. 20ul of sample was used to record renilla and firefly luciferase expression 
following the protocol described in the Dual Luciferase Reporter Assay Kit (Madison, WI).  
 
HeLa Cells 
 HeLa cells were plated by splitting 1, 75cm2 flask into 4, 60 x 15 mm dishes. 20 dishes 
were plated with 10ml MEM containing 10% CS, but only 18 dishes were used for the study. The 
cells grew at 37˚C for 24 hours, and then the media was refreshed with MEM 10% CS prior to 
transfection. Cells were transfected with 6ug of the same combinations of plasmid as previously 
described (Fig.12). The remaining procedure was performed identical to the Vero cell 
experiment.  
 
RT PCR 
 HeLa cells were plated by splitting 1, 75cm2 flask into 2, 100 x 20 mm dishes. Cells grew  
for 48 hours at 37˚C. Cells were then mock infected or infected with 20 PFU HSV-1 KOS in the 
presence of 5ug/ml Actinomycin D with MEM 1% CS.  Cells were scraped at various time points 
by first washing two times with ice-cold 1X PBS followed by scraping cells into1ml 1X PBS. Cells 
were pelleted by centrifuging at top speed for 2 minutes at 4˚C. The pellets were resuspended in 
238ul resuspension buffer containing a final concentration of 10mM Tris-Cl pH 7.5, 0.15M NaCl, 
and 1.5mM MgCl2. Samples were inverted and vortexed briefly. Next, 12.5ul resuspension buffer 
+ 10% NP40 was added and samples were placed on ice for 10 minutes. Nuclei were pelleted by 
centrifuging at top speed for 3 minutes at 4˚C. The supernatant was then transferred to new 
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tubes containing 750ul TriZol, and the solution was mixed and briefly vortexed. 200ul of 
chloroform was added and the sample was inverted and briefly vortexed. Samples were spun in 
the centrifuge at top speed for 5 minutes. The upper aqueous phase was transferred to a new 
tube, and 500ul isopropanol was added to precipitate RNA. 
 The sample was mixed and incubated at RT for 30 minutes. RNA was then pelleted by 
centrifuging at top speed for 10 minutes. The RNA was washed with 75% EtOH and 
resuspended in TE buffer pH 7.5. 50ul of RT Master Mix was then combined with 50ul of RNA 
with a concentration of 0.002-0.2ug/ul and RNA was reverse transcribed following the Applied 
Biosystems cDNA Archive Kit protocol (Foster City, CA). 10-100ng of cDNA plus RNase-free 
H2O in a total of 9ul was combined with 1ul TaqMan Gene Expression Assay and 10ul TaqMan 
Universal PCR Master Mix (Foster City, CA). The experiment included 3 replicates. The plate 
was then added to a thermal cycler 7500 HT system for RT PCR analysis.  
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CHAPTER 3 
RESULTS 
The goal of this dissertation was to better understand the mechanism of Vhs cutting of 
messenger RNA (mRNA). Studies were designed to answer the following questions: (1) Does 
Vhs cleave mRNA encoding HSV-1 thymidine kinase at specific sites? (2) Are certain stages of 
translation initiation vital for Vhs cleavage of mRNA? (3) Does Vhs cut mRNAs that utilize a cap 
for translation initiation with equal efficiency as it cuts mRNAs that utilize an internal ribosome 
entry site? (4) How does Vhs cleave mRNAs that contain stable hairpins near the 5’ cap? The 
majority of these studies were performed using an in vitro Vhs assay system where Vhs protein 
was synthesized through in vitro transcription and translation followed by addition of RNA 
substrate (1).  
The results reveal that Vhs cleaves thymidine kinase-encoding mRNA at specific sites 
near the 5’ cap. Blocking early events of translation initiation inhibits Vhs-induced mRNA 
degradation, while blocking later stages does not have a significant effect on Vhs activity.  
Additionally, Vhs is unable to cleave an mRNA that is normally translated by cap-dependent 
scanning if that mRNA is circularized to prevent it from initiating translation. Yet, Vhs retains 
the ability to specifically cut circularized RNA that does not use the traditional cap-dependent 
scanning mechanism. The later finding further supports the idea that a free 5’ end is important 
for Vhs degradation of scanned mRNAs. Furthermore, mutational studies indicate that Vhs may 
be associating with the scanning complex to reach some of its preferred cut sites. Inhibiting the 
scanning process by incorporating stable hairpins into the 5’ end of the RNA greatly reduces Vhs  
site-specific cutting. Interestingly, cutting at the 5’ end of mRNA is more efficient if the mRNA 
contains a sequence with no predicted secondary structure in the 5’ UTR.  
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Vhs Degradation of mRNA 
Previous studies have shown that in vitro translated Vhs is the only viral protein 
required for RNase activity in a rabbit reticulocyte lysate system (1-5). In these assays antibodies 
against Vhs inhibit cleavage of mRNA (4).  Additionally Vhs-1, a single point mutant where 
threonine is replaced by isoleucine at nucleotide 214, causes Vhs loss of function and is unable to 
cleave mRNA (4). During their investigation of RNA degradation, Smiley et al. showed that Vhs 
cleaves SRP-α mRNA at regions within the 5’ quadrant (5). This observation gives rise to a 
question, previously not addressed, of whether the 5’ cap scanning complex plays a significant 
role in Vhs cutting.  
Vhs has been shown to associate with translation initiation factors and also have a 
preference for cleaving some mRNAs at specific sites near the 5’ end (5-8). These two findings 
support a model in which Vhs selectively cuts mRNA by associating with translation initiation 
factors. It is possible that, upon recruitment to the cap, Vhs maintains binding to these factors 
and travels with them in as a component of the scanning complex during translation initiation. 
Additional questions remain about the mechanism of Vhs cleavage, such as whether the initial 
processes of translation initiation are required for Vhs activity, and whether the AUG start 
codon has any importance.  
 
Determining the Cut Sites in pBK2 mRNA 
Vhs Cleavage of Internally-labeled, 5’ Cap-labeled, and 3’ Poly(A) Tail-labeled mRNA 
To begin investigating the mechanism of Vhs cutting, an HSV-1 mRNA that encodes 
thymidine kinase (pBK2) was tested in a Vhs assay. pBK2 mRNA was selected for study because 
it undergoes the traditional cap-dependent scanning process during translation initiation and it 
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is degraded with half life rates comparable to cellular mRNAs in vivo (9). In the first study, 
mRNA substrate was internally labeled with *α-32P]GTP during an in vitro transcription reaction. 
The mRNA was then added to a rabbit reticulocyte lysate in vitro translation system that either 
lacked or contained Vhs protein. Figure 13 shows typical results obtained from the in vitro 
translation reaction, prior to target mRNA addition, confirming that Vhs is only present when 
pKOSamp mRNA is added to the system.  After mRNA substrate was combined with RRL, 
samples were removed at various time points followed by mRNA extraction and analysis via 
autoradiography (Fig. 14). There was a rapid disappearance of full length mRNA, accompanied 
by the appearance of one or more smaller sized fragments (Fig. 14). Vhs cleavage of pBK2 
mRNA was not targeted to a region located in the middle of the transcript, because no distinct 
bands were detected. Instead, Vhs produced products just slightly smaller than full length. This 
indicated that the cleavage was originating from one of the ends of the mRNA (Fig. 14). Since the 
mRNA was internally labeled, it was not possible to determine from what end the cutting 
originated.  
To further test this question, pBK2 RNA was synthesized in a large scale in vitro 
transcription reaction. Following transcription, the RNA was capped using an m7G capping kit 
(EPICENTRE) containing vaccinia virus capping enzyme. During the capping process the RNA 
cap was either labeled with *α-32P]GTP or given a cold cap with non-radioactive GTP. After the 
capping reaction, the mRNA with a labeled cap was added to a cold poly(A) tailing reaction, and 
the mRNA that received a cold cap was added to a hot polyA tailing reaction with *α-32P]ATP. 
The mRNA substrates were then added to a Vhs assay and removed at the indicated time points 
(Fig. 15). Figure 15 shows a sharp disappearance of full length 5’ cap-labeled pBK2 mRNA at the 
9 minute time point. This disappearance was not accompanied by the appearance of any large  
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Figure 13.Sythesis of Vhs protein in a Rabbit Reticulocyte Lysate System 
Figure 13 shows a SDS protein gel from an S-35 methionine-labeled in vitro translation reaction in a rabbit 
reticulocyte lysate system. –pKOSamp RNA represents a negative control where pKOSamp mRNA was not 
added to the system and instead was replaced with water. +pKOSamp RNA represents an in vitro 
translation reaction that contained pKOSamp mRNA (encodes Vhs). Samples incubated for 1.5 hours at 
30˚C and where then run on an SDS-PAGE gel, dried, and viewed using autoradiography. 
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0’ 0’1’ 1’3’ 6’ 3’9’ 6’ 9’15’ 15’Min
RRL (no Vhs) RRL + Vhs
 
Figure 14.Vhs Degradation of Internally Labeled pBK2 mRNA 
Figure 14 shows internally labeled pBK2 mRNA in the absence (RRL) or presence (RRL + Vhs) of in vitro 
translated Vhs protein. The mRNA was subjected to a time course assay with the minutes at which 
mRNA was removed listed above. RRL= rabbit reticulocyte lysate that lacked Vhs protein. Vhs=rabbit 
reticulocyte lysate that contained Vhs. Min=minutes mRNA incubated in rabbit reticulocyte lysate prior 
to removal. 
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A. B.
0’
5’ cap-labeled pBK2 RNA 3’ poly A tail-labeled pBK2 RNA
RRL Vhs RRL Vhs
3’ 9’ 15’ 0’ 0’ 0’3’ 3’ 3’9’ 9’ 9’15’ 15’ 15’
Figure 15.Vhs Degradation of Cap-labeled vs. Tail-labeled mRNA 
Pictured above is pBK2 mRNA containing a 5’ labeled cap with a non-radioactive polyA tail (A) and 
pBK2 mRNA containing a 5’ non-radioactive cap with a 3’ labeled polyA tail (B). The gel was 
visualized by autoradiography representing total mRNA remaining after the Vhs assay. Lanes 
marked by RRL represent mRNA in the absence of Vhs and lanes marked by Vhs represent mRNA in 
the presence of Vhs (A and B).  0’, 3’, 9’, and 15’ represent minutes mRNA incubated in rabbit 
reticulocyte lysate before extraction. RRL=rabbit reticulocyte lysate lacking Vhs.Vhs=rabbit 
reticulocyte lysate containing Vhs. 
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fragments that were close in size to full length (Fig. 15). However, Vhs cleavage of 3’ poly(A) 
tail-labeled pBK2 mRNA resulted in appearance of a smear of products that were large enough 
to visualize on a 1.3% agarose 1XMOPS gel (Fig. 15 compare A and B). The results suggest that 
Vhs cleaves pBK2 mRNA at regions near the 5’ end, and produces cleavage products that are too 
small to be visualized by a 1.3% agarose gel. This result supports previous reports from studies 
using northern blot analysis to examine cells that were infected with wild type HSV-1 which 
showed that the 5’ end of pBK2 mRNA was preferentially cleaved (8).  
In order to examine the cut sites more closely, mRNA was run on a 7% polyacrylamide 
8M urea 1X TBE gel using a DNA sequencing apparatus. By analyzing cap-labeled mRNA with 
this method, it was easy to identify specific cut sites produced by Vhs. Vhs cut pBK2 mRNA at 
several prominent sites all within the first 300 bases from the 5’ end (Fig. 16). However, this 
same type of end-directed cutting was not identified when analyzing the 3’ poly(A) tail-labeled 
mRNA to examine the downstream products produced by cutting (Fig. 16). Instead, Vhs cut this 
mRNA to produce cleavage products that were slightly shorter than full length substrate and 
were retained at the top of the gel (Fig. 16). The results of the two gels indicate a method of Vhs 
degradation involving Vhs cleavage of pBK2 mRNA at sites near the 5’ end, leaving a trailing 
product of larger mRNA that is detectable through 3’ poly(A) tail labeling.   
 
Vhs Titration 
To further characterize Vhs activity, it was important to set up a Vhs assay with serial 
two fold dilutions of Vhs (in order to confirm that the nuclease activity was due to Vhs alone). 
Cap-labeled pBK2 mRNA was added to RRL samples that contained different concentrations of 
Vhs. These dilutions were obtained by using a sample that contained RRL with undiluted Vhs  
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Figure 16.Analysis of Smaller pBK2 mRNA Cleavage Products   
pBK2 substrate mRNA labeled at the 5’ end with a capping kit (A.) or at the 3’ end with a polyA tailing 
kit (B.) was added to a Vhs assay that either lacked (RRL) or contained (Vhs) Vhs protein. It was then 
removed at the indicated time points, extracted with TriZol, and run on a polyacrylamide sequencing 
gel. The mRNA was then visualized through autoradiography. Marker sizes are listed between the two 
gels. RRL=rabbit reticulocyte lysate lacking Vhs. Vhs=rabbit reticulocyte containing Vhs. M=ФX174Hinf1 
markers. 
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protein (1X). After the in vitro translation reaction, the 1X sample was diluted in half with rabbit 
reticulocyte lysate that lacked Vhs to make the 0.5X sample. Lastly, the 0.5X sample of Vhs was  
diluted in half to make the 0.25X sample. The mRNA was added to the Vhs samples, extracted at 
various time points, and analyzed by autoradiography. RNA was degraded in a dose-dependent 
response where there was a correlation between the amount of Vhs protein in the system and the 
severity of mRNA cutting (Fig. 17). When analyzing the control samples which lacked Vhs, it 
was apparent that the system contained slight background RNase activity (Fig. 17). Yet, this 
background activity was minimal when compared to the mRNA degradation induced by Vhs 
(Fig. 17). Of particular note, for the most concentrated, undiluted sample of Vhs, complete 
mRNA degradation was achieved by the 9 minute time point. 
 
Vhs Assay Using mRNA Substrate Labeled with a Higher Specific Activity 
To enhance investigation of mRNA cut sites, two further experiments were performed 
involving (1) radioactive material with a higher specific activity or (2) an extended time point of 
mRNA and protein incubation. First, *α-32P]GTP with a specific activity of 3,000 Ci/mmol was 
used in an in vitro m7G capping reaction instead of the original 800 Ci/mmol. The rest of the Vhs 
assay was carried out identical to previous experiments. Figure 18 shows the results of the 
reaction using mRNA labeled with 3,000 Ci/mmol *α-32P]GTP (Fig. 18B) compared to an older 
experiment with 800 Ci/mmol (Fig. 18A). Vhs produced 6 prominent cut sites all within the first 
300 bases from the 5’ cap (Fig. 18) as well as several less prominent cut sites in the upstream 
region (Fig. 18B). The same cut sites that were identified when labeling mRNA with 800 
Ci/mmol were also found when labeling with 3,000 Ci/mmol (Fig. 18). Using a hotter mRNA 
target, it was possible to detect bands that were otherwise faint when labeling with 800 Ci/mmol 
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Figure 17.Degradation of pBK2 mRNA Using Serial Two Fold Dilutions of Vhs Protein 
Cap-labeled pBK2 mRNA was added to rabbit reticulocyte lysate systems with serial two fold dilutions of 
Vhs protein or with reticulocyte lysate lacking Vhs protein. mRNA was then removed from the system at 
the indicated time points, extracted, and run on a full length 1.3% agarose 1XMOPS gel. It was further 
dried and analyzed through autoradiography, analyzing the remaining full length mRNA through volume 
reports (A). Scatter plot representation of amount of mRNA remaining after incubation of mRNA 
substrate with various concentrations of Vhs (B). RRL=rabbit reticulocyte lysate without Vhs protein, 
Vhs(1X)=rabbit reticulocyte lysate with undiluted Vhs protein, Vhs(.5X)=rabbit reticulocyte lysate with 2 
fold dilution of Vhs(1X), Vhs(.25X)=rabbit reticulocyte lysate with 2 fold dilution of Vhs(.5X).  
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Figure 18. mRNA Cut Site Analysis After Using *α-32P]GTP with 3,000 Ci/mmol 
Pictured in Fig. 18 is 5’ cap-labeled pBK2 mRNA following incubation with Vhs protein. RNA was either 
labeled with a specific activity of 800 Ci/mmol (A.) or 3,000 Ci/mmol (B.) in an in vitro cap-labeling 
reaction followed by purification and addition to a rabbit reticulocyte lysate lacking (RRL) or containing 
(Vhs) Vhs. mRNA was extracted at the indicated time points and analyzed by autoradiography. 
RRL=rabbit reticulocyte lysate without Vhs.  Vhs=RRL containing Vhs.  M=ФX174Hinf1 markers. 
Min.=amount of time in minutes mRNA incubated with rabbit reticulocyte lysate. Hash marks in A 
represent the most prominent cut sites identified. Red arrows in B represent the most prominent cut 
sites identified, black arrows represent cut sites identified, and hollow circles represent faint cut sites 
detected. 
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*α-32P]GTP (Fig. 18B). Figure 19 shows the cut sites mapped to the pBK2 sequence.  
 
Vhs Assay with Extended mRNA Incubation 
To better understand the stability of the mRNA in the Vhs assay system after cleavage 
and whether Vhs cleaves mRNAs at different sites upon further time spent in the in vitro system, 
a Vhs assay was performed analyzing mRNA cleavage products at later time points following 
mRNA substrate addition to Vhs protein. In this experiment, cap-labeled mRNA substrate was 
incubated for 3, 15, 30, and 60 minutes in the presence or absence of Vhs protein followed by 
RNA extraction and analysis of the cleavage products through autoradiography. Interestingly, 
the pattern of Vhs cutting was the same over time, where it primarily produced mRNA 
fragments of the same size at the 30 and 60 minute time points as those at the 3 and 15 minute 
times (Fig. 20).  
It appears that the RRL system did not contain a large amount of background nuclease 
activity, because the cleavage products that were produced early in the time course were not 
rapidly degraded by the 60 minute time point (Fig. 20). Vhs appeared to use the same 
mechanism for cleaving pBK2 mRNA at the beginning of the Vhs assay as it did upon further 
incubation in the RRL system, because with time several of the same RNA cleavage products 
were produced (Fig. 20). As incubation time increased, novel mRNA cleavage bands migrating 
between 30 and 50 bases were identified (Fig. 20). It is not clear how these cut sites were 
produced. They could be due to cutting of the initial products of Vhs cleavage a second time by 
either Vhs or a cellular enzyme. At this time it is also uncertain if Vhs produces a single cut on 
the mRNA template, or if it remains associated with the transcript for additional rounds of 
cleavage.  
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A. Cut Sites Detected Using *α-32P]GTP with a Specific Activity of 800 Ci/mmol 
GAAUACAAGC   UUGGGCUGCA   GGUCGACUCU   AGAGGAUCUU GGUGGCGUGA                                                      
AACUCCCGCA    CCUCUUUGGC   AAGCGCCUUG UAGAAGCGCG    UAUGGCUUCG
UACCCCUGCC    AUCAACACGC  GUCUGCGUUC    GACCAGGCUG  CGCGUUCUCG 
CGGCCAUAGC   AACCGACGUA  CUGCGUUGCG    CCCUCGCCGG CAGCAAGAAG
CCACGGAAGU   CCGCCUGGAG  CAGAAAAUGC   CCACGCUACU    GCGGGUUUAU   
AUAGACGGUC   CUCACGGGAU GGGGAAAACC   ACCACCACGC    AACUGCUGGU
GGCCCUGGGU   UCGCGCGACG   AUAUCGUCUA
Kozak consensus:    AccAUGG
G
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GAAUACAAGC   UUGGGCUGCA   GGUCGACUCU   AGAGGAUCUU GGUGGCGUGA                                                      
AACUCCCGCA    CCUCUUUGGC   AAGCGCCUUG   UAGAAGCGCG   UAUGGCUUCG
UACCCCUGCC    AUCAACACGC  GUCUGCGUUC    GACCAGGCUG   CGCGUUCUCG 
CGGCCAUAGC   AACCGACGUA  CUGCGUUGCG    CCCUCGCCGG  CAGCAAGAAG
CCACGGAAGU   CCGCCUGGAG  CAGAAAAUGC   CCACGCUACU    GCGGGUUUAU   
AUAGACGGUC   CUCACGGGAU GGGGAAAACC   ACCACCACGC    AACUGCUGGU
GGCCCUGGGU   UCGCGCGACG   AUAUCGUCUA
Kozak consensus:    AccAUGG
G
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B. Cut Sites Detected Using *α-32P]GTP with a Specific Activity of 3,000 Ci/mmol  
Figure 19.Mapping pBK2 mRNA Cut Sites with 5’ Cap Labeling 
The cut sites from the 5’ cap-labeled experiments using with a specific activity of 800 Ci/mmol (A.) or 
3,000 Ci/mmol (B.) are labeled in Figure 19. The boxes include the first 330 bases of the pBK2 mRNA 
sequence. Black arrows show the estimated location where cutting occurred. The bolder arrows 
depict the most prominent cut sites and the less intense arrows show the cut sites that were less 
abundant (B). The sequence marked in red highlights the first three AUG codons of the sequence.  
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Figure 20.Vhs Assay with pBK2 mRNA Using Extended Time Points 
Cap-labeled pBK2 mRNA was added to rabbit reticulocyte lysate lacking (RRL) or containing (+ Vhs) 
Vhs protein. Sample was then removed at the indicated time points followed by RNA extraction and 
analysis through autoradiography. The red arrows indicate the prominent cut sites produced by Vhs, 
and the hollow circles indicate the less abundant RNA cleavage products. M=ФX174Hinf1 markers. 
0’, 3’, 15’, 30’, and 60’ indicate minutes mRNA substrate incubated with Vhs prior to extraction.  
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Primer Extension Analysis  
The previous study focused on using 5’ cap-labeled mRNA to identify the upstream 
products produced by Vhs cleavage. Another way to study nuclease activity is to examine the 
downstream products produced by cutting through primer extension analysis. In this study, 
pBK2 mRNA was capped in an m7G capping reaction with unlabeled GTP. The mRNA was then 
added to a RRL system either lacking or containing Vhs. Samples were removed at various time 
points followed by RNA extraction. Lastly, mRNA was analyzed in a primer extension reaction 
using three radiolabeled primers that bound to different regions near the 5’ end. The primers 
used in this study were named P165, P235, and P325. Their names indicate the length of bases 
the primers would synthesize if they bound to the RNA and reverse transcribed all the way to 
the 5’ cap. Therefore, P165 means that, if the primer were to extend to the 5’end, then it would 
produce a product of 165 bases.  
As is apparent from Figure 21, during the reverse transcription process reverse 
transcriptase stalls at many pause sites. The pause sites are likely due to mRNA structural 
barriers. Because of this, the only bands that are attributed to Vhs cutting are those identified 
solely in the 15 or 30 minute time point in the presence of Vhs. The cut sites identified are 
marked by red dots (Fig. 21A) or black arrows (Fig. 21B). The cut sites identified through primer 
extension are diagrammed in Figure 22. Primer extension analysis was a more sensitive method 
for determining RNA cut sites since, upon radiolabeling, the sample was directly added to a gel 
for analysis and did not undergo further washes. Longer incubation of Vhs with mRNA 
substrate resulted in additional cutting of mRNA (Fig. 22B). The prominent cut sites were  
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Figure 21.Primer Extension Analysis of pBK2 mRNA Cut Sites 
Primer extension analysis of pBK2 mRNA at 15 (A.) and 30 (B.) minute time points. pBK2 mRNA was 
added to rabbit reticulocyte lysate in the absence (RRL) or presence (Vhs) of Vhs protein. Samples 
were removed at the indicated time points followed by RNA extraction and analysis through primer 
extension. P165, P235, and P325 are the primers that recognize different regions of the pBK2 mRNA 
sequence, and if they extend to the 5’ cap during primer extension they produce a DNA band of 165; 
235; or 325 bases, respectively. The red dots (A) and black arrows (B) mark bands caused by Vhs 
cutting. M=ФX174 Hinf1 markers. 
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Figure 22.Mapping pBK2 mRNA Cut Sites Using Primer Extension Analysis 
The cut sites identified from the primer extension experiments are labeled in the diagrams 
above. mRNA was incubated with Vhs for 15 (A) or 30 (B) minutes. The boxes include the first 330 
bases of the pBK2 mRNA sequence. Red arrows show the estimated location of cutting. The 
bolder arrows depict the most prominent cut sites and the less intense arrows show the cut sites 
that were less abundant. The sequence marked in red highlights the first three AUG codons from 
the 5’ end. 
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repeatedly detected through primer extension (Fig. 22). Figure 22B does not show a prominent 
cut site at bases 51 or 80 because primer 165 was not used in the experiment. 
A summary of the prominent cut sites identified through both 5’ cap labeling and primer 
extension is pictured in Figure 23. The black arrows indicate the cut sites determined by 5’ cap 
labeling which represent the upstream cleavage products. The red arrows mark those found by 
primer extension analysis which identify the downstream products produced by cutting. 
Notably, most of the prominent cut sites established through the two methods line up or are 
very close to one another (Fig. 23). 
 These data support previous reports that Vhs is an endoribonuclease (2, 4, 5, 10, 11, 12, 
13). Several of the cut sites are close to and slightly upstream from the first three AUG codons of 
the pBK2 sequence (Fig. 23). This finding suggests that Vhs may interact with the scanning 
complex upon association with the eIF4F cap-binding complex, and that its cut sites may be 
reached by piggybacking on the complex during scanning. Yet, under this mechanism for 
cutting, one would expect the cut sites to be limited to regions solely upstream or at the first 
AUG codon. This is because, upon reaching the start codon, the scanning complex stalls in a 
process that is followed by loss of initiation factors and recruitment of the large ribosomal 
subunit. In this case, Vhs would not be expected to cleave mRNA near regions of the second and 
third AUGs because scanning wouldn’t progress to these areas. However, it’s important to note 
that the first two AUGs are in a suboptimal context when compared to the Kozak consensus 
sequence, but the third AUG is in an optimal context (Fig. 23). In this case, one cannot rule out 
that the scanning complex may experience leaky scanning while reading the mRNA sequence 
during translation initiation. Previous work in the lab has shown that pBK2 produces three  
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GAAUACAAGC   UUGGGCUGCA   GGUCGACUCU   AGAGGAUCUU GGUGGCGUGA                                                      
AACUCCCGCA    CCUCUUUGGC   AAGCGCCUUG   UAGAAGCGCG   UAUGGCUUCG
UACCCCUGCC    AUCAACACGC  GUCUGCGUUC    GACCAGGCUG   CGCGUUCUCG 
CGGCCAUAGC   AACCGACGUA  CUGCGUUGCG    CCCUCGCCGG  CAGCAAGAAG
CCACGGAAGU   CCGCCUGGAG  CAGAAAAUGC   CCACGCUACU    GCGGGUUUAU   
AUAGACGGUC   CUCACGGGAU GGGGAAAACC   ACCACCACGC    AACUGCUGGU
GGCCCUGGGU   UCGCGCGACG   AUAUCGUCUA
Kozak consensus:    AccAUGG
Cut site detected using cap-
labeled mRNA
Cut site detected by primer 
extension
50
100
150
200
250
300
G
Figure 23.Summary of the Prominent Cut Sites Identified through 5’ Cap-labeling and Primer 
Extension Analysis  
Figure 23 shows a diagram of the prominent cuts sites identified through primer extension analysis 
and 5’ cap-labeling of pBK2 mRNA. The black arrows show the cut sites found through 5’ cap-
labeling and the red arrows indicate those identified through primer extension analysis. The 
sequence in red highlights the first three AUGs of the pBK2 mRNA sequence. The Kozak consensus 
sequence is listed on the lower left corner, showing the optimal locations for purine residues 
surrounding the AUG codon. The first and second codons are in a suboptimal context compared to 
the Kozak consensus sequence, yet the third AUG is in an optimal context. The arrows mark the 
estimated cut site locations, and the slight differences in location could be due to uncertainties in 
size estimates between gels.  
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protein products in an in vitro RRL system, and these protein products correspond to initiating 
synthesis from the first three AUGs of the pBK2 mRNA sequence (Karr and Read, unpublished).  
 
The Effect of Translation Initiation Inhibition on Vhs Cleavage 
Cycloheximide Experiments 
To test the importance of translation initiation for mRNA cleavage, inhibition studies 
were performed that blocked various stages of translation initiation. First, as a control, studies 
were designed to test the effect of cycloheximide on Vhs activity in a RRL system. 
Cycloheximide is an antibiotic produced by Streptomyces griscus which has been shown to block 
protein synthesis in yeast and mammalian cells (15-21). The antibiotic blocks protein synthesis 
by inhibiting peptide bond formation. In the presence of cycloheximide, translation initiation 
factors and the 40S ribosomal subunit still associate near the 5’ cap and scanning occurs to the 
AUG start codon. The large ribosomal subunit still binds to the 40S subunit, but no protein is 
made. Studies with HSV-1 infected cells in the presence of Actinomycin D have found that 
cycloheximide does not inhibit Vhs’s ability to degrade mRNA (14).  
In the present study, RRL containing or lacking Vhs was incubated with 50ug/ml 
cycloheximide or water for 12 minutes at 30˚C. Following the incubation, cap-labeled pBK2 
mRNA was added to the system, and RNA was extracted at various time points followed by 
analysis on a 1.3% agarose 1X MOPS gel (Fig. 24). In the presence of cycloheximide, Vhs showed 
similar levels of mRNA degradation as the control which lacked cycloheximide (Fig. 24). This gel 
shows that protein synthesis is not required for Vhs degradation of mRNA. To study the effect 
of cycloheximide in more detail, an identical assay was performed and samples were run on a 
7% polyacrylamide 8M urea 1X TBE gel to examine site-specific cleavage (Fig. 25).   
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Figure 24.Vhs Degradation of pBK2 mRNA in the Presence of Cycloheximide 
Rabbit reticulocyte lysate containing (Vhs) or lacking (RRL) Vhs protein was combined with water or 
cycloheximide (+Cyclo) to a final concentration of 50ug/ml. After a 12 minute incubation, cap-labeled 
pBK2 mRNA was added and samples were extracted at the indicated time points listed above. RNA was 
extracted and analyzed on a 1.3% agarose 1X MOPS gel through autoradiography. After exposure, the 
gel was scanned and relative amount of mRNA remaining was quantified using ImageQuant 5.0 
software. RRL=rabbit reticulocyte lysate that lacks Vhs. Vhs=rabbit reticulocyte lysate that contains Vhs 
protein. Min=minutes mRNA incubated in rabbit reticulocyte lysate before removal. 
Cyclo=cycloheximide. 
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Figure 25.Vhs Site Specific Cleavage of pBK2 mRNA in the Presence of Cycloheximide 
Cap-labeled pBK2 mRNA samples from the same experiment performed in Figure 24 were run on a 7% 
polyacrylamide 8M urea gel to examine Vhs site-specific cutting. –Cyclo represents sample that was 
incubated with water for 12 minutes prior to addition of pBK2 mRNA. +Cyclo represents sample that was 
incubated with 50ug/ml cycloheximide prior to mRNA addition. The black arrows mark the prominent cut 
sites identified due to Vhs cutting and the hollow circles indicate the less prominent cut sites determined. 
RRL=rabbit reticulocyte lysate without Vhs. Vhs=rabbit reticulocyte lysate containing Vhs. Min.=minutes 
pBK2 mRNA incubated in rabbit reticulocyte lysate before extraction. M=ФX174Hinf1 markers.  
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Cycloheximide did not inhibit Vhs’s ability to specifically cleave pBK2 mRNA, because in its 
presence Vhs produced the exact same cutting pattern at 3 minutes of incubation (Fig. 25). It is 
possible that further cleavage of the primary mRNA degradation products is more rapid in the 
absence of cycloheximide (Fig. 25). 
 
GMP-PNP Experiments 
  In the next study, GMP-PNP, a nonhydrolyzable analogue of GTP, was used to block an 
earlier stage of translation initiation. GMP-PNP hinders GTP hydrolysis, and this process is 
required for loss of translation initiation factors from the AUG start codon and recruitment of 
the large ribosomal subunit. However, GMP-PNP does not block assembly of the 48S complex 
(22, 23). Therefore, in the presence of GMP-PNP, initiation factors and the small ribosomal 
subunit are still recruited to the 5’ cap and the scanning complex is able to scan to the start 
codon. Yet, after scanning, translation initiation is inhibited and the 60S ribosomal subunit is not 
recruited to the mRNA template.  
 Rabbit reticulocyte lysate containing or lacking Vhs was incubated with water or 2mM 
GMP-PNP for 12 minutes at 30˚C followed by addition of cap-labeled pBK2 mRNA. All samples 
contained endogenous GTP that was present in the RRL system. Samples were then aliquotted at 
various time points followed by RNA extraction and analysis through autoradiography. Studies 
found that GMP-PNP had at most a modest inhibition on Vhs cutting of mRNA (Fig. 26). 
However, at the fifteen minute time point Vhs was able to degrade mRNA to comparable levels 
as mock in the presence of GMP-PNP (Fig. 26). Next, samples were run on a 7% polyacrylamide 
8M urea 1X TBE gel to analyze Vhs site-specific cleavage in the presence of GMP- PNP (Fig. 27).  
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Figure 26.Vhs Degradation of pBK2 mRNA in the Presence of GMP-PNP 
Rabbit reticulocyte lysate containing (Vhs) or lacking (RRL) Vhs protein was incubated with 2mM 
GMP-PNP (+GMP-PNP) or water for 12 minutes prior to addition of cap-labeled pBK2 mRNA. 
Samples were removed at the indicated time points followed by RNA extraction and analysis 
through autoradiography (top picture). Following scanning, mRNA levels were quantified using 
ImageQuant 5.0 software (bottom picture). RRL=rabbit reticulocyte lysate without Vhs. Vhs=rabbit 
reticulocyte lysate containing Vhs. Min=minutes that pBK2 mRNA incubated in rabbit reticulocyte 
lysate before extraction. 
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Figure 27.Vhs Site Specific Cleavage of pBK2 mRNA in the Presence of GMP-PNP 
Prior to addition of cap-labeled pBK2 mRNA, rabbit reticulocyte lysate that contained (Vhs) or lacked 
(RRL) Vhs was incubated with 2mM GMP-PNP (+GMP-PNP) or water (-GMP-PNP) for 12 minutes at 
30˚C. Cap-labeled pBK2 mRNA was then added and samples were removed at the indicated time points 
followed by RNA extraction. Samples were then run on a 7% polyacrylamide 8M urea 1X TBE gel and 
analyzed through autoradiography. The black arrows show the prominent cut sites detected and the 
hollow circles mark the less prominent cut sites. RRL=rabbit reticulocyte lysate that does not contain 
Vhs. Vhs=rabbit reticulocyte lysate that contains Vhs. Min.=minutes that mRNA incubated in the rabbit 
reticulocyte system before removal. M=ФX174Hinf1 markers. 
4-13-09 from 4-3-09 
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Similar results were also obtained using a sequencing gel, where GMP-PNP did not hinder Vhs’s 
ability to produce the same specific cut sites (Fig. 27).This indicates that recruitment of the large 
ribosomal subunit to the mRNA template is not vital for Vhs cleavage of mRNA.  
 
AMP-PNP Experiments 
To test whether an earlier stage of translation initiation was important for Vhs cleavage 
of mRNA, ATP hydrolysis was blocked by using the nonhydrolyzable analog of ATP, AMP-
PNP. ATP is essential for RNA helicase activity of eIF4A and the eIF4F cap binding complex 
which helps unwind RNA secondary structure and make it accessible for binding of translation 
initiation factors and scanning to the start codon. AMP-PNP hinders 48S complex formation, and 
it has been reported to reduce binding of translation initiation factors to the 5’ end (23, 60). The 
experiment was performed identically to the GMP-PNP experiment, except a final concentration 
of 2mM AMP-PNP or water was incubated with rabbit reticulocyte lysate instead of GMP-PNP. 
All samples contained an endogenous mixture of ATP which was present in the RRL system. 
AMP-PNP significantly inhibited Vhs cutting of pBK2 mRNA, where in its presence degradation 
levels were similar to control levels that lacked Vhs (Fig. 28). This result suggests that ATP 
hydrolysis for unwinding mRNA secondary structure and/or for recruitment of initiation factors 
and the small ribosomal subunit to the 5’cap is necessary for Vhs cleavage. 
 To further study the effect of AMP-PNP on Vhs degradation of mRNA, samples were 
run on a 7% polyacrylamide 8M urea 1X TBE gel (Fig. 29). The arrows identify the most 
prominent cleavage products and the hollow circles identify the less prominent sites (Fig. 29). 
Vhs was still able to produce some of the same specific cut sites in the presence of AMP-PNP 
(Fig. 29 black arrows). This is because, although AMP-PNP significantly inhibited cutting of total     
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Figure 28.Vhs Degradation of pBK2 mRNA in the Presence of AMP-PNP 
Rabbit reticulocyte lysate containing (Vhs) or lacking (RRL) Vhs protein was incubated with 2mM AMP-
PNP (+AMP-PNP) or water for 12 minutes at 30˚C prior to addition of cap-labeled pBK2 mRNA. Samples 
were removed at the indicated time points followed by RNA extraction and autoradiography (top 
picture). Following scanning, mRNA was quantified with ImageQuant 5.0 software (bottom picture). 
RRL=rabbit reticulocyte lysate in the absence without Vhs. Vhs=rabbit reticulocyte lysate containing 
Vhs. Min.=minutes mRNA incubated in rabbit reticulocyte system before removal.  
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Figure 29.Vhs Site Specific Cutting of pBK2 mRNA in the Presence of AMP-PNP 
Rabbit reticulocyte lysate containing (Vhs) or lacking (RRL) Vhs incubated with 2mM AMP-PNP (+AMP-PNP) 
or water for 12 minutes at 30˚C. Cap-labeled pBK2 mRNA was then added at to the system and samples 
incubated at 30˚C at the time points indicated above. Samples were then removed followed by RNA 
extraction. RNA was run on a 7% polyacrylamide 8M urea 1X TBE gel and analyzed by autoradiography. The 
black arrows represent prominent cut sites that were not hindered by addition of AMP-PNP. Red arrows and 
hollow circles mark the more prominent and less prominent cut sites that were inhibited by AMP-PNP, 
respectively.  RRL=rabbit reticulocyte lysate that lacked Vhs. Vhs=rabbit reticulocyte lysate that contained 
Vhs. Min.=amount of minutes pBK2 mRNA incubated in rabbit reticulocyte lysate prior to extraction.  
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pBK2 mRNA, it didn’t cause complete inhibition. However, AMP-PNP strongly inhibited 
specific cutting at regions in the first 150 bases of the mRNA sequence (Fig. 29, cut sites 
highlighted in red). Cycloheximide, GMP-PNP, and AMP-PNP were all tested in an in vitro 
translation reaction using S35 methionine to confirm their inhibition on translation (Fig. 30). 
 
Cap Analog Experiments  
Another way to study the importance of early stages of translation initiation is to use an 
m7G cap analog to inhibit binding of initiation factors to the 5’ cap of the mRNA template. In the 
next study, rabbit reticulocyte lysate was incubated with 3mM cap analog or water for 12 
minutes at 30˚C followed by addition of cap-labeled pBK2 mRNA. Samples were incubated in 
RRL for various time points followed by RNA extraction. RNA was then run on a 1.3% agarose 
1X MOPS gel and analyzed by autoradiography (Fig. 31). 3mM cap analog slightly inhibited Vhs 
cleavage of pBK2 mRNA (Fig. 31 compare the 9 and 15 min. time points of Vhs in the presence 
and absence of cap analog). To get a closer look at the inhibition, another Vhs assay was 
performed with 5mM cap analog and RNA samples were run on a 7% polyacrylamide 8M urea 
1X TBE gel to look at the cap analog’s effect on site-specific cleavage (Fig. 32).  
Here, it is obvious that the cap analog inhibits Vhs cleavage of the first 80 nucleotides of 
pBK2 (Fig. 32 compare the 9 and 15 minute time points of Vhs in the presence and absence of cap 
analog). However, the inhibition was incomplete and Vhs was still able to cleave pBK2 mRNA at 
sites further downstream in the presence of cap analog (Fig. 32 Vhs + cap analog at 9 and 15 
minutes). It’s important to note that the cap analog has been reported to only have a 50% 
inhibition on translation in the rabbit reticulocyte system (25). It will be important to see if the  
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Figure 30.Cycloheximide, GMP-PNP, and AMP-PNP Inhibition on in vitro Translation 
Various inhibitors were added to rabbit reticulocyte lysate that contained all of the components of 
an in vitro translation reaction except mRNA substrate. The sample incubated for 10 minutes at 
30˚C followed by addition of unlabeled mRNA substrate. Protein was labeled with S35 methionine. 
The samples were run on an SDS PAGE gel followed by autoradiography for protein analysis. 
Reactions that contained pBK2 mRNA are shown in A-C and those that received pKOSamp mRNA 
(encodes Vhs) are shown in D. Cyclo=cycloheximide. 
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Figure 31.Vhs Degradation of pBK2 mRNA in the Presence of Cap Analog 
Pictured in Figure 31 is cap-labeled pBK2 mRNA after addition of 3mM cap analog (+3mM cap) or 
water to the rabbit reticulocyte lysate system. Cap analog was incubated with rabbit reticulocyte 
lysate for 12 minutes at 30˚C prior to addition of mRNA. Samples were removed at the indicated time 
points followed by RNA extraction and analysis on a 1X MOPS 1.3% agarose gel. Min.=minutes that 
RNA incubated in rabbit reticulocyte prior to removal. RRL=rabbit reticulocyte lysate that does not 
contain Vhs. Vhs=rabbit reticulocyte lysate that contains Vhs.  
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Figure 32.Vhs Site Specific Cutting of pBK2 mRNA in the Presence of Cap Analog 
Figure 32 shows cap-labeled pBK2 mRNA from a Vhs assay that contained 5mM cap analog (+5mM cap) or 
water. Rabbit reticulocyte lysate containing (Vhs) or lacking (RRL) Vhs was incubated with cap analog to a 
final concentration of 5mM for 12 minutes at 30˚C. Cap-labeled pBK2 mRNA was then added to the system 
and samples were removed at the indicated time points followed by RNA extraction. RNA was then run on 
a 7% polyacrylamide 7M urea 1X TBE gel and analyzed by autoradiography. Min.=amount of time in 
minutes that mRNA incubated in rabbit reticulocyte system before removal. RRL=rabbit reticulocyte lysate 
that does not contain Vhs. Vhs=rabbit reticulocyte lysate containing Vhs. M=ФX174 Hinf1 markers. 
Arrows=prominent cut sites produced by Vhs. Hollow circles=less prominent cut sites produced by Vhs. 
Red symbols=cleavage products that are inhibited in the presence of cap analog. 
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downstream cut sites that are produced in the presence of cap analog in vitro are also produced 
in vivo. 
 
Vhs Cutting of Circular RNAs 
The next group of studies was designed to take advantage of previous knowledge about 
translation initiation of circular RNA. Sarnow and colleagues had demonstrated that RNA that 
undergoes cap-dependent scanning during translation initiation was not translated if it was 
circularized (26). This is because circularizing RNA will block recruitment of translation 
initiation factors to the 5’ end, hence, inhibiting translation initiation.  However, the same article 
showed that circularizing an RNA which does not experience the traditional cap-dependent 
scanning mechanism for translation initiation but instead allows internal binding of translation 
initiation factors and the small ribosomal subunit will not hinder translation (26). Knowing that 
Vhs is an endonuclease, one might predict that it would have the ability to cleave circular RNA 
at the same sites as capped linear RNA. Yet, a considerable amount of data indicates that Vhs 
associates with cellular translation initiation factors that are necessary for cap-dependent 
scanning (6, 7, 13, 27, 28, Agarwal, D. et al. unpublished). Vhs association with eIF4H or 
eIF4AI/II appears to be vital for activity in infected HeLa cells (28, Agarwal et al. unpublished). 
These data combined with recent findings that Vhs prefers to cleave pBK2 mRNA at specific 
sites near the first three AUG codons indicate that Vhs may initially bind the mRNA template by 
associating with translation initiation factors that target to the 5’cap. If this is the case, then Vhs 
may reach its cut sites by piggy-backing on the scanning complex. If this is the mechanism Vhs 
uses for cleavage of RNA that experiences cap-dependent scanning, then Vhs would require a  
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free 5’ end to access the mRNA template and it wouldn’t be able to cut this mRNA if it is in 
circular form.  
 
pBK2 Circular RNA Experiment 
In the current study pBK2 RNA was synthesized and taken through a 
dephosphorylation reaction (Fig. 33). Next, a single, non-radioactive monophosphate was added 
to the 5’ end using polynucleotide kinase (Fig. 33). The 5’ and 3’ ends were brought together 
with a complementary oligonucleotide, and T4 DNA ligase was used to seal the ends together 
(Fig. 33). RNA was then run on an agarose gel and the circular form was gel extracted and taken 
through a Vhs assay. As a positive control, linear capped pBK2 RNA was tested in the Vhs assay 
as a comparison. In order to identify specific cut sites of circular RNA, primer extension analysis 
was performed using radiolabeled primer P165 (described previously Fig. 21). DNA samples 
were then run on a 7% polyacrylamide 8M urea 1X TBE gel and analyzed by autoradiography 
(Fig. 34). Vhs was unable to cleave circularized pBK2 RNA at the same specific sites as capped 
linear, indicating that Vhs requires a free 5’ end to specifically cut an RNA that undergoes cap-
dependent scanning for translation initiation (Fig. 34 compare Linear Vhs 15’ with Circular Vhs 
15’). A faint band correlating to cleavage at base 80 is apparent in the Circular Vhs 15’ sample, 
but it is attributed to cutting of the small amount of linear RNA contamination which is present 
in the Circular RNA sample.  
 
EMCV Circular Experiment 
As a control for the previous study, it was desirable to test Vhs cleavage of circular RNA 
that did not use the typical cap-dependent scanning mechanism during translation initiation.  
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Figure 33.Circularization of pBK2 RNA 
Pictured in Figure 33 is a diagram showing how pBK2 RNA was circularized (on left side). RNA was 
dephosphorylated with CIP followed by incorporation of a single monophosphate in a PNK 
reaction with unlabeled ATP. The 5’ and 3’ ends were brought together using a complementary 
bridging primer followed by a ligation reaction with T4 DNA ligase. The RNA was heated to remove 
the bridging oligonucleotide and run on an agarose gel to extract circular RNA (pictured on right). 
CIP=calf alkaline phosphatase. PNK=polynucleotide kinase.  
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Figure 34.Primer Extension Analysis of Vhs Cleavage of Capped Linear pBK2 mRNA and Circular pBK2 
RNA 
Sequencing gel of DNA from primer extension analysis of RNA samples after Vhs assay with capped, 
linear (Linear) or circular (Circular) pBK2 RNA. Hash marks show the less prominent cut sites and 
arrows mark the prominent cut sites. Pictured below the gel is a diagram of the first 100 bases of the 
pBK2 sequence with the cut sites labeled in regards to the pBK2 sequence. RRL=rabbit reticulocyte 
lysate without Vhs. Vhs=rabbit reticulocyte that contains Vhs. Min.=amount of time in minutes that 
RNA incubated in rabbit reticulocyte lysate before removal. M.=ФX174 Hinf1 markers 
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Vhs has previously been shown to target cutting just downstream of the EMCV IRES (1-2). 
Additional studies have shown that a T214I Vhs point mutant, Vhs-1, (which is unable to bind 
eIF4H) is still able to target cutting downstream of the EMCV IRES (3). For the next study, it was 
desirable to test a previously studied mRNA that internally directed the recruitment of the small 
ribosomal subunit and various initiation factors. EMCV RNA was chosen for the following study 
because it had previously been studied in an RRL system. 
First, to confirm that the system was set up properly, it was important to repeat the 
study previously performed by the Smiley lab to show that Vhs cuts EMCV at a specific region 
downstream of the IRES. Cap-labeled EMCV mRNA was incubated with RRL containing or 
lacking Vhs for various times followed by RNA extraction. The RNA was then run on a 1.3% 
agarose 1X MOPS gel and visualized by autoradiography (Fig. 35). Vhs targeting at a site 
downstream from the EMCV IRES was observed (Fig. 35). The EMCV RNA used for the study 
contained an IRES between bases 16-518 from the 5’ cap.  
After Vhs targeting downstream of the EMCV IRES was confirmed, studies continued to 
test Vhs cleavage of circular EMCV RNA. EMCV RNA was synthesized using a T7 RiboMAX kit 
that contained GMP instead of GTP to add a single monophosphate to the 5’ end. After 
synthesis, the RNA was circularized using the same method as that described in Figure 33. 
Circular EMCV RNA was then gel extracted (Fig. 36B) and tested in a Vhs assay with linear cap-
labeled EMCV as a comparison. Following the Vhs assay, RNA was analyzed by primer 
extension analysis using a primer that bound to bases 681-700 of the RNA sequence. After 
primer extension, the DNA was run on a 7% polyacrylamide 8M urea 1X TBE gel and visualized 
by autoradiography. 
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Figure 35.Vhs Site Specific Targeting Downstream of the EMCV IRES 
Cap-labeled EMCV mRNA in the absence (RRL) or presence (Vhs) of Vhs protein. Min.=amount of 
time in minutes that mRNA incubated in rabbit reticulocyte lysate system prior to removal. 
RRL=rabbit reticulocyte lysate that contains Vhs. Vhs=rabbit reticulocyte lysate that lacks Vhs.  
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Figure 36.Primer Extension Analysis of Vhs Cleavage of EMCV RNA 
Cartoon depiction of EMCV IRES structure showing location of initiation factor binding in regards to the 
AUG start codon (A). Agarose gel of circular vs. linear EMCV RNA (B). Sequencing gel of DNA samples from 
primer extension analysis of RNA from Vhs assays with capped linear RNA and circular EMCV RNA (C). 
Black arrows mark cut sites produced by Vhs. RRL=rabbit reticulocyte lysate that lacks Vhs. Vhs=rabbit 
reticulocyte lysate that contains Vhs. Min.=amount of time in minutes RNA  was incubated with rabbit 
reticulocyte lysate prior to removal. M=ФX174 Hinf1 markers.  
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Vhs cleavage of capped, linear EMCV mRNA produced three prominent cut sites (Fig. 
36C). Vhs was able to produce two of these specific cut sites when EMCV RNA was circularized, 
indicating that it does not require a free 5’ end in order to cleave an RNA that does not use cap-
dependent scanning as a mechanism for translation initiation (Fig. 36C compare lane e with lane 
j). The primer used for cut site analysis bound to nucleotides 681-700 from the 5’ cap. So, for 
linear mRNA, when the primer extended to the 5’ cap during reverse transcription, it produced 
a DNA band of 700 bases (Fig. 36C a-e). However, for circularized RNA, primer extension did 
not create a run off band of 700 bases, and instead the primer extension stopped at random sites 
beyond 700 bases (Fig. 36C f-j top of gel). Figure 36 shows where the cut sites are located in 
regards to the EMCV sequence. Vhs specifically cleaved capped, linear EMCV mRNA near bases 
510, 618, and 630. These regions were at the end of the IRES or just downstream from this region 
of high secondary structure (Fig. 37). The two reproducible cut sites produced in circular EMCV 
RNA were near bases 510 and 630 (Fig. 37).  
 
Vhs Cleavage of pBK2 AUG Mutants 
Mutating the First AUG to a Non-AUG 
 The previous experiments showed the importance of having a free 5’ end for Vhs site-
specific cleavage of pBK2 RNA, an RNA that uses cap-dependent scanning during translation. 
To further test whether the scanning process might be involved in Vhs cleavage, studies were 
performed with pBK2 mutants which contained mutations in or surrounding the first AUG 
codon. In the first study the pBK2 sequence was mutated to change the first AUG codon to a 
non-AUG, CCC sequence. If Vhs is associating with translation initiation factors for recruitment 
to the 5’ end and accessing its cut sites by piggybacking on the scanning complex, a plausible  
 
 
108 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
GGGCGAAUUA AUUCCGGUUA UUUUCCACCA UAUUGCCGUC UUUUGGCAAU
GUGAGGGCCC GGAAACCUGG CCCUGUCUUC UUGACGAGCA UUCCUAGGGG
UCUUUCCCCU CUCGCCAAAG GAAUGCAAGG UCUGUUGAAU GUCGUGAAGG
AAGCAGUUCC UCUGGAAGCU UCUUGAAGAC AAACAACGUC UGUAGCGACC
CUUUGCAGGC AGCGGAACCC CCCACCUGGC GACAGGUGCC UCUGCGGCCA
AAAGCCACGU GUAUAAGAUA CACCUGCAAA GGCGGCACAA CCCCAGUGCC
ACGUUGUGAG UUGGAUAGUU GUGGAAAGAG UCAAAUGGCU CACCUCAAGC
GUAUUCAACA AGGGGCUGAA GGAUGCCCAG AAGGUACCCC AUUGUAUGGG
AUCUGAUCUG GGGCCUCGGU GCACAUGCUU UACAUGUGUU UAGUCGAGGU
UAAAAAACGU CUAGGCCCCC CGAACCACGG GGACGUGGUU UUCCUUUGAA
AAACACGAUG AUAAUAUGGC CACCACCCAU AUGAAAGAAA CCGCUGCUGC
UAAAUUCGAA CGCCAGCACA UGGACAGCCC AGAUCAGGGU ACCCUGGUGC
CACGCGGUUC CAUGGGAUAU CGGAUCCAAA UGGAAGACGC CAAAAACAUA
AAGAAAGGCC CGGCGCCAUU CUAUCCUCUA GCAACUGCAU AAGGCUAUGA
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Figure 37.Diagram of EMCV Sequence Showing Vhs Cut Sites 
Pictured in Figure 37 is the EMCV RNA substrate sequence from the Vhs assay in Figure 36. The 
three arrows show the cut sites produced by Vhs cutting of capped, linear RNA. The red arrows 
mark those that were obtained from Vhs cutting of circular EMCV RNA.  The sequence marked in 
blue is the region that contains the EMCV IRES. The sequence highlighted in orange represents 
the first AUG after the EMCV IRES. 
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model is that its cut sites are determined by the amount of time that the complex spends in any 
one area of the RNA sequence. This amount of time could be affected by the degree of RNA 
secondary structure or the length of time the complex spends pausing to locate the start codon.  
For this experiment it was hypothesized that mutating the first AUG to a non-AUG 
would hinder Vhs site specific cleavage near the area. Under this prediction the scanning  
complex would spend a shorter amount of time in the region when it lacked an AUG codon 
because it would no longer pause at the AUG to allow for removal of initiation factors and 
recruitment of the large ribosomal subunit. Cap-labeled wild type pBK2 and AUG1→CCC  
(pBK2 with a mutation in its first AUG to convert it to CCC) mRNA were examined in a Vhs 
assay. Following RNA extraction, samples were run on a 7% polyacrylamide 8M urea 1X TBE 
gel and viewed by autoradiography (Fig. 38A). From this study it was apparent that Vhs was not 
able to specifically cleave pBK2 mRNA just upstream from the original location of the first AUG 
start codon if the AUG was mutated to a CCC (Fig. 38A compare WT pBK2 Vhs and 
AUG1→CCC at 30 min.). The same result was found through primer extension analysis of 
unlabeled WT pBK2 and AUG1→CCC transcripts following a Vhs assay using primer 165 (Fig. 
38B). This suggests that Vhs is associating with the scanning complex to reach some of its 
cleavage sites. It also suggests that, when the scanning complex pauses on the RNA template 
after locating the AUG start codon, it leads to a higher probability that Vhs will cut RNA in that 
area due to the longer amount of time spent in that region.  
 
Mutating the Bases Surrounding the First AUG to Put it into an Optimal AUG Context 
 To continue testing the possibility that Vhs utilizes the scanning complex to reach some 
of its preferred cleavage sites, Vhs assays were performed using constructs where the  
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Figure 38.Vhs Cleavage of pBK2 mRNA with a Mutation in the First AUG Codon  
Pictured in Figure 38 is a sequencing gel of cap-labeled RNA from a Vhs assay (A) or labeled DNA from 
primer extension following a Vhs assay (B). Rabbit reticulocyte lysate was incubated with wild type pBK2 
mRNA (WT pBK2) or pBK2 mRNA with a mutation where the first AUG was replaced with CCC 
(AUG1→CCC). RNA was extracted at various time points, run on a 7% polyacrylamide 8M urea 1X TBE 
gel and visualized by autoradiography (A). For the gel in B, unlabeled WT pBK2 or AUG1→CCC RNA were 
taken through a Vhs assay followed by RNA extraction. The RNA was then used for primer extension 
analysis with primer 165, and the DNA was run on a sequencing gel. The arrow marks the cut site that 
was produced in wild type pBK2 mRNA but not AUG→CCC pBK2 mutant. RRL=rabbit reticulocyte lysate 
that does not contain Vhs. Vhs=rabbit reticulocyte lysate which contains Vhs. Min.=minutes RNA 
incubated with rabbit reticulocyte lysate prior to removal.  
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suboptimal context of the first AUG was converted to an optimal context. According to the 
Kozak consensus sequence, the region surrounding the AUG codon can have an impact on how 
strong the start codon is at initiating translation (29). An optimal start codon has a purine at 
positions -3 and +4 from the start codon, and within the purines adenine is preferntial at -3 and 
guanine at +4 (29). The strength of the start codon is also enhanced if cytosines are located at -4,  
-2, and -1 from the AUG (29).  
The pBK2 sequence was mutated to convert bases surrounding the first AUG to create an 
optimal context that read CACCAUGG from -4 to +4 of the AUG, respectively (Fig. 39A). Cap-
labeled wild type pBK2 and pBK2 mRNA with the optimal AUG mutations (AUG1-OPT) were  
studied in a Vhs assay, run on a 7% polyacrylamide 8M urea 1X TBE gel, and visualized by 
autoradiography (Fig. 39). Vhs showed enhanced cutting at regions upstream from the AUG 
codon when the regions surrounding AUG were mutated to make it an optimal start codon (Fig. 
39). This indicates that Vhs has a higher probability of cleaving mRNA near its start codon if it is 
in an optimal context, supporting the idea that Vhs travels with the scanning complex during 
translation initiation to access some of its preferred cut sites.  
Vhs cleavage of pBK2 mRNA with a single (Fig. 40A) or triple mutation (Fig. 40B) in the 
second AUG codon was also tested (Fig. 40). However, mutations in the second codon did not 
appear to hinder Vhs site specific cleavage (Fig. 40). The pBK2 mutants were tested in an in vitro 
translation reaction for their ability to make thymidine kinase (Fig. 41). This gel shows that the 
primary protein product produced corresponds to translation from the first AUG (Fig. 41). The 
second AUG does not appear to be vital for translation of pBK2 mRNA, and this seems to 
correlate with Vhs cleavage of pBK2 transcripts that have mutations in this codon. 
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Figure 39.Vhs Cleavage of pBK2 mRNA with an Optimal Start Codon 
Diagram of optimal bases surrounding the AUG start codon according to the Kozak consensus sequence (A). 
Sequencing gel of RNA from Vhs assay (B). Cap-labeled wild type pBK2 mRNA (WT pBK2) and mutated pBK2 
mRNA with an optimal start codon (AUG1-OPT) were added to rabbit reticulocyte lysate and samples were 
removed at the indicated time points followed by RNA extraction. Samples were run on a 7% polyacrylamide 
8M urea 1X TBE gel and visualized by autoradiography. The black hash mark shows a region with enhanced 
cutting. RRL=rabbit reticulocyte lysate lacking Vhs. Vhs=rabbit reticulocyte lysate that contains Vhs. 
Min.=amount of time in minutes that RNA incubated in the rabbit reticulocyte lysate system.  
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Figure 40.Vhs Degradation of pBK2 mRNA with a Mutation in the Second AUG Codon 
Sequencing gel of cap-labeled WT pBK2 mRNA and pBK2 mRNA with a single point mutation in the 
AUG to convert it to AUA (A). Sequencing gel of primer extension analysis of unlabeled WT pBK2 
mRNA and pBK2 mRNA with a mutation in the second codon to change it to CCC (AUG2→CCC) that 
were tested in a Vhs assay (B). Primer 325 was used during the reverse transcription. Arrows mark 
prominent cut sites identified and hollow circles mark less prominent cut sites. RRL=rabbit 
reticulocyte lysate that did not contain Vhs. Vhs=rabbit reticulocyte lysate that contained Vhs. 
Min.=amount of time in minutes that RNA incubated in rabbit reticulocyte system prior to removal. 
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Figure 41.Protein Synthesis of pBK2 Mutants 
Wild type pBK2, AUG1-OPT, AUG1→CCC, or AUG2→CCC mRNA were added to an in vitro 
translation reaction and protein was synthesized with S-35 labeled methionine. Samples 
were run on an SDS-PAGE gel, fixed, and visualized through autoradiography.  
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Vhs Cleavage of pBK2 RNA that Lacks a 5’ Cap 
Previous studies showed that hindering initiation factor recruitment to the 5’ end (by 
circularizing RNA or the use of AMP-PNP or cap analog) inhibited Vhs cleavage. The next 
question to answer was if a 5’ cap was required for Vhs degradation of mRNA. Knowing the 
importance of initiation factor involvement in Vhs cleavage, it was predicted that a 5’ cap would  
also be vital for tying Vhs to the 5’ end. This is because the eIF4F complex binds the 5’ cap  
 (specifically through eIF4E) during translation initiation and Vhs has previously been shown to 
associate with the eIF4F cap complex and eIF4A (7, 59).   
To test this question, 5’ cap-labeled and 5’ end-labeled pBK2 mRNA were compared in a 
Vhs assay experiment (Fig. 42). pBK2 RNA was synthesized and either labeled in an m7G 
capping reaction or taken through a dephosphorylation reaction and labeled with a single 
monophosphate at the 5’ end. pBK2 RNA was then added to rabbit reticulocyte lysate containing 
or lacking Vhs protein and incubated for various times followed by extraction. Samples were 
then run on a 7% polyacrylamide 8M urea 1X TBE gel and visualized by autoradiography (Fig. 
42). The results clearly indicated that Vhs is not able to cut pBK2 mRNA at specific sites near the 
5’ end when the RNA lacks a cap (Fig. 42 compare A and B Vhs 15’). To make sure that the lack 
of specific cutting wasn’t due to unequal amounts of labeled pBK2, 5’ end-labeled RNA was 
tested in an additional Vhs assay with comparable levels of radiolabeled mRNA (Fig. 42C).   
 
HSV-2 Vhs Degradation of pBK2 mRNA 
An in vitro Vhs assay had never been performed using Vhs from HSV-2. Within infected 
cells, HSV-2 Vhs is much more potent than HSV-1 Vhs. In cotransfection assays, cells need to be 
transfected with 40-fold less HSV-2 Vhs than HSV-1 Vhs to yield the same effect on gene  
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Figure 42.Vhs Degradation of Cap-labeled vs. 5’ End-labeled pBK2 RNA 
Vhs assay with cap-labeled (A) or 5’ end-labeled (B and C) pBK2 mRNA. A and B are from the same 
experiment. RNA from gel C was used as a comparison for RNA loading samples comparable to A. 
Black arrows mark the cut sites produced by Vhs. RRL=rabbit reticulocyte lysate without Vhs. 
Vhs=rabbit reticulocyte lysate containing Vhs. Min=minutes RNA incubated with rabbit reticulocyte 
lysate prior to removal. M=ФX174 Hinf1 markers. 
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expression (31, 32). The Vhs protein of HSV-1 strain KOS and HSV-2 strain 333 show 87% 
sequence homology (31). To test whether the difference in mRNA cleavage could be replicated in 
vitro, Vhs from HSV-1 KOS and HSV-2 333 were compared in a Vhs assay using cap-labeled 
pBK2 as the substrate mRNA (Fig. 43). Interestingly, the two proteins produced the same 
cleavage products and cut pBK2 with close to the same efficiency (Fig. 43 compare +Vhs HSV-1 
and +Vhs HSV-2 at the 15’ time point). If anything, HSV-1 Vhs may have been stronger at 
cleaving mRNA since more cleavage products appear at the HSV-1 Vhs 3’ time point (Fig. 43). 
The results indicate that additional factors, which are not present in the RRL system, are 
required for HSV-2 Vhs to achieve increased nuclease activity. It remains uncertain whether 
these are viral or cellular factors. 
 
Vhs Cleavage of mRNAs Containing an IRES 
As mentioned previously, Vhs specifically cleaves EMCV mRNA just downstream of its 
IRES. Since Vhs-1 retains the ability to cleave downstream of the EMCV IRES, it has been 
suggested that the cleavage event could be due to association with eIF4A. This is because the 
T214I mutant lacks the ability to bind eIF4H, but still associates with eIF4A and eIF4B. It was 
desirable to test if Vhs could specifically target downstream of an IRES that does not use the 
canonical factors for translation initiation. This would provide information about what factors 
might be required for cleavage. 
The cricket paralysis virus contains an internal ribosome entry site that directly recruits 
the small ribosomal subunit by mimicking a pseudo tRNA-like structure in its IRES. In doing so, 
it does not require the canonical translation initiation factors or Met-tRNAMeti because the CCU 
triplet of the IRES pseudoknot occupies the P site of the 40S small ribosomal subunit. The large  
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Figure 43.HSV-1 and HSV-2 Vhs Degradation of Cap-labeled pBK2 mRNA 
Sequencing gel of cap-labeled pBK2 mRNA following a Vhs assay with HSV-1 and HSV-2 Vhs. The 
black arrows show the cut sites produced by Vhs cleavage. Min.=amount of time in minutes pBK2 
mRNA incubated in rabbit reticulocyte lysate prior to removal. M=ФX174 Hinf1 markers. 
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ribosomal subunit is then directly recruited to form the 80S ribosome. Since substantial data 
indicate that Vhs association with translation initiation factors is vital for mRNA cleavage, it was 
hypothesized that Vhs would be less efficient at cleaving CrPV mRNA since that IRES does not 
use translation initiation factors for ribosomal recruitment during translation initiation.  
 For this study, EMCV and CrPV cap-labeled mRNA were tested in a Vhs assay followed 
by RNA extraction. The samples were then run on a 1.3% agarose 1X MOPS gel and visualized 
by autoradiography (Fig. 44). The effect of 2mM AMP-PNP was also tested in this experiment 
since ATP hydrolysis appears to be necessary for the eIF4A/eIF4G complex to induce  
conformational changes in the coding regions downstream of the IRES (33). These 
conformational changes make room for binding of the 40S ribosomal subunit during translation 
initiation of EMCV RNA (33). Vhs clearly cut downstream of the EMCV IRES and this site-
specific cutting was reduced by the addition of AMP-PNP, a non hydrolyzable analog of ATP 
(Fig. 44A red arrow). However, this same type of site-specific cutting was not observed in CrPV 
mRNA, where no sharp cleavage product was produced (Fig. 44B). In order to better see the 
EMCV cleavage product inhibition in the presence of AMP-PNP, a lighter exposure was taken 
and is shown Figure 44C.   
To analyze Vhs cleavage of CrPV and EMCV mRNA in further detail, the RNA samples 
were run on a 7% polyacrylamide 8M urea 1X TBE gel (Fig. 45 B and C). Vhs cleaved CrPV 
mRNA at nucleotides 36, 47, 102, 123, 129, 140, and 241 from the 5’ cap (Fig. 45B). The CrPV 
internal ribosome entry site is located between bases 1474-1662 of the transcript. Through 
analysis on a 1.3% agarose 1XMOPS gel and a sequencing gel, Vhs was not found to cleave CrPV 
near its IRES (Fig. 44B and 45B). Additionally, Vhs was able to produce the same cuts sites that 
were identified in the CrPV transcript in an mRNA construct (referred to as C53) that had  
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Figure 44.Vhs Site Specific Targeting of EMCV mRNA but not CrPV mRNA 
Cap-labeled EMCV mRNA(A) and CrPV mRNA (B) following Vhs assay. Lighter exposure of A (C). Red arrow 
indicates specific cleavage product just downstream of the EMCV IRES. RRL=rabbit reticulocyte lysate that 
lacks Vhs. Vhs=rabbit reticulocyte lysate which contains Vhs.  
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Figure 45.Site-specific Cleavage of CrPV and EMCV IRES-containing mRNA 
Sequencing gels of cap-labeled CrPV (B) or EMCV (C) mRNA following a Vhs assay. The RNA tested in 
gel A (C53) contains sequence that is identical to the CrPV transcript, except that it lacks the CrPV 
internal ribosome entry site. RRL=rabbit reticulocyte lysate without Vhs. Vhs=rabbit reticulocyte lysate 
that contains Vhs. Arrowhead=very prominent cut site. Arrows=prominent cut site. Hollow circles=less 
prominent cut site. 
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identical sequence to the CrPV transcript with the exception that it lacked the CrPV IRES (Fig. 
45A). Therefore, the addition of a CrPV IRES did not direct novel cutting (Fig. 45 compare A and 
B). Vhs cleaved EMCV RNA near base 550 from the 5’ cap, and it also produced less prominent 
cut sites near bases 78, 82, and 84 (Fig. 45C). The summary of the results from the sequencing gel 
further confirm that Vhs cut downstream of the EMCV IRES but not CrPV IRES (Fig. 45). 
 
The Effect of Secondary Structure on Vhs Cleavage 
 Another way to test the role of cap-dependent scanning in Vhs cleavage is to test how  
 Vhs cleaves mRNA that contains a stable hairpin near the 5’ end. in vitro studies have shown 
that hairpins with a thermal stability of -30kcal/mol that are located within the first 12 bases of 
the RNA cap have an inhibitory effect on translation initiation, most likely caused by blocking 
the cap-dependent scanning process (34). It was predicted that inhibiting the scanning process 
would also reduce Vhs site-specific cleavage of mRNA if Vhs association with the scanning 
complex is vital for cleavage.  
 
Vhs Cleavage of pBK2 mRNA with a Hairpin One Base Downstream of the 5’ Cap 
For the following study, the first 59 bases of the pBK2 transcript were replaced with a 
sequence containing a hairpin beginning one nucleotide downstream from the cap and 
extending through base 35 followed by a stretch of 8 CAA repeats (Fig. 46A). As a control, the 
first 59 bases of pBK2 were replaced with a stretch of 19 CAA repeats (Fig. 46B). The CAA 
sequence was chosen because it is predicted to have no secondary structure (35). The hairpin 
sequence used for this study was previously reported to have a thermal stability of -30 kcal/mol 
and inhibit protein synthesis in live cells when located within the first 4 bases downstream of the  
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Figure 46.Diagram of Sequences Inserted into pBK2 and Protein Gel Analysis of Constructs 
Model of the first 59 nucleotides of the pBK2 sequence which was replaced with sequence that encoded 
a -30kcal/mol hairpin 1 base downstream from the 5’ cap in the first 35 bases of the transcript followed 
by a CAA stretch of 8 CAA repeats (A). Model of the first 59 nucleotides of the pBK2 sequence which was 
replaced with a stretch of 19 CAA repeats (B). S-35 methionine-labeled protein SDS-PAGE gel (C). The 
type of mRNA added to the in vitro translation system is listed above. Sample CAA contains RNA with a 
complete CAA stretch throughout the first 59 bases, sample HP+1 contains RNA that contains a hairpin 1 
base downstream from the 5’ cap in the first 35 bases of the pBK2 sequence, and sample pBK2 WT 
contains wild type pBK2 RNA which was not mutated.  
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5’ cap (35). The RNA constructs were synthesized by in vitro transcription in a large scale 
reaction and purified through gel extraction. During the RNA synthesis the transcripts received 
a 5’ cap. They were then tested in an in vitro translation reaction using S-35 labeled methionine 
(Fig. 46C). Insertion of a hairpin beginning one nucleotide downstream from 5’ cap inhibited 
protein synthesis while insertion of a CAA stretch did not have an effect on translation (Fig. 
46C).  
The RNAs were further tested in a Vhs assay. For this experiment the RNA was 
synthesized in a large scale reaction without a cap, labeled with *α-32P]GTP in an m7G capping 
reaction, and purified through gel extraction. The RNA was then added to rabbit reticulocyte 
lysates that contained or lacked Vhs, and samples were removed at various time points. RNA 
was then extracted and run on a 7% polyacrylamide 8M urea 1X TBE gel and visualized by  
autoradiography (Fig. 47B). Interestingly, the presence of a hairpin beginning one nucleotide 
from the 5’ cap greatly reduced Vhs site-specific cutting at regions further downstream (Fig. 47 
compare A. pBK2 mRNA Vhs and B. HP +1 Vhs at 3 and 15 min.). However, Vhs still cleaved the 
mRNA and produced two prominent cut sites in the CAA region just downstream from the 
hairpin (Figure 47B). When analyzing Vhs cleavage of pBK2 mRNA with a stretch of 19 CAA 
repeats, it was found that Vhs cutting was selective for the first 65 bases from the 5’ end (Fig. 47B 
CAA19 Vhs 3 and 15 min.). Most of the cutting yielded a ladder of evenly spaced bands 
separated by approximately 3 nucleotides (Fig. 47B). It appears that Vhs cleaved the stretch of 19 
CAA repeats after every C of the CAA sequence (Fig. 47B). This is consistent with previous 
reports that Vhs cleaves mRNA after C’s and U’s (10). These data suggest that Vhs prefers 
cleaving mRNA at regions of the transcript that have a low amount of secondary structure.    
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Figure 47.Vhs Cleavage of pBK2 mRNA with a Hairpin One Nucleotide Downstream from the 5’ 
Cap or an mRNA with a CAA Stretch 
Sequencing gels of cap-labeled WT (A) +1 HP (B) and CAA stretch (B) mRNA following a Vhs assay. 
The gel pictured in A is from Figure 17 and was placed in this figure as a comparison to show how 
Vhs cuts wild type pBK2 mRNA. The gel on the right shows Vhs cutting of pBK2 mRNA with 
replacements in the first 59 bases of the transcript. The RNA labeled HP+1 contains a hairpin 
structure positioned one base from the 5’ cap that is 34 bases long followed by a 25 base stretch 
of CAA  sequence. The RNA in labeled CAA19 contains a CAA stretch of 19 repeats in the first 59 
bases of the transcript. Arrowheads mark the prominent cut sites produced by Vhs and white 
filled in circles indicate the less prominent cut sites. The diagrams to the left and right of the gel in 
B depict the location of the hairpin, CAA stretch, and pBK2 sequence. RRL=rabbit reticulocyte 
lysate that lacks Vhs. Vhs=rabbit reticulocyte lysate that contains Vhs.  
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Vhs Cleavage of pBK2 mRNA with a Hairpin 7 Bases or 13 Bases Downstream of the 5’ Cap 
To continue testing the effect of secondary structure on Vhs cleavage, pBK2 transcripts 
were constructed to contain a hairpin beginning +7 or +13 nucleotides downstream from the 5’ 
cap. Part of the pBK2 sequence was replaced with the same -30 kcal/mol hairpin sequence used 
for studying a hairpin positioned one nucleotide from the 5’ cap. Bases 8-41 or 14-47 of the wild 
type pBK2 sequence were replaced with the 34 base hairpin for construction of HP + 7 and HP 
+13, respectively. The only difference with this hairpin experiment was that the regions 
surrounding the hairpin were restored with pBK2 sequence and did not contain CAA repeats. 
The cap-labeled constructs were then studied in a Vhs assay and analyzed using a DNA 
sequencing gel (Fig. 48B). 
 Vhs was unable to produce many of the same specific cut sites (as it did in WT pBK2 
mRNA) when the mRNA contained a hairpin beginning +7 or +13 bases from the 5’ cap (Fig. 
48B). Vhs cleaved +7 HP mRNA at prominent sites near bases 58 and 252 and at less prominent 
sites at bases 42, 158, 200, and 222. The novel cut sites produced in a +7 HP transcript were at 
positions 42 and 58 (Fig. 48B). It is particularly interesting how shifting the hairpin location from 
one base downstream of the 5’ cap to 7 bases downstream restored Vhs cleavage at sites further 
downstream near nucleotides 158, 200, 222, and 252 (compare Fig. 47B with Fig. 48B). Vhs 
cleavage appeared to shift from an original preference near nucleotide 55 to a novel preference 
for a site a little further downstream at 58 (Fig. 48B) Notably, the faint targeting at position 42 is 
positioned one base downstream of the hairpin construct (Fig. 48B).  
The presence of a hairpin 13 nucleotides downstream from the 5’ cap appeared to hinder 
Vhs cleavage of the first 60 nucleotides of pBK2 mRNA (Fig. 48B). Vhs produced prominent cut 
sites at bases 61 and 252 and less prominent cut sites at bases  85, 93, 160, 200, and 222 (Fig. 48B).  
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Figure 48.Vhs Cleavage of pBK2 with +7 and +13 Shifted Hairpins 
Sequencing gels of cap-labeled WT (A), +7 HP (B), and +13 HP (B) mRNA following a Vhs assay. The gel 
pictured in A is from Figure 17 and was placed in this figure as a comparison to show how Vhs cuts wild type 
pBK2 mRNA. The gel in B shows Vhs cutting of pBK2 mRNA with hairpin shifts in the transcript. The RNA 
labeled by HP +7 is pBK2 mRNA that was replaced at bases 8-41 with a hairpin structure, which is positioned 
7 bases downstream from the 5’ cap and is 34 bases long. The RNA labeled HP + 13 contains pBK2 mRNA 
that was replaced at bases 14-47 with a hairpin structure that is positioned 13 bases downstream from the 
5’ cap. Red arrowheads mark the prominent cut sites produced by Vhs. The diagrams to the left and right of 
the gel in B depict the location of the hairpins in relation to the pBK2 sequence. RRL=rabbit reticulocyte 
lysate that lacks Vhs. Vhs=rabbit reticulocyte lysate that contains Vhs.  
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It is uncertain how the shift in hairpin location affects translation, because the +7 and +13 HP 
transcripts still need to be tested in an in vitro translation reaction. It is also unclear if the 
restoration of cutting to sites further downstream was due solely to a change in protein synthesis 
or due to the fact that the +7 and +13 HP constructs lacked a CAA repeat. The CAA unstructured 
sequence in the +1 HP construct could have been vital for targeting Vhs to regions near the cap 
leading to a decrease in preference for regions further downstream. 
 
Vhs Cleavage of Cellular IRES-containing mRNAs 
Many of the previous studies were designed to investigate the role of cap-dependent 
scanning in Vhs cleavage. In the next line of studies it was desirable to switch directions and ask 
if Vhs cleaved cellular mRNAs which use cap-independent methods for protein synthesis with 
equal efficiencies as cellular mRNAs that undergo cap-dependent scanning. Many mRNAs that 
are preferentially translated when translation efficiency is reduced, such as times of stress or 
during mitosis, have been found to contain internal ribosome entry sites (36, 37, 39). Several 
cellular mRNAs that contain IRESs encode proteins that are stimulated by stress, and some of 
these proteins are involved in serum response, inflammation, and angiogenesis (37, 38). Less 
information is available on cellular than viral IRESs and fewer generalizations can be made. 
Cellular IRESs do not require a high degree of secondary structure to be functional like viral 
IRES, and they can consist of short segments that are noncontiguous (39). It was unknown 
whether Vhs would be targeted to these RNAs with the same efficiency as mRNAs that undergo 
cap-dependent scanning since little is known about the requirements for translation of a cellular 
IRES. 
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  To test this, HeLa cells were infected or mock infected with 20 PFU WT HSV-1 KOS in 
the presence of Actinomycin D. Cells were scraped at various time points followed by RNA 
extraction and real time PCR using probes specific for 4 cellular mRNAs that contain IRESs 
(Vimentin,Nap-1-like, Cyr61, and ODC) and one cellular mRNA that is translated by cap-
dependent scanning (GAPDH). Figure 49 shows a column graph of relative mRNA levels after 5 
hrs. mock infection or infection with wild type virus. The black bars represent mock infection levels 
normalized to a value of 1, and the blue bars show RNA levels in the presence of virus. Vhs degraded 
three for the IRES-containing mRNAs with equal efficiencies as it degraded GAPDH mRNA (Fig. 49 
compare relative levels of GAPDH mRNA to other mRNAs). At the five hour time point, most RNAs 
that were infected were present in much lower abundance compared to RNAs that were infected 
with mock virus (Fig. 49). However, Cyr61 mRNA levels were 2 fold higher than mock levels at the 
5 hour time point (Fig. 49).  
The results were analyzed in a graph comparing mock and infected mRNA levels at 0 
and 5 hour time points (Fig. 50). All mRNAs were degraded when infected with HSV-1. Cyr61 
mRNA has a short half life in uninfected cells (Fig. 50). Cyr61 mRNA encodes the cysteine-rich 
angiogenic factor 61, an extracellular matrix-associating protein involved in stimulating cell 
migration, mediating cell adhesion, inducing angiogenesis, and regulating genes important for 
wound healing (40, 41, 42, 43, 44). Cyr61 gene expression is rapidly turned on and off in the cell, 
so it is, therefore, not surprising that Cyr61 mRNA has a short half-life in uninfected cells. 
However, it is surprising that Cyr61 mRNA is not as rapidly degraded in the presence of WT 
KOS (Fig. 50). It appears that HSV-1 infection stabilizes Cyr61 mRNA (Fig. 50).  
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Figure 49.Vhs Cleavage of Cellular IRES-containing mRNAs 
Column graph representation of relative mRNA levels after 5 hours infection or mock infection of 
HeLa cells with 20pfu WT KOS in the presence of Actinomycin D. Black bars represent relative mRNA 
levels after 5 hrs. mock infection. Light blue bars represent relative mRNA levels after 5 hrs. 
infection. Cyr61=cysteine-rich angiogenic factor. ODC=ornithine decarboxlyase. 
GAPDH=glyceraldehyde-3-phosphate dehydrogenase 
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Figure 50.Relative Amount of mRNA Following Mock and HSV-1 Infection After 5 Hours 
Graph representation of the relative amount of mRNA following infection or mock infection 
with WT KOS determined by Real Time PCR analysis. Dashed lines represent mRNA levels 
following mock infection and solid lines represent RNA levels following T infection. The 
type of mRNA examined is listed above each graph.  
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The Effect of Vhs on Reporter Gene Expression 
Vero Cell Experiment 
Since the cellular factors required for translation from various cellular IRESs are 
unknown, it was desirable to test viral IRESs in an in vivo system. For this study, three bicistronic 
constructs were tested that contained renilla luciferase as the upstream codon and firefly 
luciferase as the downstream codon (Fig. 51A). The control construct, C53, did not contain an 
internal ribosome entry site between the two cistrons. The other two constructs contained either 
an EMCV IRES or a CrPV IRES in the intercistronic region (Fig. 51A). Measuring the ratio of the 
upstream cistron renilla luciferase (RLUC) to the downstream cistron firefly luciferase (FLUC) is 
a standard way of analyzing IRES activity. Vero cells were transfected with one of the three 
plasmids and the increase of translation of the downstream cistron in the presence of an IRES 
was confirmed (Fig. 51B). Studies were then performed transfecting Vero cells with one of the 
target plasmids plus either pKOSamp which encodes HSV-1 KOS Vhs, p333amp which encodes 
HSV-2 333 Vhs, or control plasmid that did not encode Vhs. Cells were harvested after 48 hours 
followed by analysis of protein expression using a Promega 20/20 GloMAX luminometer (Fig. 
52). Control levels of renilla and firefly luciferase were normalized to a value of 1.  
HSV-2 Vhs shut off RLUC and FLUC protein synthesis much more rapidly than HSV-1 
Vhs (Fig. 52). Interestingly, HSV-2 Vhs turned down expression of C53 renilla luciferase more 
efficiently than the downstream cistron firefly luciferase, with an FLUC/RLUC ratio of 5.6 (Fig. 
52). However, HSV-2 Vhs had on opposite effect on the protein expression of CrPV and EMCV 
protein, whose mRNA contained an IRES, where their FLUC/RLUC ratios were 0.61 and 0.46, 
respectively (Fig. 52). In the presence of HSV-1 Vhs, the CrPV and EMCV upstream cistrons  
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Figure 51.Insertion of an IRES Between Two Cistrons Increases Translation of the Downstream Cistron 
Diagram of mRNA from a bicistronic construct that lacks (top) or contains (bottom) an IRES in between the 
two cistrons (A). The mRNA is pictured with a 5’ cap and an upstream cistron containing renilla luciferase 
(RLUC) and a downstream cistron containing firefly luciferase (FLUC) (A). Graph results showing the 
increase of translation of the second cistron when an IRES is inserted into the intergenic region (B). 
C53=construct that did not contain an IRES. This was the control whose FLUC/RLUC ratio was normalized 
to 1. CrPV IRES=construct that contained the cricket paralysis virus IRES. C64-EMCV IRES=construct that 
contained the encephalomyocarditis virus IRES. 
A. 
B. 
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Figure 52.Protein Expression of Bicistronic Constructs in the Presence of HSV-1 or HSV-2 Vhs in Vero Cells 
Vero cells were transfected with the plasmid combinations listed on the x-axis. Cells were harvested 
after 48 hours and protein levels were measured using a Promega 20/20 GloMAX luminometer. The 
control (pcDNA1.1amp) expression levels of renilla and firefly luciferase were normalized to 1. For the 
control samples, cells were transfected with DNA that did not encode Vhs. Protein levels in the presence 
of HSV-1 (pKOSamp) or HSV-2 (p333amp) Vhs were compared to control values using Excel. RLUC=renilla 
luciferase, the upstream codon. FLUC=firefly luciferase, the downstream codon.  
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were always expressed much higher than the downstream cistrons with RLUC/FLUC ratios of 
4.81 and 3.60, respectively (Fig. 52). On the other hand, in the presence of HSV-1 Vhs, the C53 
RLUC/FLUC ratio was 1.83 (Fig. 52). Notably, HSV-1 Vhs did not decrease expression of the 
CrPV upstream cistron, where the renilla luciferase level was 1.3 compared to the control (Fig. 
52). Even though HSV-1 Vhs did not reduce expression of CrPV renilla luciferase, it still reduced 
expression of the downstream cistron to 27% (Fig. 52). HSV-1 Vhs had an effect of lowering the 
EMCV upstream and downstream cistrons to 36% and 10% (Fig. 52).   
 
HeLa Cells 
Previous studies by the Smiley lab, which analyzed Vhs at later times post infection, 
showed that Vhs’s effect on translation varied between HeLa and Vero cell lines (254). To 
investigate whether this difference could be observed in shutoff of the bicistronic constructs, 
HeLa cells were additionally studied. Results showed that HSV-1 Vhs was not able to decrease 
expression of the C53 and CrPV cistrons (Fig. 53). The C53 renilla and firefly protein expression 
was 128% and 96% in the presence of HSV-1 Vhs, respectively (Fig. 53). In the presence of HSV-1 
Vhs, the CrPV renilla and firefly protein expression was increased to 236% and 152%, 
respectively.  
Conversely, for mRNAs containing the EMCV IRES (C64), HSV-1 Vhs caused a slight 
reduction in the levels of renilla and firefly luciferase protein expression, where their values 
were 73% and 76%, respectively (Fig. 53). HSV-2 Vhs was also not as efficient at protein shutoff 
of the bicistronic constructs in HeLa cell as it was in Vero cells (compare Fig. 52 with Fig. 53). 
HSV-2 Vhs was able to shut off expression of the upstream cistron much more efficiently than 
the downstream (Fig. 53). Specifically, it reduced C53, CrPV, and EMCV renilla luciferase to a 
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  Figure 53.Protein Expression of Bicistronic Constructs in the Presence of HSV-1 or HSV-2 Vhs in HeLa Cells 
HeLa cells were transfected with the plasmid combinations listed on the x-axis. Cells were harvested after 
48 hours and protein levels were measured using a Promega 20/20 GloMAX luminometer. The control 
(pcDNA1.1amp) expression levels of renilla and firefly luciferase were normalized to 1. For the control 
samples, cells were transfected with DNA that did not encode Vhs. Protein levels in the presence of HSV-1 
(pKOSamp) or HSV-2 (p333amp) Vhs were compared to control values using Excel. RLUC=renilla luciferase, 
the upstream codon. FLUC=firefly luciferase, the downstream codon.  
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final percentage of 13.90%, 9.40%, and 22.90%, respectively (Fig. 53). HSV-2 Vhs was not as 
potent at decreasing expression of the downstream cistron, where C53, CrPV, and EMCV levels 
were 71.40%, 79.50%, and 65.80%, respectively (Fig. 53). HSV-1 Vhs did not show a large 
difference in the expression levels of renilla and firefly luciferase. However, addition of HSV-2 
Vhs led to larger variances between the upstream and downstream codons. The expression of 
the downstream cistron was much higher than the upstream for C53 and CrPV, resulting in 
FLUC/RLUC ratios of 5.10 and 8.50, respectively (Fig. 53). Current studies are directed at 
optimizing RNA analysis conditions to understand how the mRNA of these proteins gets 
cleaved by Vhs in both HeLa and Vero lines, in an effort to correlate RNA degradation with 
protein expression. 
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CHAPTER 4 
 
DISCUSSION 
 
 Prior to this dissertation, the role of early events in translation initiation in Vhs mRNA 
cleavage had not been analyzed. Previous studies performed in cell culture had only tested the 
effect of blocking later stages in translation initiation by using cycloheximide to inhibit protein 
synthesis (14). Many mRNAs have previously been studied in the rabbit reticulocyte system, but 
they were primarily used to examine Vhs site-specific cleavage sites in an attempt to determine 
whether Vhs preferred cleaving after a particular nucleotide or if it recognized a sequence of 
bases. This dissertation addresses the following questions: (1) How does Vhs cleavage of pBK2 
mRNA compare with its degradation of other mRNAs? (2) How is Vhs cleavage of mRNA 
affected by inhibitors of translation, mutations in and around the AUG start codon, and insertion 
of stable hairpins in the 5’ UTR? and (3) How do the data lead to a model of Vhs action? 
 
Significance of Vhs Degradation of pBK2 mRNA 
 Studies in the RRL system found that Vhs cleaved pBK2 mRNA at 6 prominent sites, all 
within the first 300 bases from the 5’ cap (Fig. 18). Several of these sites were near or just 
upstream from the first three AUGs from the cap. Most of the cut sites were identified by both 5’ 
cap-labeling and primer extension analysis, further supporting the conclusion that Vhs is an 
endonuclease (Fig. 18 and Fig. 21). Thymidine kinase mRNA had not been tested previously in 
an in vitro RRL system, but its degradation had been studied by Northern blot analysis in HSV-1 
infected Vero cells. (8). Results from these studies indicated that the 5’ end was cleaved more 
rapidly than the 3’ end, suggesting Vhs preferentially targets the 5’ cap (8). Vhs has been shown 
to degrade SRP  (the signal recognition particle receptor alpha) mRNA in vitro at specific sites 
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within the 5’ quadrant of the RNA from bases 200-700 (5). Additional studies by Smiley showed 
that secondary cleavage of the 3’ cleavage product that results from Vhs cutting of an mRNA 
with an EMCV IRES proceeds in a 5’ to 3’ direction (48). The endoribonucleolytic activity was 
concluded to be sequence nonspecific with a slight preference for cleaving between purines (5). 
The results from this dissertation and the previously mentioned experiments support a model 
where Vhs is targeted to the 5’ end of viral and many constitutively expressed cellular mRNAs. 
However, Vhs has been reported to not cleave all mRNAs at the 5’ end (4). According to 
Zelus et al., Vhs cleaves globin γ mRNA at regions near the 3’ UTR, and in these studies Vhs 
appeared to cleave preferentially at AC and CU dinucleotides (4). It has been suggested that Vhs 
cleavage near regions at the 5’ cap is dependent on the type of mRNA studied (45-47). Where it 
was previously believed that all mRNAs had similar sensitivity to Vhs cleavage, more recent 
reports have suggested that Vhs degrades certain mRNAs with different efficiencies (9, 14, 45-47, 
49, 50, 52-54). Roizman has shown that certain mRNAs, such as IEX-1, cox-2, IkB, and c-Fos, 
which contain AU-rich elements (AREs) and have very short half lives appear to be regulated 
differently upon infection (45-47). During infection these mRNAs are deadenylated and then 
cleaved just upstream of the AREs, leaving a stable 5’ product that remains in the cell for an 
extended time prior to degradation (45-47). Since the ARE is located in the 3’ UTR, these data 
support a model where Vhs is targeted to the 3’ end of the transcript. Vhs has been suggested to 
target the 3’ UTR of mRNAs containing AREs by binding the protein tristetraprolin (45, 50). This 
has been built around the findings that TPP protein levels are increased after infection with 
HSV-1 and TPP has been found to associate with Vhs in coimmunoprecipitation assays (45, 50). 
Tristetraprolin is a protein that has an important role in the degradation of some AU-rich 
mRNAs by facilitating their recruitment to the exosome (51, 56, 57).  
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At present, whether or not Vhs cleaves cellular stress-inducible IEX-1 mRNA at its 3’ 
UTR is controversial. Initial studies on HSV-1 regulation of ARE mRNAs suggested that these 
mRNAs were spared from cutting due to ICP27 binding at the ARE (58). Additional studies have 
implicated that the increase in intermediate IEX-1 mRNA products is not due to Vhs cleavage 
but is instead due to HSV-1 infection having an inhibitory effect on the normal turnover of ARE 
mRNAs (5).   
pBK2 mRNA is most likely cleaved at regions near the 5’ end because it has two defining 
characteristics. (1) It is an mRNA that is translated by cap-dependent scanning and (2) It does 
not contain an AU-rich element or other sequence to direct Vhs to its 3’ UTR. Vhs has been 
shown to associate with translation initiation factors eIF4A, eIF4H, eIF4B, and the eIF4F cap 
binding complex (6, 7, 13, 27, 59). siRNA-mediated knockdown experiments have revealed that 
eIF4H and eIF4AI/II are both vital for Vhs degradation of housekeeping mRNAs, while eIF4B is 
not required (28, Agarwal et al. unpublished). Vhs association with these initiation factors may 
be what targets it to the 5’ cap of mRNA, which would provide a clear explanation for why Vhs 
is selective for degrading mRNA opposed to non-messenger RNA.  
Analyzing cut site location can lead to predictions about how the scanning apparatus is 
composed. Currently, varying opinions exist about whether eIF4G, 4A, and 4H are located 
behind or in front of the 40 ribosomal subunit (reviewed in 73). Modeling by cryoelectron 
microscopy predicted that the factors were positioned behind the ribosome so that the ribosome 
would unwind mRNA secondary structure and the factors would serve to ‘ratchet’ mRNA 
through the binding channel using their helicase activity (74). However, an alternative model 
has proposed that eIF4G, 4A, and 4H are positioned in front of the 40S ribosomal subunit and 
are involved in unwinding mRNA secondary structure before it enters the mRNA binding 
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channel (75). Perfoming more detailed experiments on Vhs-induced cleavage of mRNA will aid 
in improving the current understanding of the orientation of the translation initiation scanning 
complex. This is because, if Vhs is found to remain associated with translation initiation factors 
during cutting, then implications can be made about where the factors are located in regards to 
other components that make up the scanning complex.    
Prior to this dissertation, no previous associations had been made between Vhs cleavage 
sites and their proximity to AUG codons. It is uncertain if this mode of cutting is specific for 
pBK2 mRNA and whether additional factors were involved in Vhs cleavage near AUG codons 
such as a pBK2 mRNA secondary structure. If Vhs associates with cellular initiation factors and 
is recruited to the 5’ end, it may remain associated with components at the 5’ cap and travel with 
the scanning complex to reach its cut sites during translation initiation. In this model for Vhs 
cleavage, many factors could have a role in Vhs’s probability of cleavage. It could be that Vhs 
has a higher probability of cleaving mRNA at regions of the transcript that are just upstream of 
mRNA with high degrees of secondary structure. Under this proposal, the scanning complex 
might pause for a longer period of time in order for eIF4A helicase unwinding of secondary 
structure.  The increased time that the complex spends in that region may allow Vhs to have 
enhanced accessibility. Since the 5’ UTR of mRNA often contains a high amount of secondary 
structure, it may be more likely that Vhs cleavage will occur in these locations if it piggybacks on 
the scanning apparatus. The AUG start codon may be an additional factor involved in Vhs 
cleavage. Following this concept, if Vhs is scanning the mRNA transcript with the scanning 
complex, then pausing at the start codon may increase the likelihood of cutting. 
 Vhs cuts pBK2 mRNA at specific sites near the first three AUGs. This lab has previously 
shown that pBK2 mRNA undergoes leaky scanning during in vitro translation in a rabbit 
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reticulocyte lysate system (Karr et al., unpublished). If pBK2 mRNA experiences leaky scanning 
during in vitro translation in a RRL system, then it is possible that Vhs occasionally scans past 
the first or second AUG while associating with the scanning complex to locate some of its 
downstream cleavage sites. On the other hand, the mRNA secondary structure of pBK2 may 
bring sites that are further downstream in the primary sequence close to the 5’ cap. 
Alternatively, the cut sites near the second and third AUG could be produced by methods other 
than scanning in a currently undefined model. It is more likely that this is the case because pBK2 
mutants with mutations in the second AUG did not affect Vhs cleavage of mRNA. It will be 
important to design future experiments directed at analyzing how Vhs cleaves a list of mRNAs 
that undergo cap-dependent scanning and to study whether the length of the 5’ UTR affects Vhs 
cleavage. 
While analyzing the data from the experiments performed for this dissertation, a trend in 
Vhs cleavage after particular nucleotides was not noticed. It is important to point out that these 
studies were not performed with a sequencing marker, so exact cut site locations could not be 
determined. Instead, the cut sites identified are estimated to be within 5 bases of the stated 
position. Results did not indicate that Vhs preferably cut mRNA at a particular sequence. It is 
believed that Vhs cutting, at some cut sites, is influenced by factors that affect migration of the 
scanning complex along the mRNA transcript during translation initiation. In this regard, 
sequence is believed to still have a role in Vhs cleavage of mRNA because it determines mRNA 
secondary structure. The data from previous in vitro studies vary in regards to Vhs cut site 
preference. GST-purified Vhs was demonstrated to have substrate specificity similar to that of 
RNase A, where it preferred cleaving mRNA after C and U bases (10, 11). However, Zelus et al. 
have reported a preference for cleavage between AC and CU dinucleotides, and work by Smiley 
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has indicated that Vhs has a slight preference for cleaving between purines but an overall lax 
sequence specificity (4, 5).  
 
Vhs Mechanism of Cleavage 
 Results obtained from mapping the cut sites of pBK2 mRNA led to studies directed at 
determining whether completion of certain stages of translation initiation is required for Vhs 
cleavage. Data from the first part of the dissertation suggest that Vhs cleavage may be tied to 
translation initiation since Vhs cleaves pBK2 mRNA at regions near the 5’ cap and some of these 
cut sites are near AUG codons. With previous knowledge that Vhs associates with translation 
initiation factors, it was believed that early events of translation initiation might be important for 
Vhs cleavage. The data indicated that protein synthesis was not required for Vhs cleavage of 
pBK2 mRNA in a RRL system, because mRNA degradation levels in the presence of 
cycloheximide were comparable to degradation levels in the absence of cycloheximide (Fig. 24 
and 25). In studies using GMP-PNP to inhibit GTP hydrolysis, it was found that recruitment of 
the large ribosomal subunit was not vital for Vhs cleavage of mRNA, albeit blocking 60S 
ribosomal recruitment had a modest inhibition on Vhs RNase activity (Fig. 26 and 27). These 
findings were in accordance with previous reports in HeLa cells that revealed HSV-1-induced 
RNA cleavage activity separated with the postribosomal fraction (55). Moreover, the 
cycloheximide experiment supported previous studies by Frenkel which showed that inhibiting 
protein synthesis of HeLa cells infected with WT KOS did not hinder Vhs cleavage (14).  
When AMP-PNP was added to reduce recruitment of translation initiation factors to the 
5’ cap and hinder ATP hydrolysis, Vhs cleavage was inhibited (Fig. 28-29). AMP-PNP also 
inhibits scanning of the scanning complex to the start codon (23). When looking more closely at 
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mRNA cleavage, it was found that AMP-PNP inhibited cleavage of the first 150 bases from the 5’ 
cap (Fig. 29). This result was very interesting because it implied that the cut sites further 
downstream from the first 150 bases may have been achieved using an alternative pathway 
other than association with the scanning complex. However, the cutting may be due to the fact 
that AMP-PNP did not completely inhibit Vhs activity. It’s possible that under these conditions 
Vhs was still able to bind some initiation factors (albeit to lesser extent) and associate with the 5’ 
cap but scanning may have been reduced. If this was the case, then perhaps the regions further 
downstream are actually close to the 5’ cap when the RNA is folded, which would explain why 
they are the most prominent cut sites in the presence of AMP-PNP. It’s important to mention 
that the cleavage sites past the first 150 bases of the transcript are also the most prominent cut 
sites produced in the absence of AMP-PNP (Fig. 18 and data not shown from previous studies 
using lower concentrations of Vhs).  
 The nonhydrolyzable ATP analog AMP-PNP hinders translation initiation in two ways. 
It reduces recruitment of translation initiation factors to the 5’ cap, and it inhibits ATP hydrolysis 
to block scanning of the scanning complex to the AUG start codon. Therefore, it remains 
uncertain what events are vital for Vhs cleavage of mRNA. However, it is likely that both kinds 
of inhibition may be involved in Vhs activity. siRNA-mediated knockdown of eIF4AI and 
eIF4AII has shown that they are necessary for Vhs cleavage of GAPDH mRNA (Agarwal et al. 
unpublished). Current work in the lab using hippuristanol, a natural inhibitor of eIF4F and free 
eIF4A found in coral Isis hippuris, suggests that inhibiting eIF4A strongly inhibits Vhs cutting of 
mRNAs (61, Agarwal et al. unpublished). Results from this dissertation have indicated that 
mRNA secondary structure has a role in regulating Vhs cleavage (Fig. 47 and Fig. 48). Since ATP 
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hydrolysis is necessary for unwinding secondary structure to make it accessible for scanning 
during translation initiation, it is believed to be important in Vhs activity.   
One way to determine the stage at which AMP-PNP has an inhibitory effect on Vhs 
activity is to study mRNA degradation in the presence of a trans-dominant R362Q eIF4A mutant. 
R362Q allows recruitment of the protein to the eIF4F cap binding complex, but it disrupts 
cycling of eIF4A through the eIF4F complex and inhibits eIF4F activity (62, 63). This mutant also 
inhibits eIF4F RNA helicase activity, so it prevents binding of the small ribosomal subunit (62). 
However, R362Q does not inhibit eIF4A/eIF4B helicase activity (62). Using a trans-dominant 
mutant would still allow recruitment of initiation factors to the 5’ cap, but it would inhibit later 
stages of translation initiation such as scanning. It would also be advantageous to perform 
similar tests using an mRNA containing the EMCV IRES to see how eIF4A inhibitors affect Vhs 
cleavage.  
 Studies testing the effect of a cap analog on Vhs site-specific cutting revealed that a free 
cap analog hindered Vhs cleavage at the first 80 bases from the pBK2 5’ cap (Fig. 32). The use of 
a cap analog does not completely inhibit translation in a RRL system because not all initiation 
factors can be sequestered from binding mRNA. It is interesting that in the presence of AMP-
PNP Vhs cleavage at the first 150 bases of pBK2 is inhibited (Fig. 29), yet in the presence of cap 
analog cutting is only inhibited before the first 80 bases. It is possible that Vhs is able to cleave 
mRNA at regions further upstream in the presence of cap analog because RNA helicase activity 
hasn’t been disrupted. The ratio between eIF4E and eIF4A in a RRL system has been determined 
to be 1:10 (62). Therefore, once eIF4E is sequestered from the system, there is still plenty of eIF4A 
that Vhs may associate with. It is uncertain if Vhs has the ability to associate with free eIF4A or if 
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it is only able to bind the eIF4F component. It is also unknown if binding free eIF4A would 
target Vhs to regions other than near the 5’ end.  
The results from the cap analog and AMP-PNP experiments indicate that Vhs may use 
more than one method for accessing its mRNA cut sites. In this case cut sites in the first 150 
bases of the sequence may be reached by traveling with the scanning complex, but cut sites 
further downstream may be accessed by alternative methods. The fact that pBK2 mRNA is 
cleaved at sites within the first 300 bases from the 5’ end and that a cap is required to achieve 
this cutting suggests that the 5’ cap is required for Vhs to gain access to the mRNA transcript. It 
is possible that Vhs binding to eIF4H and eIF4AI/II and loading onto the cap is required for Vhs 
cleavage of all mRNAs. After loading at the 5’ cap, Vhs may scan with the scanning complex to 
reach its cut sites or it may be directed to alternative sites by another mechanism (Fig. 54). Some 
of the time Vhs may be redirected to sites further downstream by a mechanism depending on 
the secondary structure of mRNA transcript or by the influence of additional protein factors that 
bind the mRNA transcript. It is not known whether Vhs cleavage of ARE-containing mRNAs 
requires a 5’ cap. It is possible that Vhs must first associate with translation initiation factors to 
target mRNA, and that Vhs then binds TPP and is redirected to the 3’ UTR to cleave the ARE. 
 Vhs appears to require a free 5’ end to access at least some of its cut sites. When pBK2 
RNA was circularized, Vhs was unable to produce the same specific cut sites near the first AUG 
as it did in linear pBK2 RNA (Fig. 34). This suggests that recruitment of initiation factors to the 5’ 
end is important for Vhs cleavage, because initiation factors cannot bind RNA at the 5’ end when 
it is circularized. The fact that Vhs was able to specifically cleave circularized EMCV RNA 
further supported the idea that Vhs associates with components of the translational apparatus to 
cleave mRNA that undergoes cap-dependent scanning.  
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 The experiments with mutant pBK2 mRNAs containing mutations in or near the first 
AUG shed light on Vhs association with the scanning complex. Unwinding of mRNA secondary 
structure in the 5’ UTR and traveling of the small ribosomal subunit along mRNA are the two  
connected processes of scanning. eIF1 and eIF1A are both required for this process, because 
they’re believed to induce a conformation conducive for 43S scanning (64, 65). eIF4A, eIF4G, and 
eIF4B and ATP are also required for scanning, and the amount of ATP and eIF4A needed for this 
process correlates with the amount of secondary structure in the 5’ UTR (64, 66, 67).  
Previous reports had never tested the effect of mutating AUG codons on Vhs cleavage. 
After observing that blocking early stages of translation initiation had an inhibitory effect on Vhs 
activity, it was predicted that mutating the AUG codon would also change Vhs site-specific 
cutting. Mutating the first AUG to a non-AUG sequence hindered Vhs site-specific cleavage in 
that area, however Vhs still cleaved mRNA at the same specific sites in other regions of the 
transcript (Fig. 38).  
This was the first study to show that mutating sequences in substrate mRNA changes 
Vhs site-specific cleavage. The data are consistent with a model in which Vhs cutting near the 
start codon is due to Vhs association with the translation scanning apparatus, and that when the 
sequence is converted to a non-AUG, the complex scans past the area and Vhs is no longer able 
to cleave the mRNA in that region. Furthermore, mutating bases surrounding the AUG to make 
it an optimal AUG resulted in increased cleavage at regions upstream (Fig. 39). This outcome 
also correlates with Vhs usage of the scanning complex to reach its cut sites. However, it is 
unknown how these mutations change the secondary structure of the RNA. It is possible that 
mutating the sequence will change the secondary structure and that this might have an effect on 
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cleavage. The secondary structures of both sequences were analyzed using mFOLD, and they 
were predicted to have the same RNA configuration. Additionally, mutating the second AUG to 
a non-AUG did not affect Vhs’s ability to produce the same site-specific cleavage products (Fig. 
40). When comparing the protein products of the various RNA constructs, it is apparent that the 
predominant protein synthesized from wild type pBK2 mRNA corresponds to translation from 
the first AUG (Fig. 41). Therefore, mutating the second AUG did not hinder protein synthesis, 
and it seems probable that this is why Vhs site-specific cleavage was unaffected. This finding 
suggests that the cut sites near the second AUG are not due to leaky scanning, and instead Vhs 
may be using another mechanism to reach the cut sites further downstream. Mutating the first 
AUG to a non-AUG caused the scanning complex to scan past the region and initiate synthesis at 
the second AUG. It is believed that the cut sites at other locations were still produced because 
the sequence surrounding the first AUG was identical to wild type pBK2. The data indicate that 
Vhs travels with the scanning complex to reach at least some of its cut sites.  
CrPV and EMCV RNA were studied to get a better idea of how Vhs targets mRNA. 
Earlier studies by the Smiley lab revealed that Vhs can cleave EMCV mRNA just downstream of 
its IRES and that the T214I point mutant retains this ability (1, 2, 3). Since Vhs-1 lacks the ability 
to associate with eIF4H, it seems that Vhs may be associating with another cellular initiation 
factor. It was previously shown that eIF4B is not vital for Vhs degradation of GAPDH mRNA in 
HeLa cells, so it was speculated that it also would not be essential for mRNA cleavage in vitro 
(28). So far, Vhs has been shown to associate with eIF4H, eIF4A, eIF4B, and the eIF4F cap 
binding complex (6, 7, 13, 27, 29). Consistent with the hypothesis that Vhs association with 
initiation factors targets it to mRNA, RRL, eIF4H, and eIF4B were shown to stimulate Vhs 
expressed in yeast Saccharomyces cerevisiae (12, 27). However, only addition of RRL restored 
 
 
149 
 
targeting downstream of an EMCV IRES, suggesting that an additional mammalian factor (other 
than eIF4B and eIF4H) was involved in targeting (27).  
If Vhs targeting downstream of an IRES was due to association with a cellular translation 
factor, then a good candidate would be eIF4A. An indirect method for testing this was to study 
two viral IRESs that had different requirements for eIF4A. The EMCV IRES does not require cap-
binding protein eIF4E, but it does require eIF2, eIF3, eIF4A and the central third of eIF4G for 
eIF4A binding (23, 70). No scanning is involved, and the large 60 S ribosomal subunit binds 
directly to the AUG located just 3’ of the IRES (68, 69). The CrPV IRES does not utilize eIF4A nor 
any initiation factors for protein synthesis, and instead the 40S ribosomal subunit binds to a 
pseudo-tRNA-like structure of the IRES (71). Vhs was able to target cleavage downstream of the 
EMCV IRES, but it was not able to specifically cleave downstream of the CrPV IRES (Fig. 44 and 
Fig. 45). This suggests that a factor involved in EMCV translation initiation plays a role in Vhs 
targeting to that IRES. It is still uncertain whether or not this factor is eIF4A, but future studies 
will investigate this by using eIF4A inhibitors.  
The fact that AMP-PNP inhibited Vhs targeting downstream of the EMCV IRES makes it 
a strong possibility that eIF4A is involved in cutting. It was also observed that Vhs cut EMCV 
RNA at regions near the 5’ end (Fig. 45). These cut sites may be produced by Vhs cap-dependent 
scanning in the in vitro system. Vhs has been suggested to use cap-dependent and cap-
independent methods for mRNA cleavage, and Vhs-1 has been speculated to only inhibit Vhs 
cap-dependent cleavage (28). It would be interesting to investigate whether the T214I point 
mutant is hindered from producing these 5’ cleavage products. The fact that Vhs cleaves at a 
specific location downstream of the EMCV IRES could be a result of the effect of a high amount 
of secondary structure in that RNA or it could be through the possible involvement of initiation 
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factors in targeting to the transcript. In this dissertation, results revealed that Vhs did not cut 
downstream of the CrPV IRES, suggesting that association with initiation factors may be what’s 
driving Vhs cleavage downstream of the EMCV IRES. 
 In summary, the data point to a model for Vhs cleavage that involves utilizing 
components of the translation initiation apparatus to reach cuts sites within the first 150 bases of 
the sequence. Targeting to the 5’ end may be achieved by binding initiation factors that are 
recruited to the cap during protein synthesis (Fig. 54). The 5’ cap is vital for site-specific 
cleavage, indicating the importance of the cap in recruitment of Vhs to the 5’ end to produce 
cleavage products within the first 300 bases of the transcript. Later stages of translation initiation 
such as binding of the large ribosomal subunit and protein synthesis are not required for Vhs 
cleavage. A free 5’ end is necessary for Vhs to produce specific cut sites, suggesting that 
initiation factors are important for Vhs selectivity.  
Our observations that mutations of AUG codons or their surrounding bases affect Vhs 
cutting support a model where Vhs piggybacks on the scanning complex to reach some of its cut 
sites (Fig. 54). However, Vhs appears to use an additional method for cleavage in the rabbit 
reticulocyte system, because it is still able to produce cut sites downstream of 150 bases in the 
presence of drugs that block early stages of translation initiation. It will be interesting to 
determine if Vhs cuts at these same sites in vivo. Possible alternative methods for Vhs cleavage 
may involve the mRNA secondary structure or proteins that bind the template and redirect Vhs 
to cut mRNA in a manner independent of the scanning process. It is still unclear how long Vhs 
remains associated with the mRNA transcript after cleavage. It has been suggested that Vhs may 
dissociate from mRNA after a single cut, and the remaining template may be degraded by 
cellular nucleases (4, 55, 72).  
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Figure 54.Model of Vhs Cleavage of mRNA 
Figure 54 shows a cartoon model of how Vhs may reach its mRNA cut sites. In step one Vhs 
binds eukaryotic translation initiation factors eIF4AI/II and eIF4H. In step two this binding 
targets Vhs to the 5’ end of the transcript. Part three shows that, once Vhs reaches the 5’ cap, it 
cleaves mRNA by scanning with the scanning complex. Vhs also uses alternative mechanisms for 
reaching its cut sites. An alternative mechanism may involve mRNA secondary structure or 
structural proteins that bind the mRNA template.  
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Vhs Cleavage of mRNA Containing Hairpins 
 Hairpins located close to the 5’ cap have an inhibitory effect on cap-dependent scanning. 
Stable hairpins were studied as an alternative way to block early events in translation initiation. 
Placing a hairpin one nucleotide downstream from the 5’ cap inhibited synthesis of thymidine 
kinase, and it strongly reduced Vhs site-specific cleavage at regions further downstream (Fig. 
47). From these results it appears that blocking the scanning process hinders Vhs’s ability to 
travel along the mRNA transcript and access RNA cut sites. The mRNA construct contained a 
stretch of 8 CAA repeats following the hairpin, and this is where Vhs cleaved the mRNA (Fig. 
47). It is possible that the CAA region is much closer to the 5’ cap than it appears since it follows 
right after the stem-loop hairpin which projects out from the cap.  It could be that having a 
region with no predicted secondary structure increases the likelihood of Vhs cutting in that area. 
The control CAA sequence results support this idea because in the presence of a stretch of 19 
CAA repeats one nucleotide downstream from the cap, Vhs produced a ladder of evenly spaced 
bands, where it appeared to cut the sequence after every C of the CAA stretch. This supports 
previous reports by Roizman that Vhs cleaves after C and U bases (10). Cleavage was strongest 
at the very end of the CAA stretch and at the very beginning of the pBK2 sequence. One 
possibility could be that the scanning complex travels through the CAA repeat region with ease 
but pauses for an extended amount of time once it reaches the pBK2 sequence which contains a 
higher degree of secondary structure.  
 Inserting a hairpin +7 or +13 bases downstream from the 5’cap restored Vhs cleavage at 
sites further downstream. It is still uncertain the effect of the +7 and +13 constructs on 
translation. It also is unclear whether cutting was restored to sites further downstream due to 
restoration of scanning or due to the absence of a CAA region at the 5’ end. Vhs did produce a 
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faint cut site immediately following the +7 hairpin construct. Similar results were obtained with 
the transcript that contained a hairpin one nucleotide downstream from the cap with a CAA 
repeat following the hairpin structure. However, Vhs did not specifically cleave the +13 
construct after its hairpin. It’s uncertain whether this is because the hairpin was at a greater 
distance from the 5’ cap. Previous reports from in vitro studies have shown that hairpins located 
in the first 12 bases from the 5’ cap have an inhibitory effect on translation, while a hairpin 
positioned 52 bases downstream from the cap did not (34). If this is the case, then perhaps it 
explains why Vhs targets downstream immediately after the +7 hairpin but not the +13 hairpin. 
If scanning is hindered in the +7 construct, then maybe Vhs docking at the 5’ cap keeps it in close 
proximity to the +7 hairpin, permitting cleavage. Current studies are testing the importance of 
the CAA unpredicted structure sequence in more depth.  
 
Significance of Vhs Cleavage of Cyr61 mRNA 
 HSV-1 infection stabilized Cyr61 mRNA. In endothelial and fibroblast cells (in the 
absence of infection) Cyr61 mRNA levels are regulated very rapidly in the cell because this 
transcript is involved in survival, adhesion, ion-transport, cell division, and motility (40, 41, 42, 
76, 77, 78). Its 3’ UTR contains an AU-rich element believed to be important for rapid mRNA 
turnover (78). It is speculated that Vhs stabilization of Cyr61 may be regulated by Vhs 
association with factors involved in ARE mRNA-mediated decay. Vhs was previously reported 
to stabilize the 5’ cleavage product of another ARE-containing cellular mRNA, IEX-1, through 
binding TPP (50, 79). TPP is involved in regulating the degradation of ARE-containing mRNAs 
(50, 56, 57, 79). It was found to first cleave IEX-1 at its ARE, followed by stabilization of the 5’ 
cleavage product (46, 47, 49). Therefore, it is suggested that Vhs may associate with TPP to 
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stabilize Cyr61 mRNA. It is possible that this mRNA may still be cleaved in its 3’ UTR, because, 
in my experiments, the probe used for Real Time PCR bound to a region upstream of the ARE. 
These findings support previous reports by Roizman that Vhs shows selectivity when degrading 
cellular mRNAs that contain an AU-rich element (46, 47, 49, 50, 79). If in fact Vhs does 
specifically cleave Cyr61 mRNA at its 3’ ARE, then this will have a large impact on cell signaling 
and show one more way that Vhs shuts off important pathways involved in biogenesis and cell 
longevity.  
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